<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Tranexamic acid for preventing postpartum haemorrhage after caesarean section - Rohwer, C - 2024 | Cochrane Library</title> <meta content="Tranexamic acid for preventing postpartum haemorrhage after caesarean section - Rohwer, C - 2024 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD016278/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Tranexamic acid for preventing postpartum haemorrhage after caesarean section - Rohwer, C - 2024 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD016278/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD016278" name="dc.identifier" scheme="DOI"/> <meta content="Tranexamic acid for preventing postpartum haemorrhage after caesarean section" name="citation_title"/> <meta content="Christa Rohwer" name="citation_author"/> <meta content="Stellenbosch University" name="citation_author_institution"/> <meta content="rohwerchrista@gmail.com" name="citation_author_email"/> <meta content="Anke Rohwer" name="citation_author"/> <meta content="Stellenbosch University" name="citation_author_institution"/> <meta content="Catherine Cluver" name="citation_author"/> <meta content="Stellenbosch University" name="citation_author_institution"/> <meta content="Katharine Ker" name="citation_author"/> <meta content="London School of Hygiene &amp; Tropical Medicine" name="citation_author_institution"/> <meta content="G Justus Hofmeyr" name="citation_author"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="11" name="citation_issue"/> <meta content="10.1002/14651858.CD016278" name="citation_doi"/> <meta content="2024" name="citation_date"/> <meta content="2024/11/13" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD016278/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD016278/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD016278/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="*Antifibrinolytic Agents [therapeutic use]; Bias; Blood Transfusion [statistics &amp; numerical data]; *Cesarean Section [adverse effects]; Oxytocics [adverse effects, therapeutic use]; Oxytocin [adverse effects, therapeutic use]; *Postpartum Hemorrhage [prevention &amp; control]; Randomized Controlled Trials as Topic; *Tranexamic Acid [therapeutic use]" name="citation_keywords"/> <meta content="" name="citation_fulltext_world_readable"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD016278&amp;doi=10.1002/14651858.CD016278&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD016278&amp;doi=10.1002/14651858.CD016278&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD016278&amp;doi=10.1002/14651858.CD016278&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD016278&amp;doi=10.1002/14651858.CD016278&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD016278&amp;doi=10.1002/14651858.CD016278&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD016278&amp;doi=10.1002/14651858.CD016278&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD016278&amp;doi=10.1002/14651858.CD016278&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD016278&amp;doi=10.1002/14651858.CD016278&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD016278&amp;doi=10.1002/14651858.CD016278&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD016278&amp;doi=10.1002/14651858.CD016278&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD016278&amp;doi=10.1002/14651858.CD016278&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD016278&amp;doi=10.1002/14651858.CD016278&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD016278&amp;doi=10.1002/14651858.CD016278&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD016278&amp;doi=10.1002/14651858.CD016278&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD016278&amp;doi=10.1002/14651858.CD016278&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD016278&amp;doi=10.1002/14651858.CD016278&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD016278&amp;doi=10.1002/14651858.CD016278&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD016278&amp;doi=10.1002/14651858.CD016278&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD016278&amp;doi=10.1002/14651858.CD016278&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD016278&amp;doi=10.1002/14651858.CD016278&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD016278&amp;doi=10.1002/14651858.CD016278&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD016278&amp;doi=10.1002/14651858.CD016278&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD016278&amp;doi=10.1002/14651858.CD016278&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="6nHUP32m";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD016278\x26doi\x3d10\x2e1002\x2f14651858\x2eCD016278\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD016278\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD016278\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","de","zh_HANT","ru","fa","fr"],languageCode:"en",accessStatus:"open-access",doi:"10.1002/14651858.CD016278",title:"Tranexamic acid for preventing postpartum haemorrhage after caesarean section",firstPublishedDate:"Nov 13, 2024 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Central Editorial Service",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=6nHUP32m&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD016278&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD016278';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD016278/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD016278/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD016278%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD016278/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD016278/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD016278/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD016278/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD016278" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Zusammenfassung in einfacher Sprache&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;淺顯易懂的口語結論&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;nrfreferences&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD016278/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD016278" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD016278/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD016278/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>5549 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD016278" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD016278/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD016278/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD016278/full#CD016278-abs-0002"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD016278/full#CD016278-sec-0114"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD016278/full#CD016278-sec-0013"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD016278/full#CD016278-sec-0014"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD016278/full#CD016278-sec-0018"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD016278/full#CD016278-sec-0019"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD016278/full#CD016278-sec-0060"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD016278/full#CD016278-sec-0108"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD016278/#"> Figures and tables </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD016278/full#CD016278-bibl-0001"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD016278/supplementarymaterials#searchstrategies"> Search strategies </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD016278/supplementarymaterials#characteristicsofstudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD016278/supplementarymaterials#analyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD016278/media/CDSR/CD016278/supinfo/CD016278-SUP-07-dataPackage.zip"> <a href="/cdsr/doi/10.1002/14651858.CD016278/media/CDSR/CD016278/supinfo/CD016278-SUP-07-dataPackage.zip"> Download data </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD016278/supplementarymaterials#othersupplementarymaterials"> Other supplementary materials </a> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD016278/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD016278/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD016278/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD016278/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD016278/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD016278/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2025 The Authors. Cochrane Database of Systematic Reviews published by John Wiley &amp; Sons, Ltd. on behalf of The Cochrane Collaboration." data-creative-commons="true" href="/cdsr/doi/10.1002/14651858.CD016278/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Tranexamic acid for preventing postpartum haemorrhage after caesarean section</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD016278/information#CD016278-cr-0004"><i class="icon corresponding-author fa fa-envelope"></i>Christa Rohwer</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD016278/information#CD016278-cr-0005">Anke Rohwer</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD016278/information#CD016278-cr-0006">Catherine Cluver</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD016278/information#CD016278-cr-0007">Katharine Ker</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD016278/information#CD016278-cr-0008">G Justus Hofmeyr</a></li> </ul> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 13 November 2024 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD016278/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD016278">https://doi.org/10.1002/14651858.CD016278</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD016278-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD016278-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD016278-abs-0010">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD016278-abs-0006">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD016278-abs-0008">Français</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD016278-abs-0001" lang="en"> <section id="CD016278-sec-0001"> <h3 class="title" id="CD016278-sec-0001">Rationale</h3> <p>Postpartum haemorrhage (PPH) is common and potentially life‐threatening. The antifibrinolytic drug tranexamic acid (TXA) is recommended for treating PPH; it reduces the risk of death from haemorrhage by one‐third when given soon after bleeding onset, but not overall risk of death. Interest in whether TXA may be effective in preventing PPH is growing. Evidence indicates that TXA given more than three hours after injury to bleeding trauma patients increases mortality. Potential harm becomes critical in prophylactic use of TXA. Reliable evidence of the effect and safety profile of TXA is required before widespread prophylactic use can be considered. </p> </section> <section id="CD016278-sec-0002"> <h3 class="title" id="CD016278-sec-0002">Objectives</h3> <p>To assess the effects of TXA for preventing PPH compared to placebo or no treatment (with or without uterotonic co‐treatment) in women during caesarean birth. </p> </section> <section id="CD016278-sec-0003"> <h3 class="title" id="CD016278-sec-0003">Search methods</h3> <p>We searched CENTRAL, MEDLINE, Embase, and WHO ICTRP to 20 February 2024 and searched reference lists of retrieved studies. </p> </section> <section id="CD016278-sec-0004"> <h3 class="title" id="CD016278-sec-0004">Eligibility criteria</h3> <p>We included randomised controlled trials (RCTs) evaluating the use of TXA alone or plus uterotonics during caesarean birth for preventing PPH. Trials needed to be prospectively registered (i.e. before starting recruitment). We applied a trustworthiness checklist. </p> </section> <section id="CD016278-sec-0005"> <h3 class="title" id="CD016278-sec-0005">Outcomes</h3> <p>The critical outcome was blood loss ≥ 1000 mL, measured using estimated or calculated methods. </p> <p>Important outcomes included maternal death, severe morbidity, blood transfusion, the use of additional surgical interventions to control PPH, thromboembolic events, use of additional uterotonics, hysterectomy, maternal satisfaction, and breastfeeding at discharge. </p> </section> <section id="CD016278-sec-0006"> <h3 class="title" id="CD016278-sec-0006">Risk of bias</h3> <p>We assessed risk of bias in the included studies using Cochrane's RoB 1 tool.</p> </section> <section id="CD016278-sec-0007"> <h3 class="title" id="CD016278-sec-0007">Synthesis methods</h3> <p>Two review authors independently selected trials, extracted data, and assessed risk of bias and trial trustworthiness. We pooled data using random‐effects meta‐analysis. We assessed the certainty of the evidence using GRADE. </p> </section> <section id="CD016278-sec-0008"> <h3 class="title" id="CD016278-sec-0008">Included studies</h3> <p>We included six RCTs with 15,981 participants. All 12 trials in the previous version of this review were not included after review of trial registrations and trustworthiness checklists. Most included studies involved women at low risk of PPH and were conducted in high‐resource settings. </p> </section> <section id="CD016278-sec-0009"> <h3 class="title" id="CD016278-sec-0009">Synthesis of results</h3> <p><b>Prophylactic TXA in addition to standard care compared to placebo in addition to standard care or standard care alone</b> </p> <p>TXA results in little to no difference in estimated blood loss ≥ 1000 mL (risk ratio (RR) 0.94, 95% confidence interval (CI) 0.79 to 1.11; 4 RCTs; n = 13,042; high certainty evidence), resulting in 8 fewer per 1000 women having estimated blood loss ≥ 1000 mL (from 30 fewer to 16 more). TXA likely results in a slight reduction in calculated blood loss ≥ 1000 mL (RR 0.83, 95% CI 0.76 to 0.92; 2 RCTs; n = 4327; moderate certainty evidence), resulting in 53 fewer per 1000 having calculated blood loss ≥ 1000 mL (from 75 fewer to 25 fewer). </p> <p>The evidence is very uncertain about the effect of TXA on maternal death (one event in placebo group, none in TXA group). No trials measured severe morbidity. </p> <p>TXA likely results in little to no difference in blood transfusion (RR 0.88, 95% CI 0.72 to 1.08; 5 RCTs; n = 15,740; moderate certainty evidence), resulting in 4 fewer per 1000 women requiring a blood transfusion (from 10 fewer to 3 more). </p> <p>TXA results in little to no difference in additional surgical interventions to control PPH (RR 1.02, 95% CI 0.86 to 1.22; 4 RCTs; n = 15,631; high certainty evidence), resulting in 1 more per 1000 women requiring additional surgical intervention (from 4 fewer to 7 more). </p> <p>The evidence is very uncertain about the effect of TXA on thromboembolic events (RR 1.40, 95% CI 0.22 to 8.90; 4 RCTs; n = 14,480; very low certainty evidence), resulting in 1 more per 1000 women having a thromboembolic event (from 2 fewer to 17 more). </p> <p>TXA results in little to no difference in the need for additional uterotonics (RR 0.88, 95% CI 0.78 to 1.00; 4 RCTs; n = 15,728; high certainty evidence), resulting in 15 fewer per 1000 women requiring additional uterotonics (from 27 fewer to 0 fewer). </p> <p>The evidence is very uncertain about the effect of TXA on hysterectomy (RR 0.80, 95% CI 0.20 to 3.29; 2 RCTs; n = 4546; very low certainty evidence), resulting in 3 fewer per 10,000 women requiring a hysterectomy (from 11 fewer to 31 more). </p> <p>One trial measuring maternal satisfaction reported no difference between groups at day two postpartum. </p> <p>No data were available on breastfeeding.</p> <p>Overall, studies had low risk of bias. We downgraded the certainty of evidence mainly for imprecision. </p> </section> <section id="CD016278-sec-0010"> <h3 class="title" id="CD016278-sec-0010">Authors' conclusions</h3> <p>Prophylactic TXA in addition to standard care during caesarean birth results in little to no difference in estimated blood loss ≥ 1000 mL and likely results in a slight reduction in calculated blood loss ≥ 1000 mL compared to placebo. </p> <p>There were no data for severe morbidity due to PPH. Event rates for further interventions to control PPH were low and similar across groups. Prophylactic TXA thus results in little to no difference between groups for additional surgical interventions (32 versus 31 per 1000), and likely results in little to no difference between groups for blood transfusions (31 versus 36 per 1000) and use of additional uterotonics (107 versus 121 per 1000). </p> <p>There were very few events for the outcomes maternal death (1 in placebo group), thromboembolic events (2 versus 3 per 1000), and hysterectomy (1 per 1000 in each group). Evidence for these serious adverse events is therefore very uncertain. </p> <p>Decisions about implementing routine prophylactic TXA during caesarean birth should not only consider outcomes related to blood loss, but also the relatively low rates of PPH morbidity and uncertainty of serious adverse events. </p> <p>Most studies included women at low risk of PPH, thereby precluding any conclusions about women at high risk of PPH. </p> <p>Cost associated with routine use of an additional drug for all caesarean births needs to be considered. </p> </section> <section id="CD016278-sec-0011"> <h3 class="title" id="CD016278-sec-0011">Funding</h3> <p>This Cochrane review was funded in part by the World Health Organization.</p> </section> <section id="CD016278-sec-0012"> <h3 class="title" id="CD016278-sec-0012">Registration</h3> <p>The published protocol and updates to the review can be accessed:</p> <p>Protocol (2009) DOI: 10.1002/14651858.CD007872</p> <p>Original Review (2010) DOI: 10.1002/14651858.CD007872.pub2</p> <p>Review Update (2015) DOI: 10.1002/14651858.CD007872.pub3.</p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD016278-abs-0002" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD016278-abs-0002">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD016278-abs-0003">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD016278-abs-0011">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD016278-abs-0007">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD016278-abs-0009">Français</a> </li> <li class="section-language"> <a class="" href="full/ru#CD016278-abs-0005">Русский</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD016278-abs-0004">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD016278-abs-0002" lang="en"> <h3>What are the benefits and risks of tranexamic acid for preventing heavy bleeding after caesarean births? </h3> <p><b>Key messages</b> </p> <p> <ul id="CD016278-list-0001"> <li> <p>The clotting medicine tranexamic acid (TXA) given during caesarean birth does not prevent heavy bleeding when blood loss is measured by collecting blood and weighing surgical sponges, or when health providers estimate the amount of blood loss. When blood loss is calculated using the proportion of red blood cells in blood before and after the caesarean birth, there is likely a slight reduction in heavy bleeding. </p> </li> <li> <p>TXA probably does not make a difference in the number of women who need further treatment to control heavy bleeding. </p> </li> <li> <p>The effect of TXA on harmful effects is uncertain.</p> </li> </ul> </p> <p><b>What is the issue?</b> </p> <p>Heavy bleeding after giving birth (postpartum haemorrhage) is a common and sometimes life‐threatening complication of birth. Most women receive drugs that stimulate the womb to contract (uterotonics) after vaginal or caesarean birth to prevent postpartum haemorrhage. Tranexamic acid (TXA) is a medication used to decrease blood loss in surgery and health conditions associated with increased bleeding. It works by helping to prevent the breakdown of blood clots. If a woman is bleeding heavily after birth, it decreases blood loss. We do not know if TXA can help prevent heavy bleeding after caesarean birth. </p> <p><b>What did we want to find out?</b> </p> <p>We wanted to know if fewer women receiving TXA at the time of surgery had heavy bleeding after a caesarean section. We also wanted to find out if receiving TXA during surgery was associated with any harmful effects. </p> <p><b>What did we do?</b> </p> <p>We searched for and selected all studies that addressed this question. We used a checklist to make sure we only included studies that we could trust. We made judgements about the quality of the studies before comparing and summarising the results of the studies. Lastly, we rated our confidence in the findings. </p> <p><b>Why is this important?</b> </p> <p>We need to find out whether TXA is effective in preventing heavy bleeding after birth when given to women at the time of a caesarean birth. If TXA works, it could reduce excessive blood loss, the use of further treatment, and possibly complications from heavy bleeding and death. </p> <p><b>What did we find?</b> </p> <p>We identified six studies with a total of 15,981 women that looked at the effects of preventive TXA. We found that TXA results in little to no difference in heavy bleeding after birth when blood loss is measured by collecting blood and weighing surgical sponges, or when health providers estimated the amount of blood loss, compared to placebo (dummy treatment). TXA likely results in a slight reduction of heavy bleeding when blood loss is calculated using the proportion of red blood cells in the blood before and after the caesarean birth. We are very uncertain about the effect of TXA on maternal death, and there is no evidence on the effect of TXA on women developing serious illness. </p> <p>It is likely that TXA has no effect on the need to receive a blood transfusion, and makes no difference to whether a women needs further surgical treatment. We are very uncertain about the effect of TXA on blood clots. TXA results in little to no difference to whether women require additional drugs to help the womb contract, and we are very uncertain about the effect of TXA on the need for surgical removal of the womb. There does not seem to be a difference between groups in maternal satisfaction, and there is no evidence on the effects of TXA on breastfeeding. </p> <p><b>What are the limitations of the evidence?</b> </p> <p>Most studies included women at low risk of heavy bleeding after birth, preventing any conclusions about women at high risk of heavy bleeding after birth. Across trials, few women experienced harmful effects; however, we cannot be certain that this is the case in the real world. </p> <p><b>What does this mean?</b> </p> <p>We found little to no difference in the number of women experiencing heavy bleeding after birth after they were given TXA preventatively during caesarean birth, and we are very uncertain about the effect of TXA on death, blood clots, and surgical removal of the womb. As these are harmful effects, health providers should take the benefit and the potential harms into account when considering routine treatment with TXA of women during caesarean birth. </p> <p>There does not seem to be a difference in the number of women needing additional treatment for heavy bleeding after receiving TXA. </p> <p>Giving every women who gives caesarean birth TXA preventatively during birth is a serious decision with many implications. We need to weigh up blood loss outcomes, as well as the relatively low rates of serious illness after postpartum haemorrhage and uncertainty regarding serious unwanted effects. </p> <p><b>How up‐to‐date is this evidence?</b> </p> <p>The evidence is current to 20 February 2024.</p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD016278-sec-0114" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD016278-sec-0114"></div> <section id="CD016278-sec-0115"> <h3 class="title" id="CD016278-sec-0115">Implications for practice</h3> <p>Prophylactic tranexamic acid (TXA) in addition to standard care during caesarean birth results in little to no difference in estimated blood loss ≥ 1000 mL and likely results in a slight reduction in calculated blood loss ≥ 1000 mL when compared to placebo. </p> <p>There were no data for severe morbidity due to postpartum haemorrhage (PPH). Event rates for further interventions to control PPH were low and similar across groups. Prophylactic TXA thus results in little to no difference between groups for additional surgical interventions (32 versus 31 per 1000), and likely results in little to no difference between groups for blood transfusions (31 versus 36 per 1000) and use of additional uterotonics (107 versus 121 per 1000). </p> <p>There were very few events for the outcomes maternal death (1 event in the placebo group), thromboembolic events (2 versus 3 per 1000), and hysterectomy (1 per 1000 in each group). The evidence for these serious adverse events is therefore very uncertain. </p> <p>Decisions about implementing routine prophylactic TXA during caesarean birth should not only consider outcomes related to blood loss, but also the relatively low rates of PPH morbidity and uncertainty of serious adverse events. </p> <p>Most studies included women at low risk of PPH, therefore we could draw no conclusions about women at high risk of PPH. </p> <p>The cost associated with routine use of an additional drug for all caesarean births should also be taken into consideration. </p> <section id="CD016278-sec-0116"> <h4 class="title">Equity‐related implications for practice</h4> <p>Although TXA is not a very expensive drug, in resource‐constrained settings any additional intervention used routinely at all caesarean births will impact available expenditure on other services. </p> </section> </section> <section id="CD016278-sec-0117"> <h3 class="title" id="CD016278-sec-0117">Implications for research</h3> <p>Further randomised controlled trials (RCTs) on the effectiveness of TXA to prevent PPH after caesarean birth should focus on women at high risk of PPH. There is also a need for RCTs on other interventions to prevent PPH after caesarean birth. Researchers should ensure that they use sound methods and the core outcome set for PPH when conducting RCTs. </p> <p>Further research on the methods of measuring blood loss after caesarean birth may be required to determine a gold standard method. </p> <p>Further research is also required to investigate strategies to reduce the risk of drug error deaths from inadvertent spinal administration of TXA. </p> <section id="CD016278-sec-0118"> <h4 class="title">Equity‐related implications for research</h4> <p>Research should be relevant to the needs of individuals in low‐ and middle‐income countries, where the burden of mortality from haemorrhage is greatest. </p> </section> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD016278-sec-0013" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD016278-sec-0013"></div> <div class="table" id="CD016278-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Summary of findings table ‐ Prophylactic tranexamic acid in addition to standard care compared to placebo with standard care or standard care alone in women having caesarean births</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Prophylactic tranexamic acid in addition to standard care compared to placebo with standard care or standard care alone in women having caesarean births</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> women having caesarean births<br/><b>Setting:</b> hospitals (mainly in high‐resource settings)<br/><b>Intervention:</b> prophylactic tranexamic acid in addition to standard care<br/><b>Comparison:</b> placebo with standard care or standard care alone </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p>Outcomes</p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p>Anticipated absolute effects<sup>*</sup> (95% CI) </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p>Relative effect<br/>(95% CI) </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p>№ of participants<br/>(studies) </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p>Certainty of the evidence<br/>(GRADE) </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p>Comments</p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p>Risk with placebo with standard care or standard care alone</p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p>Risk with prophylactic tranexamic acid in addition to standard care</p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Estimated blood loss ≥ 1000 mL ‐ total</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>142 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>133 per 1000</b><br/>(112 to 157) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.94</b><br/>(0.79 to 1.11) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13042<br/>(4 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/>High </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Prophylactic tranexamic acid in addition to standard care results in little to no difference in estimated blood loss ≥ 1000 mL. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Calculated blood loss ≥ 1000 mL</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>312 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>259 per 1000</b><br/>(237 to 287) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.83</b><br/>(0.76 to 0.92) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4327<br/>(2 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/>Moderate<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Prophylactic tranexamic acid in addition to standard care likely results in a slight reduction in calculated blood loss ≥ 1000 mL. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Maternal death</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>1 per 10,000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>0 per 10,000</b><br/>(0 to 10) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.33</b><br/>(0.01 to 8.10) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15858<br/>(6 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>Very low<sup>b,</sup><sup>c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The evidence is very uncertain about the effect of tranexamic acid on maternal death. Our findings are based on one event in one trial. Five other trials that measured this outcome reported no deaths in either study arm. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Severe morbidity</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Not pooled</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Not pooled</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not pooled</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(0 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No studies measured this outcome.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Blood transfusion</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>36 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>31 per 1000</b><br/>(26 to 38) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.88</b><br/>(0.72 to 1.08) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15740<br/>(5 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/>Moderate<sup>b,</sup><sup>d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Tranexamic acid likely results in little to no difference in blood transfusion.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Receipt of surgical interventions to control PPH</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>31 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>31 per 1000</b><br/>(27 to 38) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.02</b><br/>(0.86 to 1.22) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15631<br/>(4 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/>High<sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Tranexamic acid results in little to no difference in use of surgical interventions to control postpartum haemorrhage. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Thromboembolic events</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>2 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>3 per 1000</b><br/>(0 to 19) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.40</b><br/>(0.22 to 8.90) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>14480<br/>(4 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>Very low<sup>e,</sup><sup>f</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The evidence is very uncertain about the effect of tranexamic acid on thromboembolic events. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Receipt of additional uterotonics</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>121 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>107 per 1000</b><br/>(95 to 121) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.88</b><br/>(0.78 to 1.00) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15728<br/>(4 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/>High </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Tranexamic acid results in little to no difference in receipt of additional uterotonics.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hysterectomy</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>13 per 10,000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>11 per 10,000</b><br/>(3 to 44) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.80</b><br/>(0.20 to 3.29) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4546<br/>(2 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>Very low<sup>g,</sup><sup>h</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The evidence is very uncertain about the effect of tranexamic acid in addition to standard care on hysterectomy. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Maternal satisfaction</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Not pooled</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Not pooled</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not pooled</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(0 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>One study measured this outcome using a Likert scale questionnaire with no difference between groups. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Breastfeeding at discharge</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Not pooled</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Not pooled</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not pooled</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(0 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No studies measured this outcome.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> confidence interval; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>See interactive version of this table: <a href="https://gdt.gradepro.org/presentations/#/isof/isof_question_revman_web_450054892459696039" target="_blank">https://gdt.gradepro.org/presentations/#/isof/isof_question_revman_web_450054892459696039</a>. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup> Study limitations: concerns about accuracy of measurement of blood loss as the calculated method is dependent on normovolaemia. Tranexamic acid has effects on both the endothelium and renal function which may affect intravascular volume and cause changes in haematocrit/haemoglobin concentrations unrelated to blood loss.<br/><sup>b</sup> No serious concerns about study limitations: studies with unclear or high risk of performance and/or detection bias contributed very little to the overall effect. <br/><sup>c</sup> Extremely serious concerns about imprecision: the 95% confidence interval includes both suggested appreciable benefit and harm. Death was a rare event with one study reporting an event. Five studies reported no death in either study arm. Downgrade by three levels.<br/><sup>d</sup> Serious concern about imprecision: the 95% confidence interval includes both suggested appreciable harm and benefit. Downgrade by one level.<br/><sup>e</sup> Serious concern about inconsistency: statistical heterogeneity present. Two studies show inconsistent direction of effect. Downgrade by one level.<br/><sup>f</sup> Very serious imprecision: the 95% confidence interval includes both suggested appreciable harm and benefit. Downgrade by two levels.<br/><sup>g</sup> No serious concerns about study limitations: knowledge of intervention received unlikely to influence surgical intervention. <br/><sup>h</sup> Extremely serious imprecision: the confidence interval is very wide and crosses both suggested appreciable harm and benefit. Downgrade by three levels. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD016278-sec-0014" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD016278-sec-0014"></div> <section id="CD016278-sec-0015"> <h3 class="title" id="CD016278-sec-0015">Description of the condition</h3> <p>Postpartum haemorrhage (PPH) is one of the most common obstetric emergencies, occurring in up to 12% of all births. It is a leading cause of maternal mortality, particularly in low‐resource settings, where 99% of deaths occur [<a href="#CD016278-bib-0001" title="CalvertC , ThomasSL , RonsmansC , WagnerKS , AdlerAJ , FilippiV . Identifying regional variation in the prevalence of postpartum haemorrhage: a systematic review and meta-analysis. PLOS ONE2012;7(7):e41114.">1</a>, <a href="#CD016278-bib-0002" title="CarroliG , CuestaC , AbalosE , GulmezogluAM . Epidemiology of postpartum haemorrhage: a systematic review. Best Practice &amp; Research: Clinical Obstetrics &amp; Gynaecology2008;22(6):999-1012.">2</a>, <a href="#CD016278-bib-0003" title="FeduniwS , WarzechaD , SzymusikI , WielgosM . Epidemiology, prevention and management of early postpartum hemorrhage - a systematic review. Ginekologia Polska2020;91(4):38-44.">3</a>, <a href="#CD016278-bib-0004" title="SayL , PattinsonR , GulmezogluA . WHO systematic review of maternal morbidity and mortality: the prevalence of severe acute maternal morbidity (near miss). BioMed Central. Reproductive Health2004;1(3):1. [DOI: 10.1186/1742-4755-1-3]">4</a>]. Many survivors of PPH require costly, urgent care, and prolonged hospital stays. Some women undergo a hysterectomy to control the bleeding, thereby denying them the chance of bearing further children. The trauma of severe postpartum bleeding can also have a significant psychological impact and adversely affect a mother’s ability to breastfeed and bond with her baby [<a href="#CD016278-bib-0005" title="ThompsonJF , HealLJ , RobertsCL , EllwoodDA . Women's breastfeeding experiences following a significant primary postpartum haemorrhage: A multicentre cohort study. International Breastfeeding Journal2010;5(5):1. [DOI: 10.1186/1746-4358-5-5] [PMCID: PMC2889881] [PMID: 20504372]">5</a>]. </p> <p>Primary PPH is often defined as blood loss greater than 500 mL after a vaginal birth, or greater than 1000 mL after a caesarean birth, within 24 hours of birth [<a href="#CD016278-bib-0006" title="World Health Organization. WHO recommendations for the prevention and treatment of postpartum haemorrhage. www.who.int/publications/i/item/9789241548502.">6</a>]. However, many patients, such as those with anaemia or with existing cardio‐respiratory or hepatic disease, are less able to compensate for blood loss, and even small amounts of blood loss can be harmful. </p> <p>A 2024 World Health Organization (WHO) systematic review and modified Delphi expert consensus on strategies for early detection and first‐response management of PPH at caesarean birth concluded that the same PPH definition should apply to both vaginal and caesarean birth; that for the intraoperative phase, early detection should be accomplished via quantitative blood loss measurement, complemented by monitoring the woman's haemodynamic status; and that first response should be triggered once the woman loses at least 500 mL of blood with continued bleeding or when she exhibits clinical signs of haemodynamic instability, and include immediate administration of uterotonics and tranexamic acid, examination to determine aetiology, and rapid initiation of cause‐specific responses. [<a href="#CD016278-bib-0007" title="PingrayV , WilliamsCR , Al-BeityFM , AbalosE , ArulkumaranS , BlumenfeldA , et al. Strategies for optimising early detection and obstetric first response management of postpartum haemorrhage at caesarean birth: a modified Delphi-based international expert consensus. BMJ Open2024;8;14(5):e079713.">7</a>] </p> <p>Most cases of PPH are attributed to uterine atony, although bleeding due to trauma to the genital tract, surgical bleeding after caesarean birth, retention of placental tissue, and failure of the coagulation system are other common causes [<a href="#CD016278-bib-0002" title="CarroliG , CuestaC , AbalosE , GulmezogluAM . Epidemiology of postpartum haemorrhage: a systematic review. Best Practice &amp; Research: Clinical Obstetrics &amp; Gynaecology2008;22(6):999-1012.">2</a>]. </p> <p>Implementation of evidence‐based third stage of labour care [<a href="#CD016278-bib-0008" title="HershAR , CarroliG , HofmeyrGJ , GargB , GulmezogluM , LumbiganonP , et al. Third stage of labor: evidence-based practice for prevention of adverse maternal and neonatal outcomes. American Journal of Obstetrics &amp; Gynecology2024;230(3S):S1046-S1060.e1.">8</a>], in particular the use of prophylactic oxytocin, has been the focus of efforts to reduce PPH. However, the number of patients suffering PPH remains stubbornly high, and in some populations is in fact increasing. With the global increase in caesarean births, the contribution of post‐caesarean birth haemorrhage to maternal mortality is increasing. In South Africa, post‐caesarean haemorrhage is the only cause of maternal mortality that continues to increase [<a href="#CD016278-bib-0009" title="HofmeyrGJ . Maternal deaths from bleeding associated with caesarean delivery: A national emergency. South African Medical Journal2016;7;106(5):22.">9</a>]. </p> <p>There is a need for other effective interventions beyond the use of uterotonic drugs.</p> </section> <section id="CD016278-sec-0016"> <h3 class="title" id="CD016278-sec-0016">Description of the intervention and how it might work</h3> <p>Tranexamic acid (TXA) is an antifibrinolytic drug that inhibits fibrinolysis by blocking the interaction between plasmin and fibrin. Since it was first identified in the early 1960s, TXA has primarily been used for heavy menstrual bleeding and for reducing bleeding during surgical procedures in high‐risk patients. More recently, early treatment with TXA has been shown to be effective in patients with life‐threatening haemorrhage caused by trauma and childbirth [<a href="#CD016278-bib-0010" title="KerK , RobertsI , ShakurH , CoatsTJ . Antifibrinolytic drugs for acute traumatic injury. Cochrane Database of Systematic Reviews2015, Issue 5. Art. No: CD004896. [DOI: 10.1002/14651858.CD004896.pub4]">10</a>, <a href="#CD016278-bib-0011" title="ShakurH , BeaumontD , PavordS , Gayet‐AgeronA , KerK , MousaHA . Antifibrinolytic drugs for treating primary postpartum haemorrhage. Cochrane Database of Systematic Reviews2018, Issue 2. Art. No: CD012964. [DOI: 10.1002/14651858.CD012964]">11</a>]. In the CRASH 2 Trial, TXA given within one hour reduced mortality by 32%; given between one and three hours, by 21%; and beyond three hours TXA increased mortality by 44% (P = 0.004). The mechanism for this increase in mortality is unclear. TXA has multiple pharmacological effects. A pharmacovigilance study found a 32.6‐fold increase in adverse renal vascular and ischaemic conditions in women of childbearing age [<a href="#CD016278-bib-0012" title="StampfliD , WeilerS , WeinigerCF , BurdenAM , HeesenM . Renal ischemic adverse drug events related to tranexamic acid in women of child-bearing age: an analysis of pharmacovigilance data. European Journal of Clinical Pharmacology2021;77(6):913-9.">12</a>]. The World Maternal Antifibrinolytic (WOMAN) trial assessed the effects of intravenous TXA in 20,060 participants with a clinical diagnosis of PPH. The results showed that TXA reduces the risk of bleeding to death after PPH by one‐third (risk ratio 0.69, 95% confidence interval 0.52 to 0.91; P = 0.008) when given within three hours of birth, with no apparent increase in adverse events [<a href="#CD016278-bib-0013" title="Woman Trial Collaborators. Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial. Lancet2017;389(10084):2105-16.">13</a>]. As a result, the WHO recommends early intravenous TXA as a treatment for established PPH [<a href="#CD016278-bib-0014" title="World Health Organization. WHO recommendation on tranexamic acid for the treatment of postpartum haemorrhage. www.who.int/publications/i/item/9789241550154.">14</a>]. However, neither the overall risk of death, nor the risk of hysterectomy, nor both (the predefined primary outcome) was reduced. </p> <p>Many deaths from PPH occur on the day of birth, most within the first few hours after. Thus, for many women who suffer a PPH, treatment is too late. This, coupled with the knowledge that TXA is most effective when given shortly after the onset of bleeding, provides reason to believe that prophylactic TXA could reduce the risk of PPH. The growing interest in prophylactic TXA has led to a growth in the number of randomised trials exploring its effects in the obstetric population. However, the quality of many of these trials has been questioned, and uncertainties around the effects of TXA remain unresolved [<a href="#CD016278-bib-0015" title="KerK , ShakurH , RobertsI . Does tranexamic acid prevent postpartum haemorrhage? A systematic review of randomised controlled trials. BJOG2016;123(11):1745-52.">15</a>]. </p> </section> <section id="CD016278-sec-0017"> <h3 class="title" id="CD016278-sec-0017">Why it is important to do this review</h3> <p>This is an update of a Cochrane review first published in 2010 [<a href="#CD016278-bib-0016" title="NovikovaN , HofmeyrGJ . Tranexamic acid for preventing postpartum haemorrhage. Cochrane Database of Systematic Reviews2010, Issue 7. Art. No: CD007872. [DOI: 10.1002/14651858.CD007872.pub2]">16</a>] and previously updated in 2015 [<a href="#CD016278-bib-0017" title="NovikovaN , HofmeyrJ , CluverC . Tranexamic acid for preventing postpartum haemorrhage. Cochrane Database of Systematic Reviews2015, Issue 6. Art. No: CD007872. [DOI: 10.1002/14651858.CD007872.pub3]">17</a>]. </p> <p>The authors of the 2015 update concluded that "TXA (in addition to uterotonic medications) decreases postpartum blood loss and prevents PPH and blood transfusions following vaginal birth and caesarean birth in women at low risk of PPH based on studies of mixed quality" [<a href="#CD016278-bib-0017" title="NovikovaN , HofmeyrJ , CluverC . Tranexamic acid for preventing postpartum haemorrhage. Cochrane Database of Systematic Reviews2015, Issue 6. Art. No: CD007872. [DOI: 10.1002/14651858.CD007872.pub3]">17</a>]. Several new trials have been conducted in recent years, and there was a need to update this review using current methodology. </p> <p>The WHO recommends intravenous TXA as a treatment for severe bleeding after childbirth [<a href="#CD016278-bib-0014" title="World Health Organization. WHO recommendation on tranexamic acid for the treatment of postpartum haemorrhage. www.who.int/publications/i/item/9789241550154.">14</a>]. In the only trial powered to measure mortality (the WOMAN trial), TXA reduced mortality ascribed to haemorrhage, but not overall mortality. Increasing TXA use by giving it to patients shortly before caesarean birth or immediately after cord clamping could confer substantial additional health benefits, but requires robust evidence of its effects, including safety. Regarding the antifibrinolytic action of TXA, concerns about an increased risk of thrombosis associated with its use persist, although no such increased risk has been observed in randomised trials [<a href="#CD016278-bib-0018" title="MuraoS , NakataH , RobertsI , YamakawaK . Effect of tranexamic acid on thrombotic events and seizures in bleeding patients: a systematic review and meta-analysis. Critical Care (London, England)2021;25(1):380.">18</a>]. Nevertheless, further reassurance based on evidence from the obstetric population may be prudent before widespread prophylactic use is considered. There is high‐quality evidence from the Clinical Randomisation of an Antifibrinolytic in Significant Haemorrhage 2 (CRASH 2) trial that TXA given to bleeding trauma patients more than three hours after injury causes a 44% increase in mortality [<a href="#CD016278-bib-0019" title="CRASH-2 collaborators; Roberts I, ShakurH , AfolabiA , BrohiK , CoatsT , DewanY , et al. The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial. Lancet2011;26;377(9771):1096-101, 1101.e1-2.">19</a>]. The evidence of an adverse effect on mortality by an as‐yet‐unexplained mechanism becomes critical when considering prophylactic use, in which the great majority of those exposed to TXA do not stand to benefit from the antifibrinolytic effects, and trials are typically underpowered to measure mortality. </p> <p>The original review has been split into two reviews, one of TXA for caesarean birth (this review) and one of TXA for vaginal birth. In addition to updated searches, this review includes revisions made to comply with changes in methodological approaches introduced since the previous version was conducted. Furthermore, in light of quality and integrity concerns affecting trials on this topic, we have implemented additional measures to help ensure that only the most reliable evidence is included. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD016278-sec-0018" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD016278-sec-0018"></div> <p>To assess the effects of tranexamic acid for preventing postpartum haemorrhage in comparison to placebo or no treatment (with or without uterotonic co‐treatment) in women during caesarean birth. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD016278-sec-0019" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD016278-sec-0019"></div> <p>We followed MECIR (Methodological Expectations for Cochrane Intervention Reviews) [<a href="#CD016278-bib-0020" title="HigginsJ , LassersonT , ChandlerJ , ToveyD , ThomasJ , FlemyngE , ChurchillR . Methodological Expectations of Cochrane Intervention Reviews (MECIR) Standards for the conduct and reporting of new Cochrane Intervention Reviews, reporting of protocols and the planning, conduct and reporting of updates. methods.cochrane.org/methodological-expectations-cochrane-intervention-reviews.">20</a>] when conducting the review and PRISMA 2020 [<a href="#CD016278-bib-0021" title="PageMJ , McKenzieJE , BossuytPM , BoutronI , HoffmannTC , MulrowCD , et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ2021;372:n71. [DOI: 10.1136/bmj.n71]">21</a>] for the reporting. </p> <p>Several amendments have been made to this review since the protocol and the previous updates were published. Details are available in <a href="#CD016278-supitem-0008">Supplementary material 8</a>. The title of the review has changed since the protocol was published. The protocol is publicly available at www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007872/full. This update of the review was split into two separate reviews. One ongoing review includes participants with vaginal births, while the current review includes participants with caesarean births. We have removed the 500 mL outcome, as this threshold relates to the definition of PPH in vaginal births. After splitting the review, only the 1000 mL outcome was considered, as this is a clinically meaningful outcome to measure and report on in caesarean births. </p> <section id="CD016278-sec-0020"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD016278-sec-0021"> <h4 class="title">Types of studies</h4> <p>We searched for all published, unpublished, and ongoing randomised controlled trials (RCTs) comparing the use of TXA alone or in addition to uterotonics during caesarean birth to prevent PPH. We excluded quasi‐RCTs (e.g. those randomised by date of birth or hospital number or alternation). We identified no cluster‐RCTs in our search. </p> <p>Since the first version of the review was published, concerns regarding the integrity of several trials in obstetrics including those assessing the effects of TXA for preventing PPH have been raised [<a href="#CD016278-bib-0015" title="KerK , ShakurH , RobertsI . Does tranexamic acid prevent postpartum haemorrhage? A systematic review of randomised controlled trials. BJOG2016;123(11):1745-52.">15</a>, <a href="#CD016278-bib-0022" title="Li. Assessing research misconduct in randomized controlled trials. Obstetrics and Gynecology2021;138(3):338-47. [DOI: 10.1097/AOG.0000000000004513]">22</a>]. For this reason, we added the inclusion criterion that trials be prospectively registered (before the first participant was enrolled) in a registry. We also applied current Cochrane trustworthiness criteria. </p> </section> <section id="CD016278-sec-0022"> <h4 class="title">Types of participants</h4> <p>Women undergoing any caesarean birth (emergency or planned) at any age or within any setting of care. We included women at low risk of PPH or with specific risk factors for PPH as reported by authors. </p> <p>We considered studies that only included a subset of relevant participants for inclusion. For example, in studies that included both caesarean and vaginal births, only relevant data that were stratified according to type of birth were extracted. If this information was not clear, we contacted the trial authors for additional information. </p> </section> <section id="CD016278-sec-0023"> <h4 class="title">Types of interventions</h4> <p>TXA used during caesarean birth to prevent PPH, alone or in combination with standard treatment (e.g. other uterotonics) compared with placebo, no intervention, or standard treatment alone (e.g. other uterotonics). </p> <p>We included any dose of TXA given at any time point shortly before or after the birth. We considered intravenous, intramuscular, and oral routes of administration, but excluded topical application of TXA, which is the subject of an existing Cochrane review [<a href="#CD016278-bib-0023" title="KerK , BeecherD , RobertsI . Topical application of tranexamic acid for the reduction of bleeding. Cochrane Database of Systematic Reviews2013, Issue 7. Art. No: CD010562. [DOI: 10.1002/14651858.CD010562.pub2]">23</a>]. </p> </section> </section> <section id="CD016278-sec-0024"> <h3 class="title" id="CD016278-sec-0024">Outcome measures</h3> <section id="CD016278-sec-0025"> <h4 class="title">Critical outcomes</h4> <p>Blood loss of ≥ 1000 mL after caesarean birth. We considered blood loss that was measured up to 48 hours. </p> <p>We included the following measurements of blood loss.</p> <p> <ul id="CD016278-list-0002"> <li> <p>Estimated blood loss: gravimetrically estimated measures of blood loss (using surgical drapes or sponges that collect blood to measure blood loss) and provider‐estimated measures of blood loss (subjective, visual estimation of how much blood was lost). </p> </li> <li> <p>Calculated blood loss (calculations based on haematocrit or haemoglobin levels pre‐ and post‐caesarean birth, height and weight). </p> </li> </ul> </p> </section> <section id="CD016278-sec-0026"> <h4 class="title">Important outcomes</h4> <p> <ul id="CD016278-list-0003"> <li> <p>Maternal death before hospital discharge or as reported by authors.</p> </li> <li> <p>Severe morbidity (defined as maternal deaths or severe morbidity events including major surgery (laparotomy, uterine artery ligation, internal iliac artery ligation, B‐Lynch suture, hysterectomy, extensive vaginal repair), admission to the intensive care unit (ICU), or vital organ failure (temporary or permanent)) before hospital discharge or as reported by authors. </p> </li> <li> <p>Receipt of blood transfusion before hospital discharge or as reported by authors.</p> </li> <li> <p>Receipt of additional surgical interventions to control PPH (including laparotomy, compression suture of uterus, devascularisation of the uterus and hysterectomy) before hospital discharge or as reported by authors. </p> </li> <li> <p>Thromboembolic events including pulmonary embolism and deep vein thrombosis before hospital discharge or as reported by authors. </p> </li> <li> <p>Receipt of additional uterotonics including oxytocin, misoprostol, ergometrine, carbetocin, or others reported by authors, before hospital discharge or as reported by authors. </p> </li> <li> <p>Hysterectomy before hospital discharge or as reported by authors.</p> </li> <li> <p>Maternal satisfaction before hospital discharge or as reported by authors.</p> </li> <li> <p>Breastfeeding at discharge or as reported by authors.</p> </li> <li> <p>Clinical diagnosis of PPH (independent of amount of blood loss) as reported by authors.</p> </li> <li> <p>Mean blood loss (mL):</p> <ul id="CD016278-list-0004"> <li> <p>estimated blood loss: gravimetrically estimated measures of blood loss (using surgical drapes or sponges that collect blood to measure blood loss) and provider‐estimated measures of blood loss (subjective, visual estimation of how much blood was lost); </p> </li> <li> <p>calculated blood loss (calculations based on haematocrit or haemoglobin levels pre‐ and post‐caesarean birth, and weight). </p> </li> </ul> </li> <li> <p>Myocardial infarction before hospital discharge or as reported by authors.</p> </li> <li> <p>Stroke before hospital discharge or as reported by authors.</p> </li> <li> <p>Seizures before hospital discharge or as reported by authors.</p> </li> <li> <p>Organ failure/dysfunction before hospital discharge or as reported by authors.</p> </li> <li> <p>ICU admission before hospital discharge or as reported by authors.</p> </li> <li> <p>Nausea before hospital discharge or as reported by authors.</p> </li> <li> <p>Vomiting before hospital discharge or as reported by authors.</p> </li> <li> <p>Headache before hospital discharge or as reported by authors.</p> </li> <li> <p>Maternal well‐being before hospital discharge or as reported by authors.</p> </li> <li> <p>Postpartum anaemia (haemoglobin &lt; 9 g/dL) before hospital discharge or as reported by authors. </p> </li> <li> <p>Skin reactions before hospital discharge or as reported by authors.</p> </li> </ul> </p> </section> </section> <section id="CD016278-sec-0027"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD016278-sec-0028"> <h4 class="title">Electronic searches</h4> <p>For this update, the Information Specialists of the Cochrane Pregnancy and Childbirth Group searched the Group's Trials Register for records available to 20 June 2021. One review author (KK) carried out further updated searches of the Cochrane Central Register of Controlled Trials (CENTRAL; 2024, Issue 2), MEDLINE (OvidSP, 1946 to 20 February 2024), Embase (OvidSP 1980 to 2024 week 8), and the WHO International Clinical Trials Registry Platform (trialsearch.who.int/) on 20 February 2024; these searches were limited to evidence added since 20 June 2021. The search strategies for each database are provided in <a href="#CD016278-supitem-0001">Supplementary material 1</a>. </p> </section> <section id="CD016278-sec-0029"> <h4 class="title">Searching other resources</h4> <p>We searched the reference lists of retrieved studies. We did not apply any language or date restrictions. </p> </section> </section> <section id="CD016278-sec-0030"> <h3 class="title" id="CD016278-sec-0030">Data collection and analysis</h3> <p>For methods used in the previous version of this review, see [<a href="#CD016278-bib-0016" title="NovikovaN , HofmeyrGJ . Tranexamic acid for preventing postpartum haemorrhage. Cochrane Database of Systematic Reviews2010, Issue 7. Art. No: CD007872. [DOI: 10.1002/14651858.CD007872.pub2]">16</a>] and [<a href="#CD016278-bib-0017" title="NovikovaN , HofmeyrJ , CluverC . Tranexamic acid for preventing postpartum haemorrhage. Cochrane Database of Systematic Reviews2015, Issue 6. Art. No: CD007872. [DOI: 10.1002/14651858.CD007872.pub3]">17</a>]. </p> <p>For the current review, we used the following methods for assessing the reports that were identified as a result of the updated search. </p> <section id="CD016278-sec-0031"> <h4 class="title">Selection of studies</h4> <p>Two review authors (CC and KK, or CR and AR) independently assessed the titles and abstracts of studies identified by the search for potential relevance. We obtained the full‐text reports of studies deemed potentially relevant, and the same review authors independently assessed the full texts for inclusion in the review. Any disagreements were resolved through discussion or consultation with all review authors if necessary. </p> <p>We created a study flow diagram to map out the number of records identified, included, excluded, or awaiting classification. </p> <p>All studies meeting our inclusion criteria were evaluated by two review authors (KK and CC, or CR and AR) against predefined criteria to select studies that, based on available information, were deemed to be sufficiently trustworthy to be included in the analysis. We resolved discrepancies through discussion and consultation with all authors. The criteria, according to the Cochrane Pregnancy and Childbirth Trustworthiness Screening Tool [<a href="#CD016278-bib-0024" title="AlfirevicZ , KellieFJ , WeeksJ , StewartF , JonesL , HampsonL , on behalf of the Pregnancy and Childbirth Editorial Board. Identifying and handling potentially untrustworthy trials - Trustworthiness Screening Tool (TST) developed by the Cochrane Pregnancy and Childbirth Group. Cochrane Pregnancy and Childbirth Group.">24</a>], were as follows. </p> <section id="CD016278-sec-0032"> <h5 class="title">Research governance</h5> <p> <ul id="CD016278-list-0005"> <li> <p>Are there any retraction notices or expressions of concern listed on the Retraction Watch Database relating to this study? </p> </li> <li> <p>Was the study prospectively registered (for those studies published after 2010)? If not, was there a plausible reason? </p> </li> <li> <p>When requested, did the trial authors provide/share the protocol and/or ethics approval letter? </p> </li> <li> <p>Did the trial authors engage in communication with the Cochrane review authors within the agreed timelines? </p> </li> <li> <p>Did the trial authors provide individual participant data upon request? If not, was there a plausible reason? </p> </li> </ul> </p> </section> <section id="CD016278-sec-0033"> <h5 class="title">Baseline characteristics</h5> <p> <ul id="CD016278-list-0006"> <li> <p>Is the study free from characteristics of the study participants that appear too similar (e.g. distribution of the mean (standard deviation) excessively narrow or excessively wide, as noted by [<a href="#CD016278-bib-0025" title="CarlisleJB . Data fabrication and other reasons for non-random sampling in 5087 randomised, controlled trial in anaesthetic and general medical journals. Anaesthesia2017;72:944-52.">25</a>])? </p> </li> </ul> </p> </section> <section id="CD016278-sec-0034"> <h5 class="title">Feasibility</h5> <p> <ul id="CD016278-list-0007"> <li> <p>Is the study free from characteristics that could be implausible (e.g. large numbers of participants with a rare condition (such as severe cholestasis in pregnancy) recruited within 12 months)? </p> </li> <li> <p>In cases with (close to) zero losses to follow‐up, is there a plausible explanation?</p> </li> </ul> </p> </section> <section id="CD016278-sec-0035"> <h5 class="title">Results</h5> <p> <ul id="CD016278-list-0008"> <li> <p>Is the study free from results that could be implausible (e.g. massive risk reduction for main outcomes with small sample size)? </p> </li> <li> <p>Do the numbers randomised to each group suggest that adequate randomisation methods were used (e.g. is the study free from issues such as unexpectedly even numbers of participants ‘randomised’ including a mismatch between the numbers and the methods, if the authors say ‘no blocking was used’ but still end up with equal numbers, or if the authors say they used ‘blocks of 4’ but the final numbers differ by 6)? </p> </li> </ul> </p> <p>Where a study was classified as ‘high risk’, we attempted to contact the study authors to address any possible lack of information/concerns. In cases where we were unable to obtain contact details for the study authors, or where adequate information remained unavailable, the study was categorised as ‘awaiting classification’ and the reasons and communications with the trial author (or lack of) described. </p> </section> <section id="CD016278-sec-0036"> <h5 class="title">Abstracts</h5> <p>We included data from abstracts only if, in addition to the trustworthiness assessment, the study authors confirmed in writing that the data to be included in the review came from the final analysis and will not change. If such information was not available/provided, the study was categorised as ‘awaiting classification’ (as above). </p> <p>See <a href="#CD016278-fig-0001">Figure 1</a> for details of how to apply the trustworthiness screening criteria. </p> <div class="figure" id="CD016278-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Applying the trustworthiness screening tool criteria. No Copyright, reproduced with permission from author Zarko Alfirevic. Alfirevic Z, Kellie FJ, Weeks J, Stewart F, Jones L, Hampson L, on behalf of the Pregnancy and Childbirth Editorial Board. Identifying and handling potentially untrustworthy trials – Trustworthiness Screening Tool (TST) developed by the Cochrane Pregnancy and Childbirth Group. Version 3.0. 2023." data-id="CD016278-fig-0001" src="/cdsr/doi/10.1002/14651858.CD016278/media/CDSR/CD016278/image_n/nCD016278-FIG-01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Applying the trustworthiness screening tool criteria. No Copyright, reproduced with permission from author Zarko Alfirevic. Alfirevic Z, Kellie FJ, Weeks J, Stewart F, Jones L, Hampson L, on behalf of the Pregnancy and Childbirth Editorial Board. Identifying and handling potentially untrustworthy trials – Trustworthiness Screening Tool (TST) developed by the Cochrane Pregnancy and Childbirth Group. Version 3.0. 2023. </p> </div> </div> </div> </section> </section> <section id="CD016278-sec-0037"> <h4 class="title">Data extraction and management</h4> <p>We designed a form to extract data using Covidence [<a href="#CD016278-bib-0026" title="Covidence systematic review software. Version 01/08/2024. Melbourne, Australia: Veritas Health Innovation, 2024. Available at www.covidence.org.">26</a>]. Two review authors (CC and KK, or CR and AR) extracted the data using the agreed‐upon form. Any discrepancies were resolved through discussion. </p> <p>When information regarding any of the above was unclear, we attempted to contact the authors of the original reports to provide further details. </p> <p>In addition to the main outcomes and details on trial design, we systematically extracted the following data for each trial. </p> <p> <ul id="CD016278-list-0009"> <li> <p>Characteristics of participants, including risk for PPH, type of caesarean birth</p> </li> <li> <p>Inclusion and exclusion criteria</p> </li> <li> <p>Characteristics of the intervention, including dose, timing, route of administration</p> </li> <li> <p>Co‐interventions, e.g. use of other uterotonics</p> </li> <li> <p>Duration and technique of assessment of blood loss</p> </li> <li> <p>Loss to follow‐up</p> </li> </ul> </p> <p>Authors of studies potentially eligible for inclusion in the review were not involved in making eligibility decisions for these studies. </p> </section> <section id="CD016278-sec-0038"> <h4 class="title">Risk of bias assessment in included studies</h4> <p>Two review authors (CC and KK, or CR and AR) independently assessed the validity of each study using the criteria outlined in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> [<a href="#CD016278-bib-0027" title="HigginsJP , AltmanDG , SterneJA , editor(s). Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from training.cochrane.org/handbook/archive/v5.1/.">27</a>]. Any disagreements were resolved by discussion. Authors of studies potentially eligible for inclusion in the review were not involved in making decisions about risk of bias for these studies. </p> <section id="CD016278-sec-0039"> <h5 class="title">(1) Random sequence generation (checking for possible selection bias)</h5> <p>We described for each included study the method used to generate the allocation sequence in sufficient detail to allow an assessment of whether it should produce comparable groups. </p> <p>We assessed the method as:</p> <p> <ul id="CD016278-list-0010"> <li> <p>low risk of bias (any truly random process, e.g. random number table; computer random number generator); </p> </li> <li> <p>high risk of bias (any non‐random process, e.g. odd or even date of birth; hospital or clinic record number); </p> </li> <li> <p>unclear risk of bias.</p> </li> </ul> </p> </section> <section id="CD016278-sec-0040"> <h5 class="title">(2) Allocation concealment (checking for possible selection bias)</h5> <p>We described for each included study the method used to conceal allocation to interventions prior to assignment and assessed whether intervention allocation could have been foreseen in advance of, or during recruitment, or changed after assignment. </p> <p>We assessed the methods as:</p> <p> <ul id="CD016278-list-0011"> <li> <p>low risk of bias (e.g. telephone or central randomisation; consecutively numbered, sealed, opaque envelopes); </p> </li> <li> <p>high risk of bias (open random allocation; unsealed or non‐opaque envelopes, alternation; date of birth); </p> </li> <li> <p>unclear risk of bias.</p> </li> </ul> </p> </section> <section id="CD016278-sec-0041"> <h5 class="title">(3) Blinding of participants, personnel, and outcome assessors (checking for possible performance and detection bias) </h5> <p>We described for each included study the methods used, if any, to blind study participants, personnel, and outcome assessors from knowledge of which intervention a participant received. We considered studies to be at low risk of bias if they were blinded, or if we judged that lack of blinding would be unlikely to affect the results. </p> <p>We assessed the methods as:</p> <p> <ul id="CD016278-list-0012"> <li> <p>low, high, or unclear risk of bias for participants;</p> </li> <li> <p>low, high, or unclear risk of bias for personnel;</p> </li> <li> <p>low, high, or unclear risk of bias for outcome assessors.</p> </li> </ul> </p> </section> <section id="CD016278-sec-0042"> <h5 class="title">(4) Incomplete outcome data (checking for possible attrition bias due to the amount, nature, and handling of incomplete outcome data) </h5> <p>We described for each included study the completeness of data, including attrition and exclusions from the analysis. We state whether attrition and exclusions were reported and the numbers included in the analysis at each stage (compared with the total randomised participants), reasons for attrition or exclusion where reported, and whether missing data were balanced across groups or were related to outcomes. Where study authors conducted sensitivity analysis of missing data for specific outcomes, we considered this when making judgements about attrition bias. </p> <p>We assessed the methods as:</p> <p> <ul id="CD016278-list-0013"> <li> <p>low risk of bias (e.g. no missing outcome data; missing outcome data balanced across groups); </p> </li> <li> <p>high risk of bias (e.g. numbers or reasons for missing data imbalanced across groups; ‘as treated’ analysis done with substantial departure of intervention received from that assigned at randomisation); </p> </li> <li> <p>unclear risk of bias.</p> </li> </ul> </p> </section> <section id="CD016278-sec-0043"> <h5 class="title">(5) Selective reporting (checking for reporting bias)</h5> <p>We described for each included study how we investigated the possibility of selective outcome reporting bias and what we found. </p> <p>We assessed the methods as:</p> <p> <ul id="CD016278-list-0014"> <li> <p>low risk of bias (where it was clear that all the study’s prespecified outcomes and all expected outcomes of interest to the review have been reported); </p> </li> <li> <p>high risk of bias (where not all the study’s prespecified outcomes have been reported; one or more reported primary outcomes were not prespecified; outcomes of interest are reported incompletely and so cannot be used; the study fails to include results of a key outcome that would be expected to have been reported); </p> </li> <li> <p>unclear risk of bias.</p> </li> </ul> </p> </section> <section id="CD016278-sec-0044"> <h5 class="title">(6) Other bias (checking for bias due to problems not covered by (1) to (5) above)</h5> <p>We described for each included study any important concerns we had about other possible sources of bias. </p> <p>We assessed whether each study was free of other problems that could put it at risk of bias: </p> <p> <ul id="CD016278-list-0015"> <li> <p>low risk of other bias;</p> </li> <li> <p>high risk of other bias;</p> </li> <li> <p>unclear if there is risk of other bias.</p> </li> </ul> </p> </section> </section> <section id="CD016278-sec-0045"> <h4 class="title">Measures of treatment effect</h4> <section id="CD016278-sec-0046"> <h5 class="title">Dichotomous data</h5> <p>For dichotomous data, we presented results as summary risk ratio (RR) with 95% confidence intervals (CI). </p> </section> <section id="CD016278-sec-0047"> <h5 class="title">Continuous data</h5> <p>For continuous data, we used the mean difference (MD) with 95% CI, as the outcomes were measured in the same way across trials. </p> <p>In future updates of this review, we will use the standardised mean difference (SMD) to combine data from trials that measure the same outcome but use different methods [<a href="#CD016278-bib-0028" title="HigginsJPT , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , WelchVA , editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 6.3 (updated February 2022). Cochrane, 2022. Available from training.cochrane.org/handbook/archive/v6.3.">28</a>]. </p> </section> </section> <section id="CD016278-sec-0048"> <h4 class="title">Unit of analysis issues</h4> <section id="CD016278-sec-0049"> <h5 class="title">Cluster‐randomised trials</h5> <p>If in future updates of this review we identify eligible cluster‐randomised trials, we will include them in the analyses along with individually randomised trials. We will adjust their sample sizes using the methods described in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> [<a href="#CD016278-bib-0028" title="HigginsJPT , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , WelchVA , editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 6.3 (updated February 2022). Cochrane, 2022. Available from training.cochrane.org/handbook/archive/v6.3.">28</a>] using an estimate of the intracluster correlation coefficient (ICC) derived from the trial (if possible), from a similar trial, or from a study of a similar population. If we use ICCs from other sources, we will report this and conduct sensitivity analyses to investigate the effect of variation in the ICC. If we identify both cluster‐randomised trials and individually randomised trials, we will synthesise the relevant information. We will consider it reasonable to combine the results from both if there is little heterogeneity between study designs, and interaction between the effect of intervention and the choice of randomisation unit is considered to be unlikely. </p> <p>We will also acknowledge heterogeneity in the randomisation unit and perform a subgroup analysis to investigate the effects of the randomisation unit. </p> </section> <section id="CD016278-sec-0050"> <h5 class="title">Cross‐over trials</h5> <p>Cross‐over trials are irrelevant for this intervention and are therefore not included.</p> </section> <section id="CD016278-sec-0051"> <h5 class="title">Multi‐armed trials</h5> <p>For outcomes reported in multi‐armed trials, we combined all relevant experimental intervention groups of the trial into a single group, and all relevant control intervention groups into a single control group. We combined both the sample sizes and the numbers of people with events from all groups for dichotomous outcomes. For continuous outcomes, we combined means and standard deviations as per the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> [<a href="#CD016278-bib-0028" title="HigginsJPT , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , WelchVA , editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 6.3 (updated February 2022). Cochrane, 2022. Available from training.cochrane.org/handbook/archive/v6.3.">28</a>]. Where we considered one of the arms irrelevant, we excluded it from the analysis [<a href="#CD016278-bib-0028" title="HigginsJPT , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , WelchVA , editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 6.3 (updated February 2022). Cochrane, 2022. Available from training.cochrane.org/handbook/archive/v6.3.">28</a>]. </p> </section> </section> <section id="CD016278-sec-0052"> <h4 class="title">Dealing with missing data</h4> <p>We noted levels of attrition in the included studies. We planned to explore the impact of including studies with high levels of missing data in the overall assessment of treatment effect by using sensitivity analysis. </p> <p>For all outcomes, we carried out analyses, to the greatest degree possible, on an intention‐to‐treat basis, that is we attempted to include all participants randomised to each group in the analyses, and to analyse all participants in the group to which they had been allocated, regardless of whether or not they received the allocated intervention. Where data were missing because the outcome was not measured in all participants, the reason for missing data was unrelated to the outcome, and missing data were balanced between groups, the denominator for each outcome in each trial was the number randomised minus any participants whose outcomes were known to be missing (modified intention‐to‐treat analysis). Where no explanation was given for missing outcome data, missing data were not balanced between groups, and the missing data were suspected to be related to the outcome, we contacted the study authors and planned to conduct sensitivity analyses. </p> </section> <section id="CD016278-sec-0053"> <h4 class="title">Reporting bias assessment</h4> <p>We planned to assess reporting biases if 10 or more studies were included in the meta‐analysis. In the current update, no meta‐analyses included more than 10 studies. If more studies are included in future updates, we will investigate reporting biases (such as publication bias) using funnel plots. We will visually assess funnel plot asymmetry. </p> </section> <section id="CD016278-sec-0054"> <h4 class="title">Synthesis methods</h4> <p>We carried out statistical analysis using RevMan [<a href="#CD016278-bib-0029" title="Review Manager (RevMan). Version 7.12.0. The Cochrane Collaboration, 2024. Available at https://revman.cochrane.org.">29</a>]. We used random‐effects meta‐analysis for combining data, as we anticipated some clinical heterogeneity sufficient to expect that the underlying treatment effects differed between trials. The random‐effects summary was treated as the average of the range of possible treatment effects, and we discuss the clinical implications of treatment effects differing between trials. We planned that if the average treatment effect was not considered clinically meaningful, we would not combine trials. If we used random‐effects analyses, we presented the results as the average treatment effect with 95% CIs, and the estimates of Tau<sup>2</sup> and I<sup>2</sup>. </p> <p>We used the I<sup>2</sup> and Chi<sup>2</sup> statistics to measure heterogeneity among the trials in each analysis. We regarded heterogeneity as substantial if I<sup>2</sup> was greater than 30%, and either Tau<sup>2</sup> was greater than zero, or there was a low P value (less than 0.10) in the Chi<sup>2</sup> test for heterogeneity. </p> <p>For the critical outcome (blood loss ≥ 1000 mL), we conducted separate meta‐analyses for estimated blood loss and calculated blood loss. For estimated blood loss, where authors reported on gravimetrically estimated and provider‐estimated blood loss, we regarded gravimetrically estimated blood loss to be superior to provider‐estimated blood loss. We conducted sensitivity analysis to explore whether there was a difference in the pooled effect if we chose provider‐estimated blood loss as the superior measure. </p> </section> <section id="CD016278-sec-0055"> <h4 class="title">Investigation of heterogeneity and subgroup analysis</h4> <p>For analyses with substantial heterogeneity, we performed random‐effects analysis and subgroup analyses. </p> <p>For the critical outcome (blood loss ≥ 1000 mL), we conducted subgroup analyses on the various ways of measuring estimated blood loss (gravimetrical versus provider estimated). </p> <p>We planned to assess the following subgroups for all outcomes.</p> <p> <ul id="CD016278-list-0016"> <li> <p>Participants at high, low, and mixed risk for PPH</p> </li> <li> <p>Participants with and without anaemia (as defined by trial author)</p> </li> <li> <p>Different doses of TXA</p> </li> <li> <p>Different routes of administering TXA</p> </li> </ul> </p> <p>The important outcomes (e.g. thromboembolic events) are included in the subgroup analysis because of their potential association with the use of TXA, which is especially important in women undergoing caesarean birth because their risk of thromboembolic events is higher than in women with vaginal birth. </p> <p>We planned to assess subgroup differences by interaction tests available within [<a href="#CD016278-bib-0029" title="Review Manager (RevMan). Version 7.12.0. The Cochrane Collaboration, 2024. Available at https://revman.cochrane.org.">29</a>] and report the results of subgroup analyses quoting the Chi² statistic and P value, and the interaction test I² value. </p> <section id="CD016278-sec-0056"> <h5 class="title">Equity‐related assessment</h5> <p>We did not investigate health inequity in this review.</p> </section> </section> <section id="CD016278-sec-0057"> <h4 class="title">Sensitivity analysis</h4> <p>We conducted sensitivity analysis for the outcome estimated blood loss ≥ 1000 mL. In the main analysis, we regarded gravimetrically estimated blood loss to be superior to provider‐estimated blood loss if the study authors reported both measures. We conducted sensitivity analysis to explore whether there was a difference in the pooled effect if we chose provider‐estimated blood loss to be the superior measure. </p> <p>We planned to perform sensitivity analyses for aspects of the review that might have affected the results, for example where there was a risk of bias associated with the quality of some of the included trials, or where there were high levels of missing data. </p> <p>We planned to perform sensitivity analysis for the critical outcome (blood loss ≥ 1000 mL). However, we did not perform sensitivity analysis as risk of bias was low across studies, and where trials had missing data for this outcome, study authors conducted sensitivity analyses showing that missing data had no impact on the effect. </p> </section> <section id="CD016278-sec-0058"> <h4 class="title">Certainty of the evidence assessment</h4> <p>For this update, we assessed the certainty of the evidence for each outcome using the GRADE approach [<a href="#CD016278-bib-0030" title="SchunemannHJ . GRADE: from grading the evidence to developing recommendations. A description of the system and a proposal regarding the transferability of the results of clinical research to clinical practice [GRADE: von der Evidenz zur Empfehlung. Beschreibung des Systems und Losungsbeitrag zur Ubertragbarkeit von Studienergebnissen]. Zeitschrift fur Evidenz, Fortbildung und Qualitat Im Gesundheitswesen2009;103(6):391-400. [PMID: 19839216]">30</a>]. We used GRADEpro GDT [<a href="#CD016278-bib-0031" title="GRADEpro GDT. Version 01/08/2024. Hamilton (ON): McMaster University (developed by Evidence Prime), 2024. Available at https://www.gradepro.org.">31</a>] to create summary of findings tables. We used the GRADE approach to produce a summary of the intervention effect and a measure of certainty for each of the outcomes described below. Based on the five GRADE considerations (study limitations, consistency of effect, imprecision, indirectness, and publication bias), we downgraded the certainty of the evidence from high by one level for serious (or by two levels for very serious) limitations. </p> <p>We performed a GRADE assessment on 10 outcomes, namely blood loss &gt; 1000 mL (estimated blood loss and calculated blood loss), maternal death, severe morbidity, receipt of blood transfusions, receipt of additional surgical interventions to control PPH, thromboembolic events, receipt of additional uterotonics, hysterectomy, maternal satisfaction, and breastfeeding. </p> <p>GRADE judgements were informed by the Standard Operating Procedures for grading evidence for guidelines put forward by the WHO. We judged imprecision by considering the range of the CI of the relative effect as well as the total cumulative study population and the total number of events per outcome. We downgraded for imprecision if there were very few events (fewer than 30) and if the CI was very wide. The threshold for suggested appreciable benefit for the relative effect was 0.75, and the threshold for suggested appreciable harm was 1.25. Where the CI crossed these thresholds, we downgraded by one, two, or three levels depending on the width of the CI. </p> <p>Authors of studies potentially eligible for inclusion in the review were not involved in making decisions about the certainty of evidence. </p> </section> </section> <section id="CD016278-sec-0059"> <h3 class="title" id="CD016278-sec-0059">Consumer involvement</h3> <p>We did not involve consumers in the review due to pressured timelines and limited resources. Our outcomes were informed by core outcome sets [<a href="#CD016278-bib-0032" title="MeherS , CuthbertA , KirkhamJJ , WilliamsonP , AbalosE , AflaifelN , et al. Core outcome sets for prevention and treatment of postpartum haemorrhage: an international Delphi consensus study. BJOG2019;126:83–93.">32</a>] that involved consumers. </p> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD016278-sec-0060" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD016278-sec-0060"></div> <section id="CD016278-sec-0061"> <h3 class="title">Description of studies</h3> <section id="CD016278-sec-0062"> <h4 class="title">Results of the search</h4> <p>The PRISMA study flow diagram in <a href="#CD016278-fig-0002">Figure 2</a> shows the results of the search process. </p> <div class="figure" id="CD016278-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD016278-fig-0002" src="/cdsr/doi/10.1002/14651858.CD016278/media/CDSR/CD016278/image_n/nCD016278-FIG-02.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> <p>Since publication of the previous version of the review, the search has been updated three times, with the last search on 20 February 2024. The combined searches yielded 366 studies for title and abstract screening. We identified 102 studies for full‐text review. Of these, we excluded 46 studies, most commonly due to lack of prospective registration (see <a href="#CD016278-sec-0073">Excluded studies</a>), and included six RCTs. Forty‐seven studies are awaiting classification, and three studies are ongoing. </p> <p>Seven studies previously included in earlier versions of this review were excluded (Abdel‐Aleem 2013 [<a href="#CD016278-bib-0033" title="Abdel-AleemH , AlhusainiTK , Abdel-AleemMA , MenoufyM , GulmezogluAM . Effectiveness of tranexamic acid on blood loss in patients undergoing elective cesarean section: randomized clinical trial. Journal of Maternal-Fetal &amp; Neonatal Medicine2013;26(17):1705-9. ">33</a>, <a href="#CD016278-bib-0034" title="ACTRN12612000313831. The use of tranexamic acid to reduce blood loss during and after cesarean section. Https://anzctr.org.au/ACTRN12612000313831.aspx (first received 2012). ">34</a>]; Goswami 2013 [<a href="#CD016278-bib-0035" title="GoswamiU , SarangiS , GuptaS , BabbarS . Comparative evaluation of two doses of tranexamic acid used prophylactically in anemic parturients for lower segment cesarean section: a double-blind randomized case control prospective trial. Saudi Journal of Anaesthesia2013;7(4):427-31. ">35</a>]; Gungorduk 2011 [<a href="#CD016278-bib-0036" title="GungordukK , YildirimG , AsiciogluO , GungordukOC , SudolmusS , ArkC . Efficacy of intravenous tranexamic acid in reducing blood loss after elective cesarean section: a prospective, randomized, double-blind, placebo-controlled study. American Journal of Perinatology2011;28(3):233-40. ">36</a>]; Gungorduk 2013 [<a href="#CD016278-bib-0037" title="GungordukK , AsiciogluO , YildirimG , ArkC , TekirdagAI , BesimogluB . Can intravenous injection of tranexamic acid be used in routine practice with active management of the third stage of labor in vaginal delivery? A randomized controlled study. American Journal of Perinatology2013;30(5):407-13. ">37</a>]; Mirghafourvand 2013 [<a href="#CD016278-bib-0038" title="MirghafourvandM , AlizadehSM , AbasalizadehF , ShirdelM . The effect of intravenous tranexamic acid on hemoglobin and hematocrit levels after vaginal delivery: a randomized controlled trial. Iranian Journal of Obstetrics, Gynecology and Infertility2013;16(60):1-8. ">38</a>, <a href="#CD016278-bib-0039" title="MirghafourvandM , Mohammad-AlizadehS , AbasalizadehF , ShirdelM . The effect of prophylactic intravenous tranexamic acid on blood loss after vaginal delivery in low risk of postpartum haemorrhage women: a double-blind randomized controlled trial. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology in press. ">39</a>]; Movafegh 2011 [<a href="#CD016278-bib-0040" title="MovafeghA , EslamianL , DorabadiA . Effect of intravenous tranexamic acid administration on blood loss during and after cesarean delivery. International Journal of Gynaecology and Obstetrics2011;115(3):224-6. ">40</a>, <a href="#CD016278-bib-0041" title="NCT01085006. The effect of tranexamic acid administration on postpartum hemorrhage during and after cesarean delivery. Http://clinicaltrials.gov/show/NCT01085006 (first received 2009). [CENTRAL: CN-01067257] ">41</a>]; Yang 2001 [<a href="#CD016278-bib-0042" title="YangH , ZhengS , ShiC . [Clinical study on the efficacy of tranexamic acid in reducing postpartum blood lose: a randomized comparative, multicenter trial] [Chinese]. Chung-Hua Fu Chan Ko Tsa Chih [Chinese Journal of Obstetrics and Gynaecology]2001;36(10):590-2. ">42</a>]). Two of these studies were excluded as the participants were women giving vaginal birth and not caesarean birth (Mirghafourvand 2013; Yang 2001). The others were excluded because they were not prospectively registered. Five previously included studies were moved to the awaiting classification category (Gai 2004 [<a href="#CD016278-bib-0043" title="GaiMY , WuLF , SuQF , TatsumotoK . Clinical observation of blood loss reduced by tranexamic acid during and after caesarian section: a multi-center, randomized trial. European Journal of Obstetrics &amp; Gynecology and Reproductive Biology2004;112:154-7. ">43</a>]; Senturk 2013; Shahid 2013 [<a href="#CD016278-bib-0044" title="ShahidA , KhanA . Tranexamic acid in decreasing blood loss during and after caesarean section. Journal of the College of Physicians and Surgeons--Pakistan: JCPSP2013;23(7):459-62. ">44</a>]; Xu 2013 [<a href="#CD016278-bib-0045" title="XuJ , GaoW , JuY . Tranexamic acid for the prevention of postpartum hemorrhage after cesarean section: a double-blind randomization trial. Archives of Gynecology and Obstetrics2013;287(3):463-8. ">45</a>]; Yehia 2014 [<a href="#CD016278-bib-0046" title="YehiaAH , KoleibMH , AbdelazimIA , AtikA . Tranexamic acid reduces blood loss during and after cesarean section: A double blinded, randomized, controlled trial. Asian Pacific Journal of Reproduction2014;3(1):53-6. ">46</a>]). The previous review had two trials awaiting classification; we excluded one of these trials (Ahmed 2015 [<a href="#CD016278-bib-0047" title="AhmedMR , Sayed AhmedWA , MadnyEH , ArafaAM , SaidMM . Efficacy of tranexamic acid in decreasing blood loss in elective caesarean delivery. Journal of Maternal-Fetal &amp; Neonatal Medicine2015;28(9):1014-8. [CENTRAL: CN-01086300] [EMBASE: 605117379] [PMID: 25068947]">47</a>, <a href="#CD016278-bib-0048" title="MagedAM , Helal, OM, ElsherbiniMM , EidMM , ElkomyRO , et al. A randomized placebo-controlled trial of peroperative tranexmaic acid among women undergoing elective cesarean delivery. Internatonal Journal Fo Gynecology and Obstetrics2015;131(3):265-8. ">48</a>, <a href="#CD016278-bib-0049" title="AhmedMR , Sayed AhmedWA , MadnyEH , ArafaAM , SaidMM . Efficacy of tranexamic acid in decreasing blood loss in elective caesarean delivery. Journal of Maternal-Fetal &amp; Neonatal Medicine 2014 Jul 28 {Epub ahead of print]. ">49</a>]), while the other remains in this category (Bhavana 2013 [<a href="#CD016278-bib-0050" title="BhavanaG , AbhishekMV , SuneetaM . Efficacy of prophylactic tranexamic acid in reducing blood loss during and after caesarean section. International Journal of Reproduction, Contraception, Obstetrics and Gynecology2016;5(6):2011-6. ">50</a>, <a href="#CD016278-bib-0051" title="BhavanaG , MittalS . Evaluation of efficacy of prophylactic injection tranexamic acid in decreasing blood loss before and after caesarean section. BJOG2013;120(Suppl s1):32. ">51</a>]). </p> <p>We applied an assessment of trustworthiness to each potentially included study, and excluded studies without prospective registration. Where information about registration or other information was required, we contacted the authors via email; we categorised these studies as awaiting classification until an adequate response was received and an eligibility decision could be made. We judged 47 studies to have some concerns regarding trustworthiness. Details are available in <a href="#CD016278-supitem-0004">Supplementary material 4</a>. </p> <p>We identified three ongoing studies (I'M WOMAN [<a href="#CD016278-bib-0052" title="Tranexamic acid to prevent heavy bleeding after childbirth in women at higher risk (I'M-WOMAN). https://clinicaltrials.gov/ct2/show/NCT05562609. ">52</a>]; NCT 06060327 [<a href="#CD016278-bib-0053" title="Comparing tranexamic acid versus ecbolics in preventing hemorrhage during and after cesarean section. https://clinicaltrials.gov/ct2/show/NCT060603272023. ">53</a>]; TRAAPrevia [<a href="#CD016278-bib-0054" title="Tranexamic acid for preventing blood loss following a cesarean delivery in women with placenta previa (traaprevia). https://www.clinicaltrials.gov/ct2/show/NCT04304625. ">54</a>]). Details are available in <a href="#CD016278-supitem-0005">Supplementary material 5</a>. </p> <p>This updated review comprises six included trials, 46 excluded trials, 47 trials awaiting classification, and three ongoing trials. </p> </section> <section id="CD016278-sec-0063"> <h4 class="title">Included studies</h4> <p>The characteristics of included studies are summarised in <a href="#CD016278-tbl-0002">Table 1</a> and <a href="#CD016278-supitem-0002">Supplementary material 2</a>. </p> <div class="table" id="CD016278-tbl-0002"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Overview of included studies and synthesis table</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p>Study ID</p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p>Trial registration number</p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p>Country</p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p>Participants</p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p>Intervention</p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p>Control</p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p>Additional interventions</p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p>Outcomes</p> </th> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p>Alam 2023</p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NCT03069859</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Canada</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Women giving birth vaginally or via CB (elective or urgent), gestational age ≥ 32 weeks. Women at low risk of PPH; n= 27 total (15 VB and 12 CB) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD016278-list-0017"> <li> <p>Tranexamic acid</p> </li> <li> <p>1 g</p> </li> <li> <p>IVI</p> </li> <li> <p>At time of shoulder delivery (VB) or during surgical site skin preparation (CB)</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Standardised protocol for oxytocin, additional uterotonics at the discretion of the physician </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD016278-list-0018"> <li> <p>PPH defined as blood loss &gt; 1000 mL</p> </li> <li> <p>Severe PPH</p> </li> <li> <p>Blood transfusion within 48 hours</p> </li> <li> <p>Emergency hysterectomy</p> </li> <li> <p>Other operative intervention</p> </li> <li> <p>Admission to ICU</p> </li> <li> <p>Safety‐related secondary outcomes</p> </li> </ul> </p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p>Lee 2023</p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NCT04427618</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Singapore</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Women ≥ 21 years old undergoing elective CB. Women at low and at high risk of PPH (44 women at high risk and 54 at low risk in the placebo group; 37 women at high risk and 59 at low risk in the TXA group; n = 200) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD016278-list-0019"> <li> <p>Tranexamic acid</p> </li> <li> <p>1 g</p> </li> <li> <p>IVI</p> </li> <li> <p>10 minutes prior to skin incision</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5 IU of oxytocin IV on delivery of baby</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD016278-list-0020"> <li> <p>Calculated estimated blood loss (cEBL)</p> </li> <li> <p>Gravimetrically estimated of blood loss</p> </li> <li> <p>Provider‐estimated blood loss</p> </li> <li> <p>Need for additional medical interventions (additional uterotonics, additional TXA, blood transfusion) </p> </li> <li> <p>Need for additional surgical interventions</p> </li> <li> <p>Maternal and neonatal adverse event</p> </li> </ul> </p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p>Ogunkua 2022</p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NCT03856164</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>USA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Women ≥ 18 years old with singleton, term pregnancies, with elective repeat CB (second or third). Women at low risk of PPH; n = 110 </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD016278-list-0021"> <li> <p>Tranexamic acid</p> </li> <li> <p>1 g x 2 (before and after delivery)</p> </li> <li> <p>IVI</p> </li> <li> <p>10 minutes prior to skin incision and immediately following placental delivery</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Oxytocin infusion on delivery of baby (all participants)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD016278-list-0022"> <li> <p>Mean calculated blood loss at 24 hours</p> </li> <li> <p>Provider‐estimated blood loss</p> </li> </ul> </p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p>Pacheco 2023</p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NCT03364491</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>USA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Women ≥ 18 years old, giving birth by scheduled or unscheduled caesarean section. Women at low risk of PPH; n = 11,000 </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD016278-list-0023"> <li> <p>Tranexamic acid</p> </li> <li> <p>1 g</p> </li> <li> <p>IVI</p> </li> <li> <p>Immediately after cord clamping</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>At the dicretion of the physician. Not clear whether all women received oxytocin or not </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD016278-list-0024"> <li> <p>Maternal death or blood transfusion before hospital discharge or 7 days' postpartum, whichever occurred first </p> </li> <li> <p>Estimated blood loss &gt; 1000 mL</p> </li> <li> <p>Intervention in response to bleeding and related complications</p> </li> <li> <p>Surgical or radiologic intervention</p> </li> <li> <p>Blood transfusion</p> </li> <li> <p>Thromboembolic events</p> </li> <li> <p>New‐onset seizures</p> </li> <li> <p>Admission to ICU for more than 24 h</p> </li> <li> <p>Side effects (nausea, vomiting, dizziness)</p> </li> </ul> </p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p>Sentilhes 2021</p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NCT03431805</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>France</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Women ≥ 18 years old, singleton or multiple pregnancy, 34 weeks and more gestational age, elective or emergency CB. Women at low risk of PPH; n = 4551 </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD016278-list-0025"> <li> <p>Tranexamic acid</p> </li> <li> <p>1 g</p> </li> <li> <p>IVI</p> </li> <li> <p>3 minutes after birth, after prophylactic uterotonic agent and cord had been clamped</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Prophylactic oxytocin (5 or 10 IU) or 100 μg carbetocin and additional prophylactic uterotonic agent if necessary </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD016278-list-0026"> <li> <p>Calculated estimated blood loss ≥ 1000 mL</p> </li> <li> <p>PPH</p> </li> <li> <p>Gravimetrically estimated blood loss</p> </li> <li> <p>Surgical intervention</p> </li> <li> <p>Transfusion</p> </li> <li> <p>Adverse events</p> </li> <li> <p>Maternal satisfaction</p> </li> </ul> </p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p>Shakur‐Still 2023</p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NCT04274335</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pakistan and Zambia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Women ≥ 18 years old giving birth by caesarean section. Women at high risk of PPH (1 or more risk factors for PPH); n = 120 </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD016278-list-0027"> <li> <p>Tranexamic acid</p> </li> <li> <p>IVI, IMI: 1 g</p> </li> <li> <p>Oral: 4 g</p> </li> <li> <p>1 hour before CB</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No intervention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All women received prophylactic uterotonics (details not reported).</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD016278-list-0028"> <li> <p>Blood loss</p> </li> <li> <p>Maternal death</p> </li> <li> <p>Use of additional uterotonics</p> </li> <li> <p>Adverse events</p> </li> </ul> </p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>CB: caesarean birth<br/>ICU: intensive care unit<br/>IMI: intramuscular injection<br/>IV: intravenous<br/>IVI: intravenous injection<br/>IU: international units<br/>PPH: postpartum haemorrhage<br/>TXA: tranexamic acid<br/>VB: vaginal birth </p> </div> </div> <section id="CD016278-sec-0064"> <h5 class="title">Participants</h5> <p>Six trials involving a combined total of 15,981 randomised participants investigated the efficacy of TXA for preventing PPH in participants giving birth by caesarean section (Alam 2023 [<a href="#CD016278-bib-0055" title="AlamAQ , BarrettJ , CallumJ , KaustovL , AuS , FleetA , et al. Tranexamic acid for the prevention of postpartum haemorrhage: the TAPPH-1 pilot randomized trial and lessons learned for trials in Canadian obstetrics. Scientific Reports2023;18;13(1):4512. [DOI: 10.1038/s41598-023-30947-8] [PMCID: PMC10024764.] [PMID: 36934142]">55</a>]; Lee 2023 [<a href="#CD016278-bib-0056" title="LeeSH , Kwek ME-J, TagoreS , WrightA , KuCW , TeongAC , et al. Tranexamic acid, as an adjunct to oxytocin prophylaxis, in the prevention of postpartum haemorrhage in women undergoing elective caesarean section: a single-centre double-blind randomised controlled trial. BJOG2023;130(9):1007-15. ">56</a>]; Ogunkua 2022 [<a href="#CD016278-bib-0057" title="OgunkuaOT , DuryeaEL , NelsonDB , EddinsMM , KlucsaritsSE , McIntireDD , et al. Tranexamic acid for prevention of hemorrhage in elective repeat cesarean delivery - a randomized study. American Journal of Obstetrics and Gynecology2022;4(2):100573. ">57</a>]; Pacheco 2023 [<a href="#CD016278-bib-0058" title="PachecoLD , CliftonRG , SaadeGR , WeinerSJ , ParryS , ThorpJM , et al, For the Eunice Kennedy Shriver National Institute of Child Health, Human Development Maternal-Fetal Medicine Units Network. Tranexamic acid to prevent obstetrical hemorrhage after cesarean delivery. New England Journal of Medicine2023;388(15):1365-75. ">58</a>, <a href="#CD016278-bib-0059" title="PachecoLD . Tranexamic acid for the prevention of obstetrical hemorrhage after cesarean delivery: a randomized controlled trial. American Journal of Obstetrics and Gynecology2022;226(1):S779?S780. ">59</a>]; Sentilhes 2021 [<a href="#CD016278-bib-0060" title="SentilhesL , SenatMV , Le LousM , WinerN , RozenbergP , KayemG , et al. Tranexamic acid for the prevention of blood loss after cesarean delivery. New England Journal of Medicine2021;384(17):1623-34. [CENTRAL: CN-02268529] [PMID: 33913639]">60</a>, <a href="#CD016278-bib-0061" title="SentilhesL , SenatMV , Le LousM , WinerN , RozenbergP , KayemG , et al. Tranexamic acid for the prevention of postpartum hemorrhage after cesarean delivery: the TRAAP2 trial. American Journal of Obstetrics &amp; Gynecology2021;224(2):S1. [CENTRAL: CN-02247791] [EMBASE: 2010867550]">61</a>, <a href="#CD016278-bib-0062" title="SentilhesL , DanielV , Deneux-TharauxC . TRAAP2 - TRAnexamic Acid for Preventing postpartum hemorrhage after cesarean delivery: a multicenter randomized, doubleblind, placebo-controlled trial - a study protocol. BMC Pregnancy and Childbirth2020;20(1):63. [CENTRAL: CN-02085587] [EMBASE: 630806397] [PMID: 32005192]">62</a>, <a href="#CD016278-bib-0063" title="EUCTR2017-001144-36-FR. Tranexamic acid for preventing postpartum hemorrhage following a cesarean delivery [TRAnexamic Acid for Preventing postpartum hemorrhage following a Cesarean Delivery: a multicenter randomised, double blind placebo controlled trial (TRAAP2) - TRAAP2]. www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2017-001144-36-FR. [CENTRAL: CN-02067652] ">63</a>, <a href="#CD016278-bib-0064" title="NCT03742947. Haemostasis and tranexamic acid in caesarean delivery [Study of peripartum haemostasis and effects of tranexamic acid in caesarean delivery: biologic ancillary study in TRAAP2 patients recruited at the Bordeaux University Hospital: BIO-TRAAP]. clinicaltrials.gov/show/NCT03742947 (first received 15 November 2018). [CENTRAL: CN-01918391] ">64</a>]; Shakur‐Still 2023 [<a href="#CD016278-bib-0065" title="Shakur-StillH , RobertsI , Grassin-DelyleS , ChaudhriR , GeerA , ArribasM , et al. Alternative routes for tranexamic acid treatment in obstetric bleeding (WOMAN-PharmacoTXA trial): a randomised trial and pharmacological study in caesarean section births. British Journal of Obstetrics and Gynaecology2023;130(10):1177-18. ">65</a>]). The two biggest trials combined comprised 15,551 participants (i.e. 97% of the total number of participants included in this review) (Pacheco 2023; Sentilhes 2021). </p> <p>One trial included 27 participants giving birth vaginally (n = 15) and by caesarean section (n = 12) (Alam 2023). </p> <p>Three trials included participants having either elective or emergency caesarean births (Alam 2023; Pacheco 2023; Sentilhes 2021). Lee 2023 included only elective caesarean births, while Ogunkua 2022 included only elective repeat caesarean births. Shakur‐Still 2023 did not specify whether participants underwent elective or emergency caesarean births. </p> <p>One trial included participants who had one or more risk factors for PPH (Shakur‐Still 2023), while another trial included both high‐ and low‐risk women (Lee 2023). All other trials included women at low risk of PPH (Alam 2023; Ogunkua 2022; Pacheco 2023; Sentilhes 2021). </p> </section> <section id="CD016278-sec-0065"> <h5 class="title">Interventions</h5> <p>All included studies assessed the effect of TXA in addition to standard care.</p> <p>Four trials administered oxytocin to all participants on delivery of the baby (Lee 2023; Ogunkua 2022; Sentilhes 2021; Shakur‐Still 2023), and Sentilhes 2021 specified that additional prophylactic uterotonic agents were given if necessary. Sentilhes 2021 reported administering 5 or 10 international units (IU) or 100 µg carbetocin, while Lee 2023 specified that the dose of oxytocin was 5 IU intravenous injection. Ogunkua 2022 did not specify the dose. Pacheco 2023 administered oxytocin at the discretion of the physician, and it is unclear whether all participants received it. </p> <p>Alam 2023 stated that standardised protocols were followed for oxytocin after delivery, but the details are unclear. In Shakur‐Still 2023, all participants received prophylactic uterotonics, but no further detail was provided. </p> </section> <section id="CD016278-sec-0066"> <h5 class="title">Timing of TXA</h5> <p>TXA was administered at different times in the trials.</p> <section id="CD016278-sec-0067"> <h6 class="title">Caesarean section</h6> <p> <ul id="CD016278-list-0029"> <li> <p>At least 10 minutes prior to skin incision and again after placental delivery (Ogunkua 2022). </p> </li> <li> <p>10 minutes prior to skin incision (Lee 2023).</p> </li> <li> <p>During the 3 minutes after birth, after the prophylactic uterotonic agent had been administered and the cord had been clamped (Pacheco 2023; Sentilhes 2021). </p> </li> <li> <p>During surgical site skin preparation (Alam 2023).</p> </li> <li> <p>1 hour (± 30 minutes) before caesarean section (Shakur‐Still 2023).</p> </li> </ul> </p> </section> </section> <section id="CD016278-sec-0068"> <h5 class="title">Route and dose of TXA</h5> <p>Intravenous TXA was administered as a fixed dose in all six trials: 1 g in five trials (Alam 2023; Lee 2023; Pacheco 2023; Sentilhes 2021; Shakur‐Still 2023) and 2 g in one trial (Ogunkua 2022). </p> <p>The Shakur‐Still 2023 trial also included a group receiving 1 g intramuscular TXA and a group receiving 4 g oral TXA. </p> </section> <section id="CD016278-sec-0069"> <h5 class="title">Comparisons</h5> <p>Five trials compared TXA to placebo (normal saline) (Alam 2023; Lee 2023; Ogunkua 2022; Pacheco 2023; Sentilhes 2021). </p> <p>One trial compared different routes of administering TXA (intravenous, intramuscular, and oral) with a control (standard care) group (Shakur‐Still 2023). </p> </section> <section id="CD016278-sec-0070"> <h5 class="title">Measurement of blood loss ≥ 1000 mL</h5> <p>Two trials calculated blood loss ≥ 1000 mL using formulae that included haematocrit and haemoglobin levels as well as relevant patient details (Lee 2023; Sentilhes 2021). One trial measured blood loss ≥ 1000 mL using provider estimation of physicians (Ogunkua 2022), and one trial estimated intraoperative blood loss of more than 1 litre, assessed on the basis of data obtained from the anaesthesia record and the operative report (Pacheco 2023). </p> </section> <section id="CD016278-sec-0071"> <h5 class="title">Settings</h5> <p>Five trials were conducted in high‐resource settings (Alam 2023; Lee 2023; Ogunkua 2022; Pacheco 2023; Sentilhes 2021), and one trial was conducted in lower‐resource settings (Shakur‐Still 2023). The high‐resource settings included the USA (Ogunkua 2022; Pacheco 2023), Canada (Alam 2023), France (Sentilhes 2021), and Singapore (Lee 2023). Shakur‐Still 2023 was conducted in Zambia and Pakistan. </p> </section> <section id="CD016278-sec-0072"> <h5 class="title">Contact with trial authors</h5> <p>We emailed the corresponding authors of all trials to request additional information about outcomes after the review was aligned to the WHO outcomes. The authors of Alam 2023 and Shakur‐Still 2023 provided additional information, while responses from the other authors were not received in time for review submission. </p> </section> </section> <section id="CD016278-sec-0073"> <h4 class="title">Excluded studies</h4> <p>Details of the excluded studies are provided in <a href="#CD016278-supitem-0003">Supplementary material 3</a>. </p> <p>We excluded 46 studies for the following reasons.</p> <p> <ul id="CD016278-list-0030"> <li> <p>Retrospectively registered (Abdel‐Aleem 2013; Ahmed 2015; Gungorduk 2011; Gungorduk 2013; Igboke 2022 [<a href="#CD016278-bib-0066" title="IgbokeFN , ObiVO , DimejesiBI , LawaniLO . Tranexamic acid for reducing blood loss following vaginal delivery: a double-blind randomized controlled trial. BioMed Central Pregnancy and Childbirth2022;22(178):1. [DOI: 10.1186/s12884-022-04462-z]">66</a>]; Ismail 2017 [<a href="#CD016278-bib-0067" title="IsmailAM , AbbasAM , ShahatMA , AliMK . Evaluation of subendometrial and intramyometrial blood flow after intravenous tranexamic acid for prevention of postpartum hemorrhage in vaginal delivery: a randomized controlled study. Journal of Gynecological Research and Obstetrics2017;3(2):046-52. [CENTRAL: CN-01609034] ">67</a>]; Jafarbegloo 2021 [<a href="#CD016278-bib-0068" title="JafarbeglooE , FaridnyiaF , AhangariR , MohammadbeigiA . Prophylactic use of tranexamic acid on blood loss in cesarean delivery: a randomized controlled- clinical trial. Trauma Monthly2021;26(1):19-24. ">68</a>]; Milani 2019 [<a href="#CD016278-bib-0069" title="MilaniF , SharamiSH , FarzadiS , HaryalchiK , AtrkarroshanZ . Prophylactic effect of tranexamic acid on hemorrhage during and after the cesarean section. International Journal of Women's Health and Reproduction Sciences2019;7(1):74-8. [CENTRAL: CN-01793985] [EMBASE: 625996781]">69</a>]; Movafegh 2011; Naeiji 2020 [<a href="#CD016278-bib-0070" title="NaeijiZ , DelshadiyanN , SalehS , MoridiA , RahmatiN , FathiM . Prophylactic use of tranexamic acid for decreasing the blood loss in elective cesarean section: a placebo-controlled randomized clinical trial. Journal of Gynecology Obstetrics and Human Reproduction2020;50(1):101973. [CENTRAL: CN-02210140] [EMBASE: 2010158550] [PMID: 33221559]">70</a>]; Pakniat 2019 [<a href="#CD016278-bib-0071" title="PakniatH , CheginiV , ShojaeiA , KhezriMB , AnsariI . Comparison of the effect of intravenous tranexamic acid and sublingual misoprostol on reducing bleeding after cesarean section: a double-blind randomized clinical trial. Journal of Obstetrics and Gynaecology of India2019;69(3):239-45. [CENTRAL: CN-02004087] ">71</a>]; Samimi 2013 [<a href="#CD016278-bib-0072" title="SamimiM , MoravvejiSA , Heidari-ShiraziF . The effect of tranexamic acid on pregnancy outcome and vaginal post-parturition hemodynamics. Feyz: Journal of Kashan University of Medical Sciences2013;17(2):114-22. [CENTRAL: CN-02134955] ">72</a>]; Sujita 2018 [<a href="#CD016278-bib-0073" title="SujitaA , SongthamwatS , SongthamwatM . Effectiveness of tranexamic acid for reducing postpartum blood loss in the first two hours after vaginal delivery: a randomised controlled trial. Journal of Clinical and Diagnostic Research2018;12(3):QC01-4. [CENTRAL: CN-01572688] [EMBASE: 621390430]">73</a>, <a href="#CD016278-bib-0074" title="SujitaA , SongthamwatM , SongthamwatS . Efficacy of tranexamic acid for reducing blood loss after vaginal delivery: a randomized control trial, double blind. Journal of Obstetrics and Gynaecology Research2017;43:41. [CENTRAL: CN-01744328] [EMBASE: 616813318]">74</a>]). </p> </li> <li> <p>Not registered (Abbas 2019 [<a href="#CD016278-bib-0075" title="AbbasAM , ShadyNW , SallamHF . Bilateral uterine artery ligation plus intravenous tranexamic acid during cesarean delivery for placenta previa: a randomized double-blind controlled trial. Journal of Gynecology Obstetrics and Human Reproduction2019;48(2):115-9. [CENTRAL: CN-01930043] [PMID: 30412786]">75</a>]; Bose 2017 [<a href="#CD016278-bib-0076" title="BoseD , BeegumR . Sublingual misoprostol vs intravenous tranexamic acid in reducing blood loss during cesarean section: a prospective randomized study. Journal of SAFOG2017;9(1):9-13. [CENTRAL: CN-01430856] [EMBASE: 619028533]">76</a>]; Goswami 2013; Ray 2016 [<a href="#CD016278-bib-0077" title="RayI , BhattacharyaR , ChakrabortyS , BagchiC , MukhopadhyayS . Role of intravenous tranexamic acid on caesarean blood loss: a prospective randomised study. Journal of Obstetrics and Gynaecology of India2016;66(Suppl 1):S347-52. [CENTRAL: CN-01761234] [EMBASE: 610988100] [PMID: 27651628]">77</a>]). </p> </li> <li> <p>Quasi‐randomised (Chandak 2017 [<a href="#CD016278-bib-0078" title="ChandakAV , GuptaI , SreemayiC . Efficacy of tranexamic acid in decreasing blood loss during and after cesarean section: a randomized case controlled prospective study. International Journal of Science and Research2017;6(1):1321-3. ">78</a>]; Gohel 2007 [<a href="#CD016278-bib-0079" title="GohelM , PatelP , GuptaA , DesaiP . Efficacy of tranexamic acid in decreasing blood loss during and after cesarean section: a randomized case controlled prospective study. Journal of Obstetrics and Gynaecology of India2007;57(3):228-30. ">79</a>]; Sekhavat 2009 [<a href="#CD016278-bib-0080" title="SekhavatL , TabatabaiiA , DaliliM , FarajkhodaT , TaftiAD . Efficacy of tranexamic acid in reducing blood loss after cesarean section. Journal of Maternal-Fetal &amp; Neonatal Medicine2009;22(1):72-5. ">80</a>]). </p> </li> <li> <p>Participants with established PPH at time of randomisation (Ducloy‐Bouthors 2018 [<a href="#CD016278-bib-0081" title="Ducloy-Bouthors A-S, JeanpierreE , SaidiI , Baptiste A-S, SimonE , LannoyD , et al. TRAnexamic acid in hemorrhagic CESarean section (TRACES) randomized placebo controlled dose-ranging pharmacobiological ancillary trial: study protocol for a randomized controlled trial. Trials2018;19(1):149. [CENTRAL: CN-01464518] [EMBASE: 620904152]">81</a>, <a href="#CD016278-bib-0082" title="Bouthors A-S, HennartB , JeanpierreE , Baptiste A-S, SaidiI , SimonE , et al. Therapeutic and pharmaco-biological, dose-ranging multicentre trial to determine the optimal dose of TRAnexamic acid to reduce blood loss in haemorrhagic CESarean delivery (TRACES): study protocol for a randomised, double-blind, placebo-controlled trial. Trials2018;19(1):148. [CENTRAL: CN-01464283] [EMBASE: 620904151]">82</a>, <a href="#CD016278-bib-0083" title="Ducloy-Bouthors A-S, JeanpierreE , HennartB , Baptiste A-S, GiovannoniS , SaidiI , et al. TRAnexamic acid to reduce blood loss in haemorrhagic CESarean delivery: therapeutic and pharmaco-biological dose-ranging multicentre randomised double-blind placebo-controlled study: TRACES trial methodology [Tranexamic Acid to Reduce Blood Loss in Hemorrhagic Caesarean Delivery: a Multicenter Randomized Double Blind Placebo Controlled Therapeutic and Pharmaco-biological Dose Ranging Study (TRACES) for Its Optimal Benefit/Risk]. Transfusion Medicine (Oxford, England)2017;27:61-62, Abstract no: P95. [CENTRAL: CN-01558936] ">83</a>]; Hunt 2013 [<a href="#CD016278-bib-0084" title="HuntBJ . Tranexamic acid for the treatment of postpartum haemorrhage-preliminary results of the woman trial. Transfusion Medicine (Oxford, England)2013;23(Suppl 1):7. ">84</a>]; Javadi 2015 [<a href="#CD016278-bib-0085" title="JavadiEH , SadeghipourZ , BarikaniA , JavadiM . Tranexamic acid in the control of uterine atony during labor. Biotechnology and Health Sciences2015;2(2):e26898. ">85</a>]; Sahaf 2014 [<a href="#CD016278-bib-0086" title="SahhafF , AbbasalizadehS , GhojazadehM , VelayatiA , KhandanlooR , SalehP , et al. Comparison effect of intravenous tranexamic acid and misoprostol for postpartum haemorrhage. Nigerian Medical Journal2014;55(4):348-53. [CENTRAL: CN-01076651] [PMCID:: PMC4124551] [PMID: 25114373]">86</a>]; Zargar 2018 [<a href="#CD016278-bib-0087" title="ZargarM , NikbakhtR , AhmadiM . The effect of tranexamic acid on preventing post-partum hemorrhage due to uterine atony: a triple-blind randomized clinical trial. Current Clinical Pharmacology2018;13(2):136-9. [CENTRAL: CN-01649688] [EMBASE: 624513891] [PMID: 29732978]">87</a>]). </p> </li> <li> <p>Not randomised (Bhatia 2015 [<a href="#CD016278-bib-0088" title="BhatiaSK , DeshpandeH . Role of tranexamic acid in reducing blood loss during and after caesarean section. Medical Journal of Dr D.Y. Patil University2015;8(1):21-5. ">88</a>]; Halder 2013 [<a href="#CD016278-bib-0089" title="HalderS , SamantaB , SardarR , ChattopadhyayS . Tranexamic acid used before caesarean section reduces blood loss based on pre- and postoperative hemoglobin level: a case-control study. Journal of the Indian Medical Association2013;111(3):184-6. ">89</a>]; Rashmi 2012 [<a href="#CD016278-bib-0090" title="RashmiPS , SudhaTR , PrabhudevP , PatilR , VijayanathV . Role of tranexamic acid in reducing blood loss during and after cesarean section. A randomized case control prospective study. Journal of Medical Research and Practice2012;1(2):40-3. ">90</a>]; Sahu 2019 [<a href="#CD016278-bib-0091" title="SahuJ , MishraN . Role of intravenous tranexamic acid in reducing blood loss during caesarean section: study at tribal-dominated area hospital in Chhattisgarh, India [Role of intravenous tranexamic acid in reducing blood loss during caesarean section: study at tribal-dominated area hospital in Chhattisgarh, India]. Journal of Obstetrics and Gynaecology Research2019;45(4):841-8. [CENTRAL: CN-01932139] [EMBASE: 626068178]">91</a>]; Singh 2014 [<a href="#CD016278-bib-0092" title="SinghT , BuruteSB , DeshpandeHG , JethaniS , RatwaniK . Efficacy of tranexamic acid in decreasing blood loss during and after caesarean section: a randomized case control prospective study. Journal of Evolution of Medical and Dental Sciences2014;3:2780-8. ">92</a>]). </p> </li> <li> <p>Topical TXA (Sallam 2018 [<a href="#CD016278-bib-0093" title="NCT03778242. Oxytocin and tranexamic acid in pregnant women with twin pregnancy undergoing cesarean section [Effects of Co-administered Oxytocin and Intravenous Tranexamic Acid on Prevention of Postpartum Hemorrhage in Pregnant Women With Twin Pregnancy Undergoing Elective Cesarean Section: a Double-Blind Randomized Clinical Trial]. Https://clinicaltrials.gov/show/nct03778242 (first received 2018 Dec 18). [CENTRAL: CN-01918664] ">93</a>]). </p> </li> <li> <p>Vaginal deliveries (Ker 2024 [<a href="#CD016278-bib-0094" title="The WOMAN-2 Trial Collaborators. Tranexamic acid for the prevention of postpartum bleeding in women with anaemia: study protocol for an international, randomised, double-blind, placebo-controlled trial. Trials2018;19(712):https://doi.org/10.1186/s13063-018-3081-x. ">94</a>, <a href="#CD016278-bib-0095" title="World maternal antifibrinolytic trial_2 (WOMAN-2). https://clinicaltrials.gov/ct2/show/NCT03475342. ">95</a>, <a href="#CD016278-bib-0096" title="KerK , RobertsI , ChaudhriR , FawoleB , BeaumontD , BalogunE , et al. Tranexamic acid for the prevention of postpartum bleeding in women with anaemia: study protocol for an international, randomised, double-blind, placebo-controlled trial. Trials2018;19(1):712. [CENTRAL: CN-01792461] [EMBASE: 625692661] [PMID: 30594227]">96</a>, <a href="#CD016278-bib-0097" title="ISRCTN62396133. World maternal antifibrinolytic trial-2 [Tranexamic acid for the prevention of postpartum bleeding in Women with anaemia: an international, randomised, double-blind, placebo controlled trial]. Http://www.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN62396133 (first received 2017). [CENTRAL: CN-01885095] ">97</a>]; Mei 2019 [<a href="#CD016278-bib-0098" title="MeiLL , RueyS , WenEP , GhaniNA , WahabAV . Tranexamic acid usage in third stage labour in reducing post-partum haemorrhage in high risk mothers following a vaginal delivery: a randomised prospective, double-blinded clinical trial. In: Medical Journal of Malaysia. Vol. 74. Malaysian Medical Association, 2019:2. [CENTRAL: CN-02205541] [EMBASE: 633276952]">98</a>]; Mirghafourvand 2013; Sentilhes 2018 [<a href="#CD016278-bib-0099" title="SentilhesL , DanielV , DarsonvalA , DeruelleP , VardonD , PerrotinF , et al. Study protocol. TRAAP - TRAnexamic Acid for Preventing postpartum hemorrhage after vaginal delivery: a multicenter randomized, double-blind, placebo-controlled trial. BMC Pregnancy and Childbirth2015;15(1):135. [CENTRAL: CN-01076658] [EMBASE: 2015125583] [PMCID:: PMC4465316] [PMID: 26071040]">99</a>, <a href="#CD016278-bib-0100" title="Durand-ZaleskiI , Deneux-TharauxC , SecoA , MalkiM , FrenkielJ , SentilhesL . An economic evaluation of tranexamic acid to prevent postpartum haemorrhage in women with vaginal delivery: the randomised controlled TRAAP trial. BJOG2021;128(1):114-20. [CENTRAL: CN-02178159] [EMBASE: 2006051932] [PMID: 32770781]">100</a>, <a href="#CD016278-bib-0101" title="SentilhesL , WinerN , AzriaE , SenatMV , Le RayC , VardonD , et al. Tranexamic acid for the prevention of blood loss after vaginal delivery. New England Journal of Medicine2018;379(8):731-42. [CENTRAL: CN-01626893] [PMID: 30134136]">101</a>, <a href="#CD016278-bib-0102" title="EUCTR2014-001748-39-FR. Impact de l'injection d'acide tranexamique en prevention de l'hemorragie du post partum apres un accouchement par voie basse [TRAnexamic Acid for Preventing postpartum hemorrhage following a vaginal delivery: a multicenter randomised, double blind placebo controlled trial - TRAAP]. Http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2014-001748-39-FR (first received 2015). [CENTRAL: CN-01864814] ">102</a>, <a href="#CD016278-bib-0103" title="SentilhesL , WinerN , AzriaE , Senat M-V, Le RayC , VardonD , et al. Tranexamic acid for the prevention of postpartum hemorrhage after vaginal delivery: the TRAAP trial. American Journal of Obstetrics and Gynecology2018;218(1 Supplement 1):S2-3. [CENTRAL: CN-01450841] [EMBASE: 620309567]">103</a>, <a href="#CD016278-bib-0104" title="SentilhesL , DanielV , DarsonvalA , DeruelleP , VardonD , PerrotinF , et al. Study protocol. TRAAP - TRAnexamic Acid for Preventing postpartum hemorrhage after vaginal delivery: a multicenter randomized, double-blind, placebo-controlled trial. BMC Pregnancy and Childbirth2015;15:135. [CENTRAL: CN-01257586] [PMID: 26071040]">104</a>, <a href="#CD016278-bib-0105" title="NCT02302456. Tranexamic acid for preventing postpartum haemorrhage following a vaginal delivery (TRAAP). Clinicaltrials.gov/ct2/show/NCT02302456 (first received Date first received: 17 November 2014). ">105</a>]; Shady 2017 [<a href="#CD016278-bib-0106" title="ShadyNW , SallamHF , ElsayedAH , AbdelkaderAM , AliSS , AlanwarA , et al. The effect of prophylactic oral tranexamic acid plus buccal misoprostol on blood loss after vaginal delivery: a randomized controlled trial. Journal of Maternal-Fetal &amp; Neonatal Medicine2017;27:1-7. [CENTRAL: CN-01440910] [EMBASE: 619981098]">106</a>]; Shady 2019 [<a href="#CD016278-bib-0107" title="ShadyNW , SallamHF , ElsayedAH , AbdelkaderAM , AliSS , AlanwarA , et al. The effect of prophylactic oral tranexamic acid plus buccal misoprostol on blood loss after vaginal delivery: a randomized controlled trial. Journal of Maternal-Fetal &amp; Neonatal Medicine2019;32(11):1806-12. [CENTRAL: CN-01944542] [PMID: 29241383]">107</a>]; TAAPP‐V [<a href="#CD016278-bib-0108" title="Tranexamic acid along with AMTSL for preventing PPH in vaginal delivery: TAAPP-V. CTRI/2021/05/033500. ">108</a>]; Tali 2016 [<a href="#CD016278-bib-0109" title="TaliK , Ignacio AlensuelaA . The effect of prophylactic intravenous tranexamic acid in reducing blood loss after vaginal delivery in women at low risk of postpartum haemorrhage: a prospective, randomised, double-blind, placebo-controlled study. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2016;56(Suppl 1):61. [CENTRAL: CN-01252518] [EMBASE: 613101716]">109</a>]; Yang 2001; Zheng 2000 [<a href="#CD016278-bib-0110" title="ZhengSR , LiMZ , ChiGZ . Effects of tranexamic acid on decreasing blood loss within two hours after delivery. A multicenter randomized comparative study. Blood2000;96(11):846a. [CENTRAL: CN-00486589] ">110</a>]). </p> </li> <li> <p>Only trial registration available (Maged 2015 [<a href="#CD016278-bib-0111" title="ACTRN12615000312549. Efficiency and safety of preoperative Tranexamic acid in reducing perioperative blood loss in elective cesarean section. Https://anzctr.org.au/ACTRN12615000312549.aspx (first received 2015). ">111</a>, <a href="#CD016278-bib-0112" title="MagedAM , HelalOM , ElsherbiniMM , EidMM , ElkomyRO , DahabS , et al. A randomized placebo-controlled trial of preoperative tranexamic acid among women undergoing elective cesarean delivery. International Journal of Gynaecology and Obstetrics2015;131(3):265-8. [CENTRAL: CN-01140746] [EMBASE: 2015345374] [PMID: 26341174]">112</a>]; NCT02350179 [<a href="#CD016278-bib-0113" title="NCT02350179. Efficacy of tranexamic acid in reducing blood loss during and after caesarean section [Efficacy of Tranexamic Acid in Reducing Blood Loss During and After Caesarean Section]. Https://clinicaltrials.gov/show/NCT02350179 (first received 2015 Jan 1). [CENTRAL: CN-01551809] ">113</a>]; NCT02688127 [<a href="#CD016278-bib-0114" title="NCT02688127. Efficacy of tranexamic acid in reducing blood loss during cesarean section because of placenta previa [Efficacy of Tranexamic Acid In Reducing Blood Loss Among Pregnant Women During Cesarean Section Because Of Placenta Previa]. Https://clinicaltrials.gov/show/NCT02688127 (first received 2016 February 23). [CENTRAL: CN-01555966] ">114</a>]; Shirazi 2012 [<a href="#CD016278-bib-0115" title="IRCT201204079399N1. A placebo-controlled clinical trial to assess efficacy of tranexamic acid in reducing hemorrhage after vaginal delivery. Http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT201204079399N1 (first received 2012). [CENTRAL: CN-01864636] ">115</a>]; Sujata 2016 [<a href="#CD016278-bib-0116" title="SujataN , TobinR , KaurR , AnejaA , KhannaM , HanjooraVM . Randomized controlled trial of tranexamic acid among parturients at increased risk for postpartum hemorrhage undergoing cesarean delivery. International Journal of Gynaecology and Obstetrics2016;133(3):312-5. [CENTRAL: CN-01158811] [EMBASE: 20160186494] [PMID: 26952346]">116</a>, <a href="#CD016278-bib-0117" title="CTRI/2015/05/005752. Tranexamic acid to reduce bleeding after cesarean section in high risk patients [Role of Tranexamic acid in reducing the use of uterotonic drugs in parturients at increased risk for obstetric haemorrhage undergoing cesarean section]. Http://www.who.int/trialsearch/Trial2.aspx?TrialID=CTRI/2015/05/005752 (first received 2015). [CENTRAL: CN-01847694] ">117</a>]). </p> </li> </ul> </p> <p>We categorised 47 studies for which inadequate information on methods was presented or available from the author to permit inclusion as awaiting classification. We contacted the authors via email, and the studies remained in this category until a response was received (Al‐Nasrawi 2019 [<a href="#CD016278-bib-0118" title="Al-NasrawiH . Evaluation of the role of tranexamic acid in prevention of postpartum bleeding: a case control study. Indian Journal of Forensic Medicine and Toxicology2019;13(4):895-900. [CENTRAL: CN-02077566] [EMBASE: 2003259860]">118</a>]; Bangsah 2023 [<a href="#CD016278-bib-0119" title="Bangash, AG, Riaz, S, Akhtar, Z, et al. Tranexamic acid plus oxytocin prophylaxis in reducing blood loss and preventing postpartum hemorrhage during cesarean section. Journal of Medical Sciences (Taipei, Taiwan)2023;31(3):203�207. [DOI: 10.52764/jms.23.31.3.8]">119</a>]; Bhavana 2013; Dawoud 2023 [<a href="#CD016278-bib-0120" title="DawoudM , Al-HusseinyM , HelalO , ElsherbiniM , Abdel-RasheedM , SediekM . Intravenous tranexamic acid vs. sublingual misoprostol in high-risk women for postpartum haemorrhage following cesarean delivery; a randomised clinical trial. BioMed Central Pregnancy and Childbirth2023;23(1):611. [DOI: 10.1186/s12884-023-05935-5]]">120</a>]; Diab 2020 [<a href="#CD016278-bib-0121" title="DiabKM , Mohamed andAG AbdelhayRM . The Efficacy of Intravenous Tranexamic Acid in Reduction of Blood Loss in Women at High Risk of Postpartum Hemorrhage. In: From the Department of Obstetrics and Gynecology, Faculty of Medicine Ain Shams University, Cairo, Egypt. 2020. ">121</a>]; Farhadifar 2021 [<a href="#CD016278-bib-0122" title="FarhadifarF , ShahgheibiS , ZareS , RezaieM , SeyedolshohadaeF , SharamiSR , et al. Investigation of prophylactic effect of tranexamic acid in preventing postpartum hemorrhage in besat hospital in sanandaj. Pakistan Journal of Medical and Health Sciences2021;15(3):966-9. [CENTRAL: CN-02275027] [EMBASE: 2011993833]">122</a>]; Gai 2004; Ghosh 2014 [<a href="#CD016278-bib-0123" title="GhoshA , ChaudhuribP , MuhuriB . Efficacy of intravenous tranexamic acid before cesarean section in preventing post partum hemorrhagea prospective randomised double blind placebo controlled study. International Journal of Biological &amp; Medical Research2014;5(4):4461-4. ">123</a>]; Gobbur 2011 [<a href="#CD016278-bib-0124" title="GobburVR , ReddySV , BijapurUJ . Efficacy of tranexamic acid in reducing blood loss during lower segment caesarean section. In: 54th All India Congress of Obstetrics and Gynaecology; 2011 January 5-9; Hyderabad, Andhra Pradesh, India. 2011:92. ">124</a>]; Gobbur 2014 [<a href="#CD016278-bib-0125" title="GobburVR , ShiragurSS , JhanwarUR , TehaliaMJ . Efficacy of tranexamic acid in reducing blood loss during lower segment caesarean section. International Journal of Reproduction, Contraception, Obstetrics and Gynecology2014;3(2):414-7. [CENTRAL: CN-02272414] ">125</a>]; Gwanzura 2022 [<a href="#CD016278-bib-0126" title="Gwanzura. Efficacy of tranexamic acid in preventing postpartum haemorrhage after elective caesarean section. Clinical Trials.gov (https://Clinicaltrials.gov/Study/NCT03463993) Last updated: 01/06/2022. ">126</a>]; Gwanzura 2023 [<a href="#CD016278-bib-0127" title="The efficacy of tranexamic acid in preventing postpartum haemorrhage after caesarean section (ETAPPH). https://clinicaltrials.gov/ct2/show/study/NCT04733157. ">127</a>]; Hemapriya 2020 [<a href="#CD016278-bib-0128" title="HemapriyaL , MoreG , KumarA . Efficacy of tranexamic acid in reducing blood loss in lower segment cesearean section: a randomised controlled study. Journal of Obstetrics and Gynaecology of India2020;70(6):479-84. [CENTRAL: CN-02178207] [EMBASE: 2006073040] [PMID: 33417631]">128</a>]; Ifunanya 2019 [<a href="#CD016278-bib-0129" title="IfunanyaNJ , ChukwuIC , NobertOC , BlessingO , ChibuzorU , UchennaO . Tranexamic acid versus placebo for prevention of primary postpartum haemorrhage among high risk women undergoing caesarean section in Abakaliki: a randomized controlled trial. Open Journal of Obstetrics and Gynecology2019;9(6):914-22. ">129</a>]; Kafayat 2019 [<a href="#CD016278-bib-0130" title="KafayatH , JanjuaM , NaheedI , IqbalT . To assess the prophylactic role of tranexamic acid in reducing blood loss during and after two hours of caesarean section. Pakistan Journal of Medical and Health Sciences2019;12(4):1662-5. [CENTRAL: CN-01914956] [EMBASE: 2001674035]">130</a>]; Kremer 2019 [<a href="#CD016278-bib-0131" title="KremerM , CortezC . Perioperative administration of tranexamic acid for placenta previa and accreta study (TAPPAS): a randomized trial. Obstetrics and Gynecology2019;133(Suppl 1):1. [CENTRAL: CN-02228782] [EMBASE: 633844323]">131</a>, <a href="#CD016278-bib-0132" title="NCT02806024. Perioperative administration of tranexamic acid for placenta previa and accreta study [Perioperative Administration of Tranexamic Acid for Placenta Previa and Accreta Study (TAPPAS): a Randomized, Placebo-controlled Double Blind Trial]. Https://clinicaltrials.gov/show/NCT02806024 (first received 2016 June 20). [CENTRAL: CN-01559173] ">132</a>]; Lakshmi 2016 [<a href="#CD016278-bib-0133" title="LakshmiSJ , AbrahamR . Role of prophylactic tranexamic acid in reducing blood loss during elective caesarean section: a randomized controlled study. Journal of Clinical and Diagnostic Research2016;10(12):OC17-21. [CENTRAL: CN-01286685] [EMBASE: 613547126]">133</a>]; Malathi 2016 [<a href="#CD016278-bib-0134" title="MalathiP , AnupamaD , HabithaP . Effect of injection tranexamic acid on peri-operative blood loss during cesarean section. International Archives of Integrated Medicine2016;3(10):280-9. ">134</a>]; Markley 2015 [<a href="#CD016278-bib-0135" title="MarkleyJC , TsenLC , VarelmannDJ , FarberMK . The influence of prophylactic tranexamic acid on thromboelastography during cesarean delivery: a randomized, double-blind, placebo-controlled trial. In: Society for Obstetric Anesthesia and Perinatology (SOAP) 47th Annual Meeting; 2015 May 13-17; Colorado, USA. 2015:T-36. ">135</a>]; Masood 2023 [<a href="#CD016278-bib-0136" title="JaveriaM , ZartajH , NadiaA , RobinaJ , NazishS , FaizaM . Comparison of estimated blood loss between tranexamic acid and control in women undergoing elective cesarean section. Pakistan Journal of Medical &amp; Health Sciences2023;17(04):288-90. [DOI: 10.53350/pjmhs2023174288]">136</a>]; Moradan 2018 [<a href="#CD016278-bib-0137" title="MoradanS , AnarakiRM , MirmohammadkhaniM . Prophylactic effect of misoprostol versus tranexamic acid in conjunction with oxytocin in reduction of post-partum hemorrhage after cesarean sectionin: a randomized clinical trial. Koomesh2018;20(4):620-5. [CENTRAL: CN-01651839] [EMBASE: 624107599]">137</a>]; Nandal 2022 [<a href="#CD016278-bib-0138" title="NandalI , KocharSP , DahiyaA , KaurR . Role of intravenous tranexamic acid in reducing blood loss during caesarean delivery. International Medical Journal2022;29(1)(23):252022. ">138</a>]; Nargis 2020 [<a href="#CD016278-bib-0139" title="NargisN , DewanF . Prophylactic use of tranexamic acid during caesarean section in preventing postpartum haemorrhage-a prospective randomised double blind placebo controlled study. Bangladesh Journal of Obstetrics and Gynecology2020;33(2):125-30. [CENTRAL: CN-02193474] [EMBASE: 2007609862]">139</a>]; Obi 2019 [<a href="#CD016278-bib-0140" title="ObiVO , UmeoraOU , DimejesiIB , AsiegbuO , MgbafuluCC , IfemelummaCC , et al. Efficacy of intravenous tranexamic acid at reducing blood loss during elective caesarean section in Abakaliki: a double blind randomized placebo controlled trial. African Journal of Medical and Health Sciences2019;18(2):10-7. ">140</a>]; Ortuanya 2024 [<a href="#CD016278-bib-0141" title="OrtuanyaKE , ElejeGU , EzugwuFO , OduguBU , IkechebeluJI , UgwuEO , et al. Prophylactic tranexamic acid for reducing intraoperative blood loss during cesarean section in women at high risk of postpartum hemorrhage: A double-blind placebo randomized controlled trial. Women's Health (London, England)2024;20:17455057231225311. [DOI: 10.1177/17455057231225311] [PMCID: PMC10822094.] [PMID: 38279808]">141</a>]; Poonia 2012 [<a href="#CD016278-bib-0142" title="PooniaM , BansalA , BhardwajN , KumariS . Role of tranexamic acid in reducing blood loss after caesarean section: a randomized case control prospective study. Journal of Medical Science and Research2012;3(2):44-6. ">142</a>]; Ramani 2014 [<a href="#CD016278-bib-0143" title="RamaniB . Intravenous 1 gram tranexamic acid for prevention of blood loss and blood transfusion during caesarean section: a randomized case control study. International Journal of Reproduction, Contraception, Obstetrics and Gynecology2014;3(2):366-9. ">143</a>]; Ramesh 2015 [<a href="#CD016278-bib-0144" title="RameshAC , RajniS , DekaN . Efficacy of tranexamic acid in decreasing blood loss during and after cesarean section: A randomized case controlled prospective study. Indian Journal of Public Health Research and Development2015;6(2):12-5. [CENTRAL: CN-01076660] [EMBASE: 604818004]">144</a>]; Rashid 2024 [<a href="#CD016278-bib-0145" title="Dr MamunR , Dr DebdutB , Dr RituS , Dr DebobrotoR , Dr JayasreeH . Effectivity of intravenous tranexamic acid in addition to oxytocin on blood loss during and after caesarean delivery�a rct. Journal of Cardiovascular Disease Research2024;15(1):1. ">145</a>]; Roy 2016 [<a href="#CD016278-bib-0146" title="RoyP , SujathaMS , BhandiwadA , BiswasB . Role of tranexamic acid in reducing blood loss in vaginal delivery. Journal of Obstetrics and Gynaecology of India2016;66(Suppl 1):S246-50. [CENTRAL: CN-01730606] [EMBASE: 609598409] [PMID: 27651612]">146</a>]; Salas 2017 [<a href="#CD016278-bib-0147" title="SalasMT . A single-blinded randomized controlled trial on the effect of prophylactic intravenous administration of tranexamic acid on the reduction of blood loss during and after primary cesarean section. Journal of Obstetrics and Gynaecology Research2017;43:26-7, Abstract no: 0086. [CENTRAL: CN-01760536] [EMBASE: 616813053]">147</a>]; Senturk 2013; Shah 2019 [<a href="#CD016278-bib-0148" title="PravinS , AjayA , ShailajaC , PappuR , Nisha KB . Tranexamic acid in prevention of postpartum hemorrhage in elective cesarean section. International Journal of Reproduction, Contraception, Obstetrics and Gynecology2019;8(2):372-6. [DOI: 10.18203/2320-1770.ijrcog20190017]">148</a>, <a href="#CD016278-bib-0149" title="AgrawalA . Tranexamic acid (TA) in prevention of postpartum haemorrhage in elective cesarean section. International Journal of Gynaecology and Obstetrics2018;143(Supplement 3):294-5. [CENTRAL: CN-01654075] [EMBASE: 624606757]">149</a>]; Shahid 2013; Shalaby 2022 [<a href="#CD016278-bib-0150" title="ShalabyMA , MagedAM , Al-AsmarA , El MahyM , Al-MohamadyM , Mohamed Ali RundN . Safety and efficacy of preoperative tranexamic acid in reducing intraoperative and postoperative blood loss in high-risk women undergoing cesarean delivery: a randomized controlled trial. BMC Pregnancy and Childbirth2022;22(1):201. ">150</a>]; Sharma 2011 [<a href="#CD016278-bib-0151" title="SharmaR , NajamR , MisraMK . Efficacy of tranexamic acid in decreasing blood loss during and after cesarean section. Biomedical and Pharmacology Journal2011;4(1):231-5. [CENTRAL: CN-00893909] [EMBASE: 362564557]">151</a>]; Shinde 2022 [<a href="#CD016278-bib-0152" title="SuhasS , Prashant PadmakarZ , SaiW . Study of prevention of post-partum haemorrhage after caesarean section with use of tranexamic acid. Research Journal of Pharmaceutical, Biological and Chemical Sciences2022;13(5):157. [DOI: 10.33887/rjpbcs/2022.13.5.25]">152</a>]; Singh 2023 [<a href="#CD016278-bib-0153" title="SinghKP , SinghHA . Tranexamic acid and blood loss during and after cesarean section. A randomized case control prospective study. Journal of Obstetrics and Gynaecology Research2023;49:51?522023. [DOI: 10.1111/jog.15585]">153</a>]; TA TEG [<a href="#CD016278-bib-0154" title="Tranexamic acid and thromboelastography during cesarean delivery (TA TEG). ClinicalTrials.gov (http://Clinicaltrials.gov) (accessed 25 April 2023). ">154</a>]; Taj 2014 [<a href="#CD016278-bib-0155" title="TajN , FirdousA , AkhtarN , ChaudharyMH , Sarah, BajwaZ , et al. Efficacy of tranexamic acid in reducing blood loss during and after cesarean section. Rawal Medical Journal2014;39(3):311-3. [CENTRAL: CN-01002077] [EMBASE: 373862877]">155</a>]; Tarabrin 2012 [<a href="#CD016278-bib-0156" title="TarabrinO , KaminskiyV , GalichS , TkachenkoR , GulyaevA , ShcherbakovS , et al. Efficacy of tranexamic acid in decreasing blood loss during cesarean section. Critical Care (London, England)2012;16 Suppl 1:S157. ">156</a>, <a href="#CD016278-bib-0157" title="ZaporozhanV , TarabrinO , GavrychenkoD , MazurenkoG , SalehO , LyoshenkoI . Effcacy of tranexamic acid in decreasing blood loss during cesarean section. Critical Care (London, England)2013;17 (Suppl 2):S135-S136. ">157</a>]; Tarabrin 2012a [<a href="#CD016278-bib-0158" title="TarabrinO , GalichS , TkachenkoR , GulyaevA , ShcherbakovS , GavrychenkoD . Reduced blood loss during caesarean section under the action of tranexamic acid. European Journal of Anaesthesiology2012;29:97. [CENTRAL: CN-01155631] ">158</a>, <a href="#CD016278-bib-0159" title="TarabrinO , KaminskiyV , GalichS , TkachenkoR , GulyaevA , ShcherbakovS , et al. Efficacy of tranexamic acid in decreasing blood loss during cesarean section. Critical Care (London, England)2012;16(Suppl 1):S157. [CENTRAL: CN-02272422] [EMBASE: 70735379]">159</a>]; Torky 2020 [<a href="#CD016278-bib-0160" title="TorkyH , El-Desouky E-S, Abo-ElmagdI , MohamedA , AbdalhamidA , El-ShahatA , et al. Pre-operative tranexemic acid vs. etamsylate in reducing blood loss during elective cesarean section: randomized controlled trial. Journal of Perinatal Medicine2020;49(3):353-6. [CENTRAL: CN-02191237] [EMBASE: 633191392] [PMID: 33064669]">160</a>]; Vishal 2023 [<a href="#CD016278-bib-0161" title="Anish KumarV , Mohit KumarA , Sanjay KumarS , GV KrishnaP , Yashi. Safety and efficacy of prophylactic tranexanic acid in reducing blood loss during and after caesarean delivery: a comparative study. International Journal of Academic Medicine and Pharmacy2023;5(3):407-13. [DOI: 10.47009/jamp.2023.5.3.88]">161</a>]; Xu 2013; Yehia 2014; Zargar 2018; Zizi 2013 [<a href="#CD016278-bib-0162" title="ZiziA , ArisS , SuharjonoHN . To study the role of tranexamic acid in reducing blood loss during and after caesarean section in Sarawak General Hospital. Journal of Surgical Academia2013;3(1):50. ">162</a>]). Details are provided in <a href="#CD016278-supitem-0004">Supplementary material 4</a>. </p> </section> </section> <section id="CD016278-sec-0074"> <h3 class="title">Risk of bias in included studies</h3> <p>Risk of bias in the included trials is presented in <a href="#CD016278-fig-0003">Figure 3</a> and <a href="#CD016278-fig-0004">Figure 4</a>. </p> <div class="figure" id="CD016278-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD016278-fig-0003" src="/cdsr/doi/10.1002/14651858.CD016278/media/CDSR/CD016278/image_n/nCD016278-FIG-03.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <div class="figure" id="CD016278-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD016278-fig-0004" src="/cdsr/doi/10.1002/14651858.CD016278/media/CDSR/CD016278/image_n/nCD016278-FIG-04.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <section id="CD016278-sec-0075"> <h4 class="title">Random sequence generation and allocation concealment</h4> <p>All included trials used computer‐generated randomisation and a method of central randomisation or sequentially numbered drug containers and were judged to be at low risk of bias for both the generation of the randomisation sequence and allocation concealment. </p> </section> <section id="CD016278-sec-0076"> <h4 class="title">Blinding of participants, personnel, and outcome assessors</h4> <p>Three trials reported that participants, clinicians, and investigators were blind to allocation and were assessed as being at low risk of bias (Alam 2023; Pacheco 2023; Sentilhes 2021). Ogunkua 2022 reported that both participants and providers were blind to allocation (low risk of bias), although there was no information on blinding of outcome assessment (unclear risk of bias). Shakur‐Still 2023 was not blinded, as TXA was administered via different routes and no placebo was given; the study was therefore judged to have a high risk of detection and performance bias. Blinding was unclear in Lee 2023, as the drugs were prepared by an unblinded staff member and then handed to a blinded staff member, making it possible that staff members were unblinded at this point (unclear risk of bias). </p> </section> <section id="CD016278-sec-0077"> <h4 class="title">Incomplete outcome data</h4> <p>Most of the included trials had minimal missing outcome data overall and presented outcome data on an intention‐to‐treat basis (Alam 2023; Ogunkua 2022; Pacheco 2023; Sentilhes 2021; Shakur‐Still 2023). Two trials had missing outcome data for the outcome calculated blood loss ≥ 1000 mL (Pacheco 2023; Sentilhes 2021). However, both of these studies performed sensitivity analysis showing that the missing data did not impact the effect. In Sentilhes 2021, outcome data were missing for gravimetrically estimated blood loss. Although the proportion of missing data was large (20% and 21% in the TXA and placebo groups, respectively), the study authors reported that they did not include data for this outcome from the first five months of the trial due to unreliable measurements. We therefore judged the missing outcome data to be balanced across groups and unrelated to the outcome. In addition, Pacheco 2023 had missing data for safety outcomes. We contacted the trial authors, who reported that they were unable to contact these participants for follow‐up. Missing data were balanced across groups (8% in each group). We thus judged these studies to be at low risk of attrition bias. We assessed Lee 2023 as at unclear risk of attrition bias as some participants withdrew, and it is possible that they were at a high risk of PPH. Furthermore, three participants were excluded from the analysis due to significant intraoperative events, although the study objective includes women at high risk of PPH. </p> </section> <section id="CD016278-sec-0078"> <h4 class="title">Selective reporting</h4> <p>All trials were prospectively registered, and data on all prespecified outcomes were presented. We therefore judged all trials as being at low risk of bias for this domain. </p> </section> <section id="CD016278-sec-0079"> <h4 class="title">Other bias</h4> <p>We had no concerns regarding any other aspects of trials, therefore we assessed all trials as being at low risk of bias for this domain. </p> </section> </section> <section id="CD016278-sec-0080"> <h3 class="title" id="CD016278-sec-0080">Synthesis of results</h3> <p>Details of analyses are provided in <a href="#CD016278-supitem-0006">Supplementary material 6</a>. </p> <p>See <a href="./full#CD016278-tbl-0001">summary of findings Table 1</a>. </p> <section id="CD016278-sec-0081"> <h4 class="title">Critical outcomes</h4> <section id="CD016278-sec-0082"> <h5 class="title">1.1 Estimated blood loss ≥ 1000 mL</h5> <p>Prophylactic TXA in addition to standard care results in little to no difference in estimated blood loss ≥ 1000 mL compared to placebo with standard care or standard care alone (risk ratio (RR) 0.94, 95% confidence interval (CI) 0.79 to 1.11; P = 0.45; I<sup>2</sup> = 52%; 4 RCTs; n = 13,042; high certainty evidence), resulting in 8 fewer per 1000 women having estimated blood loss ≥ 1000 mL (from 30 fewer to 16 more) (Analysis 1.1). Four RCTs contributed to the pooled effect (Lee 2023; Ogunkua 2022; Pacheco 2023; Sentilhes 2021). A forest plot is shown in <a href="#CD016278-fig-0005">Figure 5</a>. Subgroup analysis indicated no difference between gravimetrically estimated and provider‐estimated blood loss (P = 0.33, I<sup>2</sup> = 0%) (Analysis 1.1). Sensitivity analysis using provider‐estimated blood loss as the superior method had no impact on the pooled effect (RR 0.94, 95% CI 0.78 to 1.13; P = 0.50; I<sup>2</sup> = 57%). Details are available in <a href="#CD016278-fig-0006">Figure 6</a>. </p> <div class="figure" id="CD016278-fig-0005"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 5</div> </div> <hr class="top"/><img alt="Forest plot (1.1 Estimated blood loss ≥ 1000 mL)." data-id="CD016278-fig-0005" src="/cdsr/doi/10.1002/14651858.CD016278/media/CDSR/CD016278/image_n/nCD016278-FIG-05.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot (1.1 Estimated blood loss ≥ 1000 mL).</p> </div> </div> </div> <div class="figure" id="CD016278-fig-0006"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 6</div> </div> <hr class="top"/><img alt="Sensitivity analysis." data-id="CD016278-fig-0006" src="/cdsr/doi/10.1002/14651858.CD016278/media/CDSR/CD016278/image_n/nCD016278-FIG-06.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Sensitivity analysis.</p> </div> </div> </div> </section> <section id="CD016278-sec-0083"> <h5 class="title">1.2 Calculated blood loss ≥ 1000 mL</h5> <p>Prophylactic TXA in addition to standard care likely results in a slight reduction in calculated blood loss ≥ 1000 mL compared to placebo with standard care or standard care alone (RR 0.83, 95% CI 0.76 to 0.92; P &lt; 0.001; I<sup>2</sup> = 0%; 2 RCTs; n = 4327; moderate certainty evidence), resulting in 53 fewer per 1000 women having calculated blood loss ≥ 1000 mL (from 75 fewer to 25 fewer) (Analysis 1.2). Two RCTs contributed to the pooled effect (Lee 2023; Sentilhes 2021). A forest plot is shown in <a href="#CD016278-fig-0007">Figure 7</a>. </p> <div class="figure" id="CD016278-fig-0007"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 7</div> </div> <hr class="top"/><img alt="Forest plot (1.2 Calculated blood loss ≥ 1000 mL)." data-id="CD016278-fig-0007" src="/cdsr/doi/10.1002/14651858.CD016278/media/CDSR/CD016278/image_n/nCD016278-FIG-07.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot (1.2 Calculated blood loss ≥ 1000 mL).</p> </div> </div> </div> </section> </section> <section id="CD016278-sec-0084"> <h4 class="title">Important outcomes</h4> <section id="CD016278-sec-0085"> <h5 class="title">1.3 Maternal death</h5> <p>The evidence is very uncertain about the effect of prophylactic TXA in addition to standard care on maternal death compared to placebo with standard care or standard care alone. This is a rare outcome with only one event in the placebo group, and none in the TXA group (RR 0.33, 95% CI 0.01 to 8.10; P = 0.50; I<sup>2</sup> = not applicable; 6 RCTs; n = 15,858; very low certainty evidence), resulting in 1 fewer per 10,000 women dying (from 1 fewer to 9 more) (Analysis 1.3). Six RCTs measured this outcome (Alam 2023; Lee 2023; Ogunkua 2022; Pacheco 2023; Sentilhes 2021; Shakur‐Still 2023). One study with 10,995 participants reported one event in the control arm (Pacheco 2023), while all other studies (4863 participants) reported no maternal deaths in the study population. A forest plot is shown in <a href="#CD016278-fig-0008">Figure 8</a>. </p> <div class="figure" id="CD016278-fig-0008"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 8</div> </div> <hr class="top"/><img alt="Forest plot (1.2 Maternal death)." data-id="CD016278-fig-0008" src="/cdsr/doi/10.1002/14651858.CD016278/media/CDSR/CD016278/image_n/nCD016278-FIG-08.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot (1.2 Maternal death).</p> </div> </div> </div> </section> <section id="CD016278-sec-0086"> <h5 class="title">1.4 Severe morbidity</h5> <p>No trials measured this outcome (Analysis 1.4).</p> </section> <section id="CD016278-sec-0087"> <h5 class="title">1.5 Receipt of blood transfusion</h5> <p>Prophylactic TXA in addition to standard care likely results in little to no difference in blood transfusion compared to placebo with standard care or standard care alone (RR 0.88, 95% CI 0.72 to 1.08; P = 0.21; I<sup>2</sup> = 6%; 5 RCTs; n = 15,740; moderate certainty evidence), resulting in 4 fewer per 1000 women requiring a blood transfusion (from 10 fewer to 3 more) (Analysis 1.5). Five RCTs contributed to the pooled effect (Alam 2023; Lee 2023; Ogunkua 2022; Pacheco 2023; Sentilhes 2021). A forest plot is shown in <a href="#CD016278-fig-0009">Figure 9</a>. </p> <div class="figure" id="CD016278-fig-0009"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 9</div> </div> <hr class="top"/><img alt="Forest plot (1.4 Blood transfusion)." data-id="CD016278-fig-0009" src="/cdsr/doi/10.1002/14651858.CD016278/media/CDSR/CD016278/image_n/nCD016278-FIG-09.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot (1.4 Blood transfusion).</p> </div> </div> </div> </section> <section id="CD016278-sec-0088"> <h5 class="title">1.6 Receipt of additional surgical intervention to control PPH</h5> <p>Prophylactic TXA in addition to standard care results in little to no difference in additional surgical interventions to control PPH compared to placebo with standard care or standard care alone (RR 1.02, 95% CI 0.86 to 1.22; P = 0.81; I<sup>2</sup> = 0%; 4 RCTs; n = 15,631; high certainty evidence), resulting in 1 more per 1000 women requiring additional surgical intervention (from 4 fewer to 7 more) (Analysis 1.6). Four RCTs contributed to the pooled effect (Alam 2023; Lee 2023; Pacheco 2023; Sentilhes 2021). A forest plot is shown in <a href="#CD016278-fig-0010">Figure 10</a>. </p> <div class="figure" id="CD016278-fig-0010"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 10</div> </div> <hr class="top"/><img alt="Forest plot (1.5 Receipt of additional surgical intervention to control PPH)." data-id="CD016278-fig-0010" src="/cdsr/doi/10.1002/14651858.CD016278/media/CDSR/CD016278/image_n/nCD016278-FIG-10.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot (1.5 Receipt of additional surgical intervention to control PPH).</p> </div> </div> </div> </section> <section id="CD016278-sec-0089"> <h5 class="title">1.7 Thromboembolic events</h5> <p>The evidence is very uncertain about the effect of prophylactic TXA in addition to standard care on thromboembolic events compared to placebo with standard care or standard care alone (RR 1.40, 95% CI 0.22 to 8.90; P = 0.72; I<sup>2</sup> = 77%; 4 RCTs; n = 14,480; very low certainty evidence), resulting in 1 more per 1000 women having a thromboembolic event (from 2 fewer to 17 more) (Analysis 1.7). Four RCTs measured this outcome (Lee 2023; Pacheco 2023; Sentilhes 2021; Shakur‐Still 2023). Lee 2023 and Shakur‐Still 2023 reported no events, and Pacheco 2023 and Sentilhes 2021 contributed to the pooled effect. A forest plot is shown in <a href="#CD016278-fig-0011">Figure 11</a>. </p> <div class="figure" id="CD016278-fig-0011"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 11</div> </div> <hr class="top"/><img alt="Forest plot (1.7 Thrombembolic events)." data-id="CD016278-fig-0011" src="/cdsr/doi/10.1002/14651858.CD016278/media/CDSR/CD016278/image_n/nCD016278-FIG-11.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot (1.7 Thrombembolic events).</p> </div> </div> </div> </section> <section id="CD016278-sec-0090"> <h5 class="title">1.8 Receipt of additional uterotonics</h5> <p>Prophylactic TXA in addition to standard care results in little to no difference in the need for additional uterotonics compared to placebo with standard care or standard care alone (RR 0.88, 95% CI 0.78 to 1.00; P = 0.05; I<sup>2</sup> = 22%; 4 RCTs; n = 15,728; high certainty evidence), resulting in 15 fewer per 1000 women requiring additional uterotonics (from 27 fewer to 0 fewer) (Analysis 1.8). Four RCTs contributed to the pooled effect (Lee 2023; Pacheco 2023; Sentilhes 2021; Shakur‐Still 2023). A forest plot is shown in <a href="#CD016278-fig-0012">Figure 12</a>. </p> <div class="figure" id="CD016278-fig-0012"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 12</div> </div> <hr class="top"/><img alt="Forest plot (1.8 Receipt of additional uterotonics)." data-id="CD016278-fig-0012" src="/cdsr/doi/10.1002/14651858.CD016278/media/CDSR/CD016278/image_n/nCD016278-FIG-12.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot (1.8 Receipt of additional uterotonics).</p> </div> </div> </div> </section> <section id="CD016278-sec-0091"> <h5 class="title">1.9 Hysterectomy</h5> <p>The evidence is very uncertain about the effect of prophylactic TXA in addition to standard care on hysterectomy compared to placebo with standard care or standard care alone (RR 0.80, 95% CI 0.20 to 3.29; P = 0.76; I<sup>2</sup> = 0%; 2 RCTs; n = 4546; very low certainty evidence), resulting in 3 fewer per 10,000 women requiring a hysterectomy (from 11 fewer to 31 more) (Analysis 1.9). Two RCTs contributed to the pooled effect (Sentilhes 2021; Shakur‐Still 2023). A forest plot is shown in <a href="#CD016278-fig-0013">Figure 13</a>. </p> <div class="figure" id="CD016278-fig-0013"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 13</div> </div> <hr class="top"/><img alt="Forest plot (1.8 Hysterectomy)." data-id="CD016278-fig-0013" src="/cdsr/doi/10.1002/14651858.CD016278/media/CDSR/CD016278/image_n/nCD016278-FIG-13.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot (1.8 Hysterectomy).</p> </div> </div> </div> </section> <section id="CD016278-sec-0092"> <h5 class="title">1.10 Maternal satisfaction</h5> <p>One trial measured this outcome using a Likert scale questionnaire and reported no evidence of a difference between groups in maternal satisfaction at day two postpartum (Sentilhes 2021). No meta‐analysis was performed with these data (Analysis 1.10). </p> </section> <section id="CD016278-sec-0093"> <h5 class="title">1.11 Breastfeeding at discharge</h5> <p>No trials measured this outcome (Analysis 1.11).</p> </section> <section id="CD016278-sec-0094"> <h5 class="title">1.12 Clinical diagnosis of PPH</h5> <p>Prophylactic TXA in addition to standard care results in little to no difference in the clinical diagnosis of PPH compared to placebo with standard care or standard care alone (RR 0.91, 95% CI 0.79 to 1.06; P = 0.22; I<sup>2</sup> = 0%; 3 RCTs; n = 4556; high certainty evidence), resulting in 13 fewer per 1000 women receiving a clinical diagnosis of PPH (from 31 fewer to 9 more) (Analysis 1.12). Three RCTs contributed to the pooled effect (Alam 2023; Sentilhes 2021; Shakur‐Still 2023). A forest plot is shown in <a href="#CD016278-fig-0014">Figure 14</a>. </p> <div class="figure" id="CD016278-fig-0014"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 14</div> </div> <hr class="top"/><img alt="Forest plot (1.12 Clinical diagnosis of PPH)." data-id="CD016278-fig-0014" src="/cdsr/doi/10.1002/14651858.CD016278/media/CDSR/CD016278/image_n/nCD016278-FIG-14.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot (1.12 Clinical diagnosis of PPH).</p> </div> </div> </div> </section> <section id="CD016278-sec-0095"> <h5 class="title">1.13 Estimated mean blood loss</h5> <p>Prophylactic TXA in addition to standard care results in little to no difference in mean blood loss (mL) compared to placebo with standard care or standard care alone (mean difference (MD) −25.71, 95% CI −81.55 to 30.14; P = 0.37; I<sup>2</sup> = 0%; 2 RCTs; n = 3644; high certainty evidence) (Analysis 1.13). Two RCTs contributed to the pooled effect (Sentilhes 2021; Shakur‐Still 2023). A forest plot is shown in <a href="#CD016278-fig-0015">Figure 15</a>. </p> <div class="figure" id="CD016278-fig-0015"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 15</div> </div> <hr class="top"/><img alt="Forest plot (1.13 Estimated mean blood loss (mL))." data-id="CD016278-fig-0015" src="/cdsr/doi/10.1002/14651858.CD016278/media/CDSR/CD016278/image_n/nCD016278-FIG-15.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot (1.13 Estimated mean blood loss (mL)).</p> </div> </div> </div> </section> <section id="CD016278-sec-0096"> <h5 class="title">1.14 Calculated mean blood loss</h5> <p>Prophylactic TXA in addition to standard care likely results in a slight reduction in mean blood loss (mL) compared to placebo with standard care or standard care alone (MD −111.37, 95% CI −151.75 to −70.99; P &lt; 0.001; I<sup>2</sup> = 0%; 3 RCTs; n = 4695; moderate certainty evidence) (Analysis 1.14). Three RCTs contributed to the pooled effect (Lee 2023; Ogunkua 2022; Sentilhes 2021). A forest plot is shown in <a href="#CD016278-fig-0016">Figure 16</a>. </p> <div class="figure" id="CD016278-fig-0016"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 16</div> </div> <hr class="top"/><img alt="Forest plot (1.14 Calculated mean blood loss (mL))." data-id="CD016278-fig-0016" src="/cdsr/doi/10.1002/14651858.CD016278/media/CDSR/CD016278/image_n/nCD016278-FIG-16.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot (1.14 Calculated mean blood loss (mL)).</p> </div> </div> </div> </section> <section id="CD016278-sec-0097"> <h5 class="title">1.15 Myocardial infarction</h5> <p>The evidence is very uncertain about the effects of prophylactic TXA in addition to standard care on myocardial infarction compared to placebo with standard care or standard care alone. This is a rare outcome with two events in the TXA group and none in the placebo group (RR 4.93, 95% CI 0.24 to 102.62; P = 0.30; I<sup>2</sup> = not applicable; 4 RCTs; n = 14,742; very low certainty evidence), resulting in 3 more per 10,000 women having a myocardial infarction (from 1 fewer to 6 more) (Analysis 1.15). Four RCTs measured this outcome (Lee 2023; Pacheco 2023; Sentilhes 2021; Shakur‐Still 2023). One study with 10,065 participants reported two events in the TXA group and none in the control group (Pacheco 2023). The other three trials (4677 participants) reported no myocardial infarction in the study population. </p> </section> <section id="CD016278-sec-0098"> <h5 class="title">1.16 Stroke</h5> <p>The evidence is very uncertain about the effects of prophylactic TXA in addition to standard care on stroke compared to placebo with standard care or standard care alone. This is a rare outcome with two events in the TXA group and none in the placebo group (RR 4.93, 95% CI 0.24 to 102.62; P = 0.30; I<sup>2</sup> = not applicable; 4 RCTs; n = 14,742; very low certainty evidence), resulting in 3 more per 10,000 women having a stroke (from 1 fewer to 6 more) (Analysis 1.16). Four RCTs measured this outcome (Lee 2023; Pacheco 2023; Sentilhes 2021; Shakur‐Still 2023). One study with 10,065 participants reported two events in the TXA group and none in the control group (Pacheco 2023). The other three trials (4677 participants) reported no strokes in the study population. </p> </section> <section id="CD016278-sec-0099"> <h5 class="title">1.17 Seizures</h5> <p>The evidence is very uncertain about the effects of prophylactic TXA in addition to standard care on seizures compared to placebo with standard care or standard care alone. This is a rare event with three cases of seizures in the TXA group compared to one in the placebo group (RR 2.07, 95% CI 0.27 to 16.01; P = 0.49; I<sup>2</sup> = 0%; 4 RCTs; n = 14,392; very low certainty evidence), resulting in 1 more per 10,000 women having a seizure (from 1 fewer to 21 more) (Analysis 1.17). Four RCTs contributed to the pooled effect (Ogunkua 2022; Pacheco 2023; Sentilhes 2021; Shakur‐Still 2023). </p> </section> <section id="CD016278-sec-0100"> <h5 class="title">1.18 Organ failure/dysfunction</h5> <p>The evidence is very uncertain about the effect of prophylactic TXA in addition to standard care on organ failure/dysfunction compared to placebo with standard care or standard care alone. Two RCTs measured this outcome (Alam 2023; Sentilhes 2021). There were no events in any of the trials (n = 4379). We assessed the certainty of the evidence as very low (Analysis 1.18). </p> </section> <section id="CD016278-sec-0101"> <h5 class="title">1.19 ICU admission</h5> <p>Prophylactic TXA in addition to standard care may result in little to no difference in ICU admission compared to placebo with standard care or standard care alone (RR 1.35, 95% CI 0.89 to 2.03; P = 0.16; I<sup>2</sup> = 0%; 3 RCTs; n = 14,507; low certainty evidence), resulting in 2 more per 1000 women requiring ICU admission (from 1 fewer to 6 more) (Analysis 1.19). Three RCTs measured this outcome (Alam 2023; Pacheco 2023; Sentilhes 2021). Two trials (14,495 participants) contributed to the pooled effect (Pacheco 2023; Sentilhes 2021), while Alam 2023 (12 participants) reported no events. </p> </section> <section id="CD016278-sec-0102"> <h5 class="title">1.20 Nausea</h5> <p>The evidence is very uncertain about the effect of prophylactic TXA in addition to standard care on nausea compared to placebo with standard care or standard care alone (RR 1.04, 95% CI 0.79 to 1.36; P = 0.79; I<sup>2</sup> = 85%; 3 RCTs; n = 15,438; very low certainty evidence), resulting in 6 more per 1000 women reporting nausea (from 33 fewer to 56 more) (Analysis 1.20). Three RCTs contributed to the pooled effect (Pacheco 2023; Sentilhes 2021; Shakur‐Still 2023). </p> </section> <section id="CD016278-sec-0103"> <h5 class="title">1.21 Vomiting</h5> <p>Prophylactic TXA in addition to standard care results in little to no difference in vomiting compared to placebo with standard care or standard care alone (RR 0.97, 95% CI 0.82 to 1.14; P = 0.68; I<sup>2</sup> = 0%; 2 RCTs; n = 11,086; high certainty evidence), resulting in 1 fewer per 1000 women vomiting (from 9 fewer to 7 more) (Analysis 1.21). Two RCTs contributed to the pooled effect (Pacheco 2023; Shakur‐Still 2023). </p> </section> <section id="CD016278-sec-0104"> <h5 class="title">1.20 Headache</h5> <p>No trials measured this outcome (Analysis 1.22).</p> </section> <section id="CD016278-sec-0105"> <h5 class="title">1.21 Maternal well‐being</h5> <p>No trials measured this outcome (Analysis 1.23).</p> </section> <section id="CD016278-sec-0106"> <h5 class="title">1.22 Postpartum anaemia (haemoglobin &lt; 9 g/dL)</h5> <p>No trials measured this outcome (Analysis 1.24).</p> </section> <section id="CD016278-sec-0107"> <h5 class="title">1.23 Skin reactions</h5> <p>No trials measured this outcome (Analysis 1.25).</p> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD016278-sec-0108" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD016278-sec-0108"></div> <section id="CD016278-sec-0109"> <h3 class="title" id="CD016278-sec-0109">Summary of main results</h3> <p>This review is a substantive update to the previous version. We included six RCTs involving a combined total of 15,981 participants who underwent elective or emergency caesarean birth (Alam 2023; Lee 2023; Ogunkua 2022; Pacheco 2023; Sentilhes 2021; Shakur‐Still 2023). One trial included women at high risk of PPH (Shakur‐Still 2023); one trial included both women at high and low risk of PPH (Lee 2023), while the four remaining trials included women at low risk of PPH (Alam 2023; Ogunkua 2022; Pacheco 2023; Sentilhes 2021). Risk of bias was low across most studies, with unclear or high risk of performance and detection bias in two small studies that did not contribute a large proportion to the meta‐analysis. </p> <p>High certainty evidence shows that TXA in addition to standard care results in little to no difference in estimated blood loss ≥ 1000 mL when compared to placebo with standard care or standard care alone. TXA in addition to standard care compared to placebo with standard care or standard care alone likely results in a slight reduction in calculated blood loss ≥ 1000 mL. There were no available data on the effect of TXA on severe morbidity. TXA likely makes little to no difference to the risk of receiving a blood transfusion, and results in little to no difference in additional surgical interventions to control bleeding compared to placebo. The evidence is very uncertain about the effect of TXA on thromboembolic events and hysterectomy. TXA likely results in little to no difference in the need for additional uterotonics compared to placebo. One trial measured maternal satisfaction using a Likert scale questionnaire and reported no evidence of a difference between groups in maternal satisfaction at day two postpartum (Sentilhes 2021). No data were available on breastfeeding at discharge. </p> </section> <section id="CD016278-sec-0110"> <h3 class="title" id="CD016278-sec-0110">Limitations of the evidence included in the review</h3> <p>We presented a stratified analysis for the critical outcome, blood loss ≥ 1000 mL, as blood loss was measured differently across studies. These measures were: calculated blood loss (based on pre‐ and postoperative haematocrit or haemoglobin), gravimetrically estimated blood loss (weighing of sponges, measuring of collected fluid), and provider‐estimated blood loss (visual estimation of blood loss). We analysed estimated blood loss (gravimetrically estimated and provider estimated) and calculated blood loss separately. A systematic review of evidence regarding surgical blood loss measurement found that none of the above methods is ideal, and that a gold standard measure is lacking[<a href="#CD016278-bib-0163" title="GerdessenL , MeybohmP , ChoorapoikayilS , HerrmannE , TaeuberI , NeefV , et al. Comparison of common perioperative blood loss estimation techniques: a systematic review and meta-analysis. Journal of Clinical Monitoring and Computing2021;35(2):245-58.">163</a>]. </p> <p>There is no published guidance on which measure is preferred, as neither the publication on the PPH Core outcome set [<a href="#CD016278-bib-0032" title="MeherS , CuthbertA , KirkhamJJ , WilliamsonP , AbalosE , AflaifelN , et al. Core outcome sets for prevention and treatment of postpartum haemorrhage: an international Delphi consensus study. BJOG2019;126:83–93.">32</a>], nor the WHO guideline on assessment of PPH, provide an answer [<a href="#CD016278-bib-0164" title="World Health Organization. WHO recommendations on the assessment of postpartum blood loss and use of a treatment bundle for postpartum haemorrhage. World Health Organization. [URL: https://www.who.int/publications/i/item/9789240085398]">164</a>]. The gravimetric and provider estimation methods are both associated with measurement inaccuracies. It is difficult to separate blood from amniotic and other fluids used during surgery when using gravimetric methods, and provider‐estimated methods are highly subjective. The calculation method is dependent on normovolaemia for accuracy. The fact that both the hypervolaemia of normal pregnancy and the hypovolaemia of pre‐eclampsia revert towards normovolaemia after pregnancy may cause substantial errors in calculations based on preoperative compared with postoperative haemoglobin or haematocrit levels. In addition, TXA has effects on both the endothelium [<a href="#CD016278-bib-0165" title="DiebelLN , MartinJV , LiberatiDM . Early tranexamic acid administration ameliorates the endotheliopathy of trauma and shock in an in vitro model. Journal of Trauma and Acute Care Surgery2017;82:1080-1086.">165</a>] and renal function [<a href="#CD016278-bib-0012" title="StampfliD , WeilerS , WeinigerCF , BurdenAM , HeesenM . Renal ischemic adverse drug events related to tranexamic acid in women of child-bearing age: an analysis of pharmacovigilance data. European Journal of Clinical Pharmacology2021;77(6):913-9.">12</a>] which may affect intravascular volume and cause changes in haematocrit/haemoglobin concentrations unrelated to blood loss. </p> <p>We therefore downgraded the certainty of evidence for the outcome calculated blood loss by one level, given our concern that the measurements may be influenced by physiological changes after birth and TXA. In our review, effect estimates for calculated blood loss favour TXA when compared to placebo, while those for estimated blood loss show no difference between groups, indicating a possible overestimation of the effect of TXA for calculated blood loss. Morbidity due to excessive blood loss was low and similar across groups. </p> <p>Risk of bias in the included studies was mostly low, with unclear and high risk of performance and detection bias in two small studies that had very little weight in the meta‐analysis (Lee 2023; Shakur‐Still 2023). We therefore did not downgrade the certainty of evidence due to study limitations. </p> <p>As part of the GRADE assessment, we made judgements about imprecision based on the range of the CI of the relative effect as well as the total number of participants and events per outcome. We downgraded for imprecision if there were very few events (fewer than 30) and if the CI was very wide. The threshold for suggested appreciable benefit for the relative effect was 0.75, and the threshold for suggested appreciable harm was 1.25. Where the CI crossed these thresholds, we downgraded by one, two, or three levels depending on the width of the CI. Reasons for imprecision judgements are included in the footnotes of <a href="./full#CD016278-tbl-0001">summary of findings Table 1</a>. </p> <p>Most trials measured blood loss over a 48‐hour period (Lee 2023; Pacheco 2023; Sentilhes 2021), whereas one trial only measured it for 24 hours postoperatively (Ogunkua 2022), which could lead to a difference in measurements. However, the latter trial's contribution to the meta‐analysis was small relative to other studies. </p> <p>The studies included in the meta‐analysis were undertaken in mostly high‐resource settings. The study population included mostly women at low risk of PPH, except in one trial with a small sample size (Shakur‐Still 2023). Our findings are therefore not directly applicable to women at high risk of PPH. </p> <p>All trials assessed the effect of TXA in addition to standard care, which mostly comprised routine administration of oxytocin after delivery. Furthermore, rates of additional uterotonics differed across trials, ranging from 6% to 50% of participants. </p> <p>Additionally, most of the data (95% randomised women) included in this review came from two trials in which TXA was administered after birth, immediately after cord clamping. This differs from much of the recent, high‐quality evidence for the effects of TXA in other surgical procedures, in which TXA was given before skin incision [<a href="#CD016278-bib-0166" title="DevereauxPJ , MarcucciM , PainterTW , ConenD , LomivorotovV , SesslerDI , et al. Tranexamic acid in patients undergoing noncardiac surgery. New England Journal of Medicine2022;386:1986-97.">166</a>, <a href="#CD016278-bib-0167" title="MylesPS , SmithJA , ForbesA , SilbertB , JayarajahM , PainterT , et al. Tranexamic acid in patients undergoing coronary-artery surgery. New England Journal of Medicine2017;376:136-48.">167</a>]. </p> </section> <section id="CD016278-sec-0111"> <h3 class="title" id="CD016278-sec-0111">Limitations of the review processes</h3> <p>We have updated the outcomes in this review, that is we added blood transfusion to important outcomes and removed haemoglobin below 6 g/dL. The reason is the importance of blood transfusion as an outcome when evaluating an intervention for preventing haemorrhage. Blood transfusions are used in the treatment of severe haemorrhage, but they are costly, associated with significant adverse reactions, and may not be available in low‐resource settings. Blood transfusion is an outcome assessed in other Cochrane reviews on PPH [<a href="#CD016278-bib-0168" title="MousaHA , BlumJ , Abou El SenounG , ShakurH , AlfirevicZ . Treatment for primary postpartum haemorrhage. Cochrane Database of Systematic Reviews2014, Issue 2. Art. No: CD003249. [DOI: 10.1002/14651858.CD003249.pub3]">168</a>] and TXA [<a href="#CD016278-bib-0023" title="KerK , BeecherD , RobertsI . Topical application of tranexamic acid for the reduction of bleeding. Cochrane Database of Systematic Reviews2013, Issue 7. Art. No: CD010562. [DOI: 10.1002/14651858.CD010562.pub2]">23</a>, <a href="#CD016278-bib-0169" title="PerelP , KerK , Morales UribeCH , RobertsI . Tranexamic acid for reducing mortality in emergency and urgent surgery. Cochrane Database of Systematic Reviews2013, Issue 1. Art. No: CD010245. [DOI: 10.1002/14651858.CD010245.pub2]">169</a>]. </p> <p>We included six studies in this review, after applying the Cochrane Pregnancy and Childbirth trustworthiness criteria [<a href="#CD016278-bib-0024" title="AlfirevicZ , KellieFJ , WeeksJ , StewartF , JonesL , HampsonL , on behalf of the Pregnancy and Childbirth Editorial Board. Identifying and handling potentially untrustworthy trials - Trustworthiness Screening Tool (TST) developed by the Cochrane Pregnancy and Childbirth Group. Cochrane Pregnancy and Childbirth Group.">24</a>]. There are many studies in the awaiting classification category, as further required information from trial authors was not yet received. The author team decided to strictly apply this trustworthiness tool due to known concerns about data integrity in this field of study [<a href="#CD016278-bib-0015" title="KerK , ShakurH , RobertsI . Does tranexamic acid prevent postpartum haemorrhage? A systematic review of randomised controlled trials. BJOG2016;123(11):1745-52.">15</a>, <a href="#CD016278-bib-0022" title="Li. Assessing research misconduct in randomized controlled trials. Obstetrics and Gynecology2021;138(3):338-47. [DOI: 10.1097/AOG.0000000000004513]">22</a>]. </p> <p>There were very few events for some outcomes, namely maternal mortality, myocardial infarction, stroke, and thromboembolic events. Rare events often lead to a wide 95% CIs around the relative effect. The sample size for these outcomes was large, and thus it is likely that randomisation has achieved prognostic balance [<a href="#CD016278-bib-0028" title="HigginsJPT , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , WelchVA , editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 6.3 (updated February 2022). Cochrane, 2022. Available from training.cochrane.org/handbook/archive/v6.3.">28</a>]. Where events are rare and sample sizes are big, it is more reliable to use the absolute effect for clinical decision‐making [<a href="#CD016278-bib-0170" title="GordonHG , AndrewDO , ReginaK , JanB , PabloA , RindD , et al. GRADE guidelines 6. Rating the quality of evidence - imprecision. Journal of Clinical Epidemiology2011;64:1283-93. [DOI: 10.1016/j.jclinepi.2011.01.012]">170</a>, <a href="#CD016278-bib-0028" title="HigginsJPT , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , WelchVA , editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 6.3 (updated February 2022). Cochrane, 2022. Available from training.cochrane.org/handbook/archive/v6.3.">28</a>]. Myocardial infarction, stroke, and seizures are all potential adverse effects of TXA. Reported events were too few for meaningful statistical analysis, but the fact that there were seven of these events with TXA versus one with placebo, and 53/7296 versus 39/7211 ICU admissions (RR 1.35, 95% CI 0.89 to 2.03), is reason for caution before recommending widespread prophylactic use. </p> <p>We planned to conduct subgroup analysis on risk of PPH, presence of anaemia, dose of TXA, and route of TXA. However, our included trials were homogeneous with regard to all of these characteristics. The Shakur‐Still 2023 trial was the only study that investigated different routes of administration of TXA, was conducted in low‐resource settings, and included women at high risk for PPH. The trial included 116 participants, and the data made only a small contribution to the various meta‐analyses. Furthermore, the 95% CIs of the RRs were very wide, and there was good overlap with the 95% CIs of other trials included in the analyses. Statistical heterogeneity was mostly absent. These subgroup analyses were therefore precluded. </p> </section> <section id="CD016278-sec-0112"> <h3 class="title" id="CD016278-sec-0112">Agreements and disagreements with other studies or reviews</h3> <p>We are aware of six other systematic reviews that have been published on this question since 2020 [<a href="#CD016278-bib-0171" title="Al-DarderyNM , AbdelwahabOA , AbouzidM , AlbakriK , ElkhadragyA , KatameshBE , et al. Efficacy and safety of tranexamic acid in prevention of postpartum hemorrhage: a systematic review and meta-analysis of 18,649 patients. BioMed Central Pregnancy and Childbirth2023;23(1):817.">171</a>, <a href="#CD016278-bib-0172" title="AssisIC , GoveiaCS , MirandaD , FerreiraRS , RiccioLG . Analysis of the efficacy of prophylactic tranexamic acid in preventing postpartum bleeding: systematic review with meta-analysis of randomized clinical trials. Brazilian Journal of Anesthesiology2023;73(4):467-76.">172</a>, <a href="#CD016278-bib-0173" title="CheemaHA , AhmadAB , EhsanM , ShahidA , AyyanM , AzeemS , et al. Tranexamic acid for the prevention of blood loss after cesarean section: an updated systematic review and meta-analysis of randomized controlled trials. American Journal of Obstetrics &amp; Gynecology MFM2023;5(8):101049.">173</a>, <a href="#CD016278-bib-0174" title="FerrariFA , GarzonS , RaffaelliR , CromiA , CasarinJ , GhezziF , et al. Tranexamic acid for the prevention and the treatment of primary postpartum haemorrhage: a systematic review. Journal of Obstetrics and Gynaecology2022;42(5):1-13.">174</a>, <a href="#CD016278-bib-0175" title="LeeAL , WangM , RoyD , WangJ , GokhaleA , Miranda-CacdacL , et al. Prophylactic tranexamic acid prevents postpartum hemorrhage and transfusions in cesarean deliveries: a systematic review and meta-analysis. American Journal of Perinatology2024;41(S 01):e2254-e2268. [DOI: 10.1055/a-2109-3730] [PMID: 37311543]">175</a>, <a href="#CD016278-bib-0176" title="YangF , WangH , ShenM . Effect of preoperative prophylactic intravenous tranexamic acid on perioperative blood loss control in patients undergoing cesarean delivery: a systematic review and meta-analysis. BioMed Central Pregnancy and Childbirth2023;23(1):420.">176</a>]. The large number of reviews in such a short period of time is indicative of the importance and relevance of this clinical question. Most of these reviews found a larger effect on the reduction of PPH compared to our findings. However, these reviews did not apply the trustworthiness tool. Two reviews [<a href="#CD016278-bib-0171" title="Al-DarderyNM , AbdelwahabOA , AbouzidM , AlbakriK , ElkhadragyA , KatameshBE , et al. Efficacy and safety of tranexamic acid in prevention of postpartum hemorrhage: a systematic review and meta-analysis of 18,649 patients. BioMed Central Pregnancy and Childbirth2023;23(1):817.">171</a>, <a href="#CD016278-bib-0172" title="AssisIC , GoveiaCS , MirandaD , FerreiraRS , RiccioLG . Analysis of the efficacy of prophylactic tranexamic acid in preventing postpartum bleeding: systematic review with meta-analysis of randomized clinical trials. Brazilian Journal of Anesthesiology2023;73(4):467-76.">172</a>] that reported a larger effect did not include any of the trials included in our review, but included studies we excluded or assessed as awaiting classification. Similarly, the previous version of this review also found a larger effect in the reduction of PPH. None of the trials included in the previous version of this review were included in this version, as we are awaiting additional information from study authors. Two systematic reviews [<a href="#CD016278-bib-0173" title="CheemaHA , AhmadAB , EhsanM , ShahidA , AyyanM , AzeemS , et al. Tranexamic acid for the prevention of blood loss after cesarean section: an updated systematic review and meta-analysis of randomized controlled trials. American Journal of Obstetrics &amp; Gynecology MFM2023;5(8):101049.">173</a>, <a href="#CD016278-bib-0174" title="FerrariFA , GarzonS , RaffaelliR , CromiA , CasarinJ , GhezziF , et al. Tranexamic acid for the prevention and the treatment of primary postpartum haemorrhage: a systematic review. Journal of Obstetrics and Gynaecology2022;42(5):1-13.">174</a>] reported that the lack of high‐quality evidence made it difficult to establish conclusions with high certainty. </p> <p>Two previous Cochrane reviews of trials in surgical patients observed less bleeding and fewer blood transfusions with TXA [<a href="#CD016278-bib-0177" title="HenryDA , CarlessPA , MoxeyAJ , O'ConnellD , StokesBJ , FergussonDA , et al. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database of Systematic Reviews2011, Issue 3. Art. No: CD001886. [DOI: 10.1002/14651858.CD001886.pub4]">177</a>, <a href="#CD016278-bib-0169" title="PerelP , KerK , Morales UribeCH , RobertsI . Tranexamic acid for reducing mortality in emergency and urgent surgery. Cochrane Database of Systematic Reviews2013, Issue 1. Art. No: CD010245. [DOI: 10.1002/14651858.CD010245.pub2]">169</a>]. </p> <p>The effect of TXA on mortality following emergency surgery was reported to be uncertain in a Cochrane review that included three trials (260 participants) [<a href="#CD016278-bib-0169" title="PerelP , KerK , Morales UribeCH , RobertsI . Tranexamic acid for reducing mortality in emergency and urgent surgery. Cochrane Database of Systematic Reviews2013, Issue 1. Art. No: CD010245. [DOI: 10.1002/14651858.CD010245.pub2]">169</a>]. A large, high‐quality RCT showed a decrease in all‐cause mortality and death due to bleeding in trauma patients who received a short course of TXA versus placebo [<a href="#CD016278-bib-0178" title="CRASH-2 trial collaborators, ShakurH , RobertsI , BautistaR , CaballeroJ , CoatsT , et al. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet2010;376(9734):23-32. [DOI: 10.1016/S0140-6736(10)60835-5]">178</a>]. The findings of our review are consistent with previous reports on the need for further well‐designed studies with a larger number of participants to evaluate the effect of TXA on maternal mortality, severe morbidity, and additional surgical interventions to prevent PPH. </p> <p>Although the association of TXA with thromboembolic events has been hypothesised, it has not been proven to date [<a href="#CD016278-bib-0178" title="CRASH-2 trial collaborators, ShakurH , RobertsI , BautistaR , CaballeroJ , CoatsT , et al. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet2010;376(9734):23-32. [DOI: 10.1016/S0140-6736(10)60835-5]">178</a>, <a href="#CD016278-bib-0179" title="GandhiR , EvansHM , MahomedSR , MahomedNN . Tranexamic acid and reduction of blood loss in total knee and hip arthroplasty: a meta-analysis. BMC Research Notes2013;6:184.">179</a>, <a href="#CD016278-bib-0180" title="KerK , EdwardsP , PerelP , ShakurH , RobertsI . Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysis. BMJ2012;344:e3054.">180</a>, <a href="#CD016278-bib-0023" title="KerK , BeecherD , RobertsI . Topical application of tranexamic acid for the reduction of bleeding. Cochrane Database of Systematic Reviews2013, Issue 7. Art. No: CD010562. [DOI: 10.1002/14651858.CD010562.pub2]">23</a>, <a href="#CD016278-bib-0181" title="PoeranJ , RasulR , SuzukiS , DanningerT , Opperer, BoettnerF , et al. Tranexamic acid use and postoperative outcomes in patients undergoing total hip or knee arthroplasty in the United States: retrospective analysis of effectiveness and safety. BMJ (Clinical Research Ed.)2014;349:4829.">181</a>]. Our review is in agreement with other publications suggesting that larger studies are required to assess this outcome and establish the safety of TXA. </p> <p>Seizures are a known dose‐dependent adverse effect of TXA [<a href="#CD016278-bib-0182" title="MergoumAM , MergoumAS , LarsonNJ , DriesDJ , CookA , BlondeauB , et al. Tranexamic acid use in the surgical arena: a narrative review. Journal of Surgical Research2024;5:302:208-2210.">182</a>]. There were very few events (three with TXA versus one with placebo) in this review. </p> <p>Mild side effects are more common in TXA versus placebo or no intervention [<a href="#CD016278-bib-0183" title="Ducloy-BouthorsAS , JudeB , DuhamelA , BroisinF , HuissoudC , Keita-Meyer, et al. High-dose tranexamic acid reduces blood loss in postpartum haemorrhage. Critical Care (London, England)2011;15:R177.">183</a>, <a href="#CD016278-bib-0184" title="PeitsidisP , KadirRA . Antifibrinolytic therapy with tranexamic acid in pregnancy and postpartum. Expert Opinion on Pharmacotherapy2011;12(4):503-16.">184</a>]. Our review found little or no increase in mild side effects. </p> <section id="CD016278-sec-0113"> <h4 class="title">Risk of drug error deaths</h4> <p>There appear to be increasing reports in recent years of deaths from inadvertent use of TXA instead of bupivacaine for spinal analgesia at caesarean birth [<a href="#CD016278-bib-0185" title="MoranNF , BishopDG , FawcusS , MorrisE , Shakur-StillH , DevallAJ , et al. Tranexamic acid at cesarean delivery: drug-error deaths. British Journal of Obstetrics and Gynaecology2023;130(1):114-7. [DOI: 10.1111/1471-0528]">185</a>]. A plausible explanation is the increasing use of TXA at caesarean birth, resulting in TXA being kept on the anaesthetic drug trolley. Both medications are supplied in 10‐millilitre clear glass ampoules, and some manufacturers’ ampoules are similar in appearance. Informal discussions with senior obstetricians in several countries have confirmed that such cases have occurred, but were not reported due to medicolegal concerns [GJH personal communication]. The global extent of the problem is therefore difficult to determine. </p> </section> </section> </section> </section> <section class="additionalInformation"> <div class="section-header section-collapse-header" id="CD016278-sec-0119" lang="en"> <h2 class="title section-collapse-title"> Additional information <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="additionalInformation" lang="en"> <div class="section-header" id="CD016278-sec-0119"></div> <section id="CD016278-sec-0120"> <h3 class="title">Acknowledgements</h3> <p>Cochrane Pregnancy and Childbirth Group team for technical support for previous versions of the review. </p> <p>N Novikova for participating in designing the original review, and writing the protocol and review and the first update. </p> <p>This Cochrane review is associated with the Research, Evidence and Development Initiative (READ‐It). READ‐It (project number 300342‐104) is funded by UK aid from the UK government; however, the views expressed do not necessarily reflect the UK government’s official policies. </p> <section id="CD016278-sec-0121"> <h4 class="title">Editorial and peer‐reviewer contributions</h4> <p>Cochrane Pregnancy and Childbirth supported the authors in the development of this review. </p> <p>The following people conducted the editorial process for this article:</p> <p> <ul id="CD016278-list-0031"> <li> <p>Sign‐off Editor (final editorial decision): David M Haas, Indiana University School of Medicine, USA; </p> </li> <li> <p>Managing Editor: Sam Hinsley, Cochrane Central Editorial Service (selected peer reviewers, provided editorial guidance to authors, edited the article); Hannah Payne, Cochrane Central Editorial Service (conducted editorial policy checks, collated peer‐reviewer comments, and supported the editorial team); </p> </li> <li> <p>Copy Editor (copy editing and production): Lisa Winer, Cochrane Central Production Service; </p> </li> <li> <p>Peer reviewers (provided comments and recommended an editorial decision): John E Varallo, MD, MPH, FACOG Global Surgery Foundation (clinical/content review); Aditi Bauskar (consumer review); Jennifer Hilgart, Cochrane (methods review); Jo Platt, Central Editorial Information Specialist (search review). </p> </li> </ul> </p> </section> </section> <section id="CD016278-sec-0122"> <h3 class="title">Contributions of authors</h3> <p>One author involved in previous published versions of this review in 2010 [<a href="#CD016278-bib-0016" title="NovikovaN , HofmeyrGJ . Tranexamic acid for preventing postpartum haemorrhage. Cochrane Database of Systematic Reviews2010, Issue 7. Art. No: CD007872. [DOI: 10.1002/14651858.CD007872.pub2]">16</a>] and 2015 [<a href="#CD016278-bib-0017" title="NovikovaN , HofmeyrJ , CluverC . Tranexamic acid for preventing postpartum haemorrhage. Cochrane Database of Systematic Reviews2015, Issue 6. Art. No: CD007872. [DOI: 10.1002/14651858.CD007872.pub3]">17</a>] is no longer included on the author byline: Rohwer C, Rohwer A, Cluver C, Ker K, Hofmeyr GJ. Some of the content retained in this review reflects her contributions. </p> <p>In the original review, N Novikova participated in designing the review and writing the protocol and review. She undertook the initial data analysis. GJ Hofmeyr conceived the review and provided guidance in designing the review. He also provided a clinical perspective and performed duplicate data extraction. </p> <p>In the first update, N Novikova assessed the new studies for eligibility, extracted data, and prepared the review. GJ Hofmeyr reviewed the drafts of the update. C Cluver performed duplicate data extraction and reviewed the draft of the update. </p> <p>In this latest version, C Cluver and K Ker, or C Rohwer and A Rohwer performed study selection, data extraction, and risk of bias and trustworthiness assessments. C Cluver and GJ Hofmeyr provided clinical perspective to the review. C Rohwer and A Rohwer conducted the analyses, prepared the summary of findings table, and drafted the review. All authors contributed to the final draft of the review and approved it for submission. </p> </section> <section id="CD016278-sec-0123"> <h3 class="title">Declarations of interest</h3> <p>Christa Rohwer: received financial support from the World Health Organization to complete the review. </p> <p>Anke Rohwer: is an editor for Cochrane Infectious Diseases, but was not involved in the editorial process for this review. </p> <p>Catherine Cluver: none known.</p> <p>Katharine Ker: none known.</p> <p>G Justus Hofmeyr: has consulted for Equalize Health, a not‐for‐profit health technology company, and done ad hoc consultation on the 'Maternawell Tray' blood loss monitoring device and integrated suction tube uterine tamponade device and has declared receiving consulting fees. The Maternawell tray is not mentioned in this review. GJH has published academic articles on tranexamic acid in medical journals. </p> </section> <section id="CD016278-sec-0124"> <h3 class="title">Sources of support</h3> <section id="CD016278-sec-0125"> <h4 class="title">Internal sources</h4> <p> <ul id="CD016278-list-0032"> <li> <p>Effective Care Research Unit, University of Witwatersrand, University of Fort Hare, South Africa, South Africa </p> </li> </ul> </p> </section> <section id="CD016278-sec-0126"> <h4 class="title">External sources</h4> <p> <ul id="CD016278-list-0033"> <li> <p>Foreign, Commonwealth and Development Office, UK</p> <p>Project number 300342‐104</p> </li> <li> <p>WHO, Other</p> <p>CR received financial support from WHO to complete this review.</p> </li> <li> <p>The Gates Foundation, Other</p> <p>KK received financial support from The Gates Foundation to work on this update.</p> </li> </ul> </p> </section> </section> <section id="CD016278-sec-0127"> <h3 class="title">Registration and protocol</h3> <p>The published protocol and updates to the review can be accessed:</p> <p>Protocol (2009) DOI: 10.1002/14651858.CD007872</p> <p>Original Review (2010) DOI: 10.1002/14651858.CD007872.pub2</p> <p>Review Update (2015) DOI: 10.1002/14651858.CD007872.pub3.</p> </section> <section id="CD016278-sec-0128"> <h3 class="title">Data, code and other materials</h3> <p>As part of the published Cochrane Review, the following is made available for download for users of the Cochrane Library: Full search strategies for each database; full citations of each unique report for all studies included, ongoing or awaiting classification, or excluded at the full text screen, in the final review; study data, including study information, study arms, and study results or test data; consensus risk of bias assessments; and analysis data, including overall estimates and settings, subgroup estimates, and individual data rows. Appropriate permissions have been obtained for such use. Analyses and data management were conducted within Cochrane’s authoring tool, RevMan, using the inbuilt computation methods. Template data extraction forms from Covidence are available from the authors on reasonable request. </p> <p>All data available in <a href="#CD016278-supitem-0007">Supplementary material 7</a>. </p> </section> <section id="CD016278-sec-0129"> <h3 class="title">What's new</h3> <p> <div class="table" id="CD016278-tblf-0001"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Date</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Event</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Description</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30 January 2025</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Amended</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Amendment to correct self‐citation.</p> </td> </tr> </tbody> </table> </div> </p> </section> <section id="CD016278-sec-0130"> <h3 class="title">History</h3> <p>Review first published: Issue 11, 2024</p> </section> </section> </section> <section class="nrfreferences"> <div class="section-header section-collapse-header" id="CD016278-bibl-0001" lang="en"> <h2 class="title section-collapse-title"> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <p>To view the full reference list, organized by study, for included studies, excluded studies, studies awaiting classification and/or ongoing studies, see the <a href="supplementarymaterials#characteristicsofstudies"><b>characteristics of studies.</b></a></p> <div class="download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD016278/media/CDSR/CD016278/supinfo/CD016278-SUP-07-dataPackage.zip"> <p> Alternatively, this grouping of references is available via the <a href="/cdsr/doi/10.1002/14651858.CD016278/media/CDSR/CD016278/supinfo/CD016278-SUP-07-dataPackage.zip"><b>downloadable data package.</b></a></p> </div> <div class="bibliographies full_references" id="CD016278-bibl-0001"> <h2>References</h2> <h2 class="title"></h2> <div class="nrf-reference-section" id="CD016278-bib-0001"> <div class="citation-journal">1. Calvert C, Thomas SL, Ronsmans C, Wagner KS, Adler AJ, Filippi V. <span class="citation-title">Identifying regional variation in the prevalence of postpartum haemorrhage: a systematic review and meta-analysis</span>. <span class="citation"> PLOS ONE </span><span class="pubYear">2012</span>;<span class="volume">7</span>(7):e41114. <ul class="citation-link-group"> <li> <a class="citation-link" href="https://doi.org/10.1371/journal.pone.0041114" target="_blank"> <span>Link to article</span> </a> </li> <li> <a class="citation-link" href="https://www.ncbi.nlm.nih.gov/pubmed/22844432" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=Identifying+regional+variation+in+the+prevalence+of+postpartum+haemorrhage:+a+systematic+review+and+meta-analysis+&amp;author=C+Calvert&amp;author=SL+Thomas&amp;author=C+Ronsmans&amp;author=KS+Wagner&amp;author=AJ+Adler&amp;author=V+Filippi&amp;publication_year=2012&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0002"> <div class="citation-journal">2. Carroli G, Cuesta C, Abalos E, Gulmezoglu AM. <span class="citation-title">Epidemiology of postpartum haemorrhage: a systematic review</span>. <span class="citation"> Best Practice &amp; Research: Clinical Obstetrics &amp; Gynaecology </span><span class="pubYear">2008</span>;<span class="volume">22</span>(6):999-1012. <ul class="citation-link-group"> <li> <a class="citation-link" href="https://doi.org/10.1016/j.bpobgyn.2008.08.004" target="_blank"> <span>Link to article</span> </a> </li> <li> <a class="citation-link" href="https://www.ncbi.nlm.nih.gov/pubmed/18819848" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=Epidemiology+of+postpartum+haemorrhage:+a+systematic+review&amp;author=G+Carroli&amp;author=C+Cuesta&amp;author=E+Abalos&amp;author=AM+Gulmezoglu&amp;publication_year=2008&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0003"> <div class="citation-journal">3. Feduniw S, Warzecha D, Szymusik I, Wielgos M. <span class="citation-title">Epidemiology, prevention and management of early postpartum hemorrhage - a systematic review</span>. <span class="citation"> Ginekologia Polska </span><span class="pubYear">2020</span>;<span class="volume">91</span>(4):38-44. <ul class="citation-link-group"> <li> <a class="citation-link" href="https://doi.org/10.5603/GP.2020.0009" target="_blank"> <span>Link to article</span> </a> </li> <li> <a class="citation-link" href="https://www.ncbi.nlm.nih.gov/pubmed/32039467" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=Epidemiology,+prevention+and+management+of+early+postpartum+hemorrhage+-+a+systematic+review+&amp;author=S+Feduniw&amp;author=D+Warzecha&amp;author=I+Szymusik&amp;author=M+Wielgos&amp;publication_year=2020&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0004"> <div class="citation-journal">4. Say L, Pattinson R, Gulmezoglu A. <span class="citation-title">WHO systematic review of maternal morbidity and mortality: the prevalence of severe acute maternal morbidity (near miss)</span>. <span class="citation"> BioMed Central. Reproductive Health </span><span class="pubYear">2004</span>;<span class="volume">1</span>(3):1. [DOI: <a href="http://dx.doi.org/10.1186/1742-4755-1-3" target="_blank"><span>10.1186/1742-4755-1-3</span></a>] <ul class="citation-link-group"> <li> <a class="citation-link" href="https://doi.org/10.1186/1742-4755-1-3" target="_blank"> <span>Link to article</span> </a> </li> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=WHO+systematic+review+of+maternal+morbidity+and+mortality:+the+prevalence+of+severe+acute+maternal+morbidity+(near+miss)+&amp;author=L+Say&amp;author=R+Pattinson&amp;author=A+Gulmezoglu&amp;publication_year=2004&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0005"> <div class="citation-journal">5. Thompson JF, Heal LJ, Roberts CL, Ellwood DA. <span class="citation-title">Women's breastfeeding experiences following a significant primary postpartum haemorrhage: A multicentre cohort study</span>. <span class="citation"> International Breastfeeding Journal </span><span class="pubYear">2010</span>;<span class="volume">5</span>(5):1. [DOI: <a href="http://dx.doi.org/10.1186/1746-4358-5-5" target="_blank"><span>10.1186/1746-4358-5-5</span></a>] [PMCID: PMC2889881] [PMID: 20504372] <ul class="citation-link-group"> <li> <a class="citation-link" href="https://doi.org/10.1186/1746-4358-5-5" target="_blank"> <span>Link to article</span> </a> </li> <li> <a class="citation-link" href="https://www.ncbi.nlm.nih.gov/pubmed/20181024" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=Women's+breastfeeding+experiences+following+a+significant+primary+postpartum+haemorrhage:+A+multicentre+cohort+study+&amp;author=JF+Thompson&amp;author=LJ+Heal&amp;author=CL+Roberts&amp;author=DA+Ellwood&amp;publication_year=2010&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0006"> <div class="citation-other">6. World Health Organization. <span class="citation-title">WHO recommendations for the prevention and treatment of postpartum haemorrhage</span>. www.who.int/publications/i/item/9789241548502. <ul class="citation-link-group"> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0007"> <div class="citation-journal">7. Pingray V, Williams CR, Al-Beity FM, Abalos E, Arulkumaran S, Blumenfeld A, et al. <span class="citation-title">Strategies for optimising early detection and obstetric first response management of postpartum haemorrhage at caesarean birth: a modified Delphi-based international expert consensus</span>. <span class="citation"> BMJ Open </span><span class="pubYear">2024</span>;<span class="volume">8;14</span>(5):e079713. <ul class="citation-link-group"> <li> <a class="citation-link" href="https://doi.org/10.1136/bmjopen-2023-079713" target="_blank"> <span>Link to article</span> </a> </li> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=Strategies+for+optimising+early+detection+and+obstetric+first+response+management+of+postpartum+haemorrhage+at+caesarean+birth:+a+modified+Delphi-based+international+expert+consensus+&amp;author=V+Pingray&amp;author=CR+Williams&amp;author=FM+Al-Beity&amp;author=E+Abalos&amp;author=S+Arulkumaran&amp;author=A+Blumenfeld&amp;publication_year=2024&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0008"> <div class="citation-journal">8. Hersh AR, Carroli G, Hofmeyr GJ, Garg B, Gulmezoglu M, Lumbiganon P, et al. <span class="citation-title">Third stage of labor: evidence-based practice for prevention of adverse maternal and neonatal outcomes</span>. <span class="citation"> American Journal of Obstetrics &amp; Gynecology </span><span class="pubYear">2024</span>;<span class="volume">230(3S)</span>:S1046-S1060.e1. <ul class="citation-link-group"> <li> <a class="citation-link" href="https://doi.org/10.1016/j.ajog.2022.11.1298" target="_blank"> <span>Link to article</span> </a> </li> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=Third+stage+of+labor:+evidence-based+practice+for+prevention+of+adverse+maternal+and+neonatal+outcomes+&amp;author=AR+Hersh&amp;author=G+Carroli&amp;author=GJ+Hofmeyr&amp;author=B+Garg&amp;author=M+Gulmezoglu&amp;author=P+Lumbiganon&amp;publication_year=2024&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0009"> <div class="citation-journal">9. Hofmeyr GJ. <span class="citation-title">Maternal deaths from bleeding associated with caesarean delivery: A national emergency</span>. <span class="citation"> South African Medical Journal </span><span class="pubYear">2016</span>;<span class="volume">7;106</span>(5):22. <ul class="citation-link-group"> <li> <a class="citation-link" href="https://doi.org/10.7196/SAMJ.2016.v106i5.10822" target="_blank"> <span>Link to article</span> </a> </li> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=Maternal+deaths+from+bleeding+associated+with+caesarean+delivery:+A+national+emergency&amp;author=GJ+Hofmeyr&amp;publication_year=2016&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0010"> <div class="citation-journal">10. Ker K, Roberts I, Shakur H, Coats TJ. <span class="citation-title">Antifibrinolytic drugs for acute traumatic injury</span>. <span class="citation"> Cochrane Database of Systematic Reviews </span><span class="pubYear">2015</span>, Issue 5. Art. No: CD004896. [DOI: <a href="http://dx.doi.org/10.1002/14651858.CD004896.pub4" target="_blank"><span>10.1002/14651858.CD004896.pub4</span></a>] <ul class="citation-link-group"> <li> <a class="citation-link" href="https://doi.org/10.1002/14651858.CD004896.pub4" target="_blank"> <span>Link to article</span> </a> </li> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=Antifibrinolytic+drugs+for+acute+traumatic+injury&amp;author=K+Ker&amp;author=I+Roberts&amp;author=H+Shakur&amp;author=TJ+Coats&amp;publication_year=2015&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0011"> <div class="citation-journal">11. Shakur H, Beaumont D, Pavord S, Gayet‐Ageron A, Ker K, Mousa HA. <span class="citation-title">Antifibrinolytic drugs for treating primary postpartum haemorrhage</span>. <span class="citation"> Cochrane Database of Systematic Reviews </span><span class="pubYear">2018</span>, Issue 2. Art. No: CD012964. [DOI: <a href="http://dx.doi.org/10.1002/14651858.CD012964" target="_blank"><span>10.1002/14651858.CD012964</span></a>] <ul class="citation-link-group"> <li> <a class="citation-link" href="https://doi.org/10.1002/14651858.CD012964" target="_blank"> <span>Link to article</span> </a> </li> <li> <a class="citation-link" href="https://www.ncbi.nlm.nih.gov/pubmed/29462500" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=Antifibrinolytic+drugs+for+treating+primary+postpartum+haemorrhage&amp;author=H+Shakur&amp;author=D+Beaumont&amp;author=S+Pavord&amp;author=A+Gayet‐Ageron&amp;author=K+Ker&amp;author=HA+Mousa&amp;publication_year=2018&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0012"> <div class="citation-journal">12. Stampfli D, Weiler S, Weiniger CF, Burden AM, Heesen M. <span class="citation-title">Renal ischemic adverse drug events related to tranexamic acid in women of child-bearing age: an analysis of pharmacovigilance data</span>. <span class="citation"> European Journal of Clinical Pharmacology </span><span class="pubYear">2021</span>;<span class="volume">77</span>(6):913-9. <ul class="citation-link-group"> <li> <a class="citation-link" href="https://doi.org/10.1007/s00228-020-03064-y" target="_blank"> <span>Link to article</span> </a> </li> <li> <a class="citation-link" href="https://www.ncbi.nlm.nih.gov/pubmed/33341923" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=Renal+ischemic+adverse+drug+events+related+to+tranexamic+acid+in+women+of+child-bearing+age:+an+analysis+of+pharmacovigilance+data+&amp;author=D+Stampfli&amp;author=S+Weiler&amp;author=CF+Weiniger&amp;author=AM+Burden&amp;author=M+Heesen&amp;publication_year=2021&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0013"> <div class="citation-journal">13. Woman Trial Collaborators. <span class="citation-title">Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial</span>. <span class="citation"> Lancet </span><span class="pubYear">2017</span>;<span class="volume">389</span>(10084):2105-16. <ul class="citation-link-group"> <li> <a class="citation-link" href="https://doi.org/10.1016/S0140-6736(17)30638-4" target="_blank"> <span>Link to article</span> </a> </li> <li> <a class="citation-link" href="https://www.ncbi.nlm.nih.gov/pubmed/28456509" target="_blank"> <span>PubMed</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0014"> <div class="citation-other">14. World Health Organization. <span class="citation-title">WHO recommendation on tranexamic acid for the treatment of postpartum haemorrhage</span>. www.who.int/publications/i/item/9789241550154. <ul class="citation-link-group"> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0015"> <div class="citation-journal">15. Ker K, Shakur H, Roberts I. <span class="citation-title">Does tranexamic acid prevent postpartum haemorrhage? A systematic review of randomised controlled trials</span>. <span class="citation"> BJOG </span><span class="pubYear">2016</span>;<span class="volume">123</span>(11):1745-52. <ul class="citation-link-group"> <li> <a class="citation-link" href="https://doi.org/10.1111/1471-0528.14267" target="_blank"> <span>Link to article</span> </a> </li> <li> <a class="citation-link" href="https://www.ncbi.nlm.nih.gov/pubmed/27558956" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=Does+tranexamic+acid+prevent+postpartum+haemorrhage?+A+systematic+review+of+randomised+controlled+trials+&amp;author=K+Ker&amp;author=H+Shakur&amp;author=I+Roberts&amp;publication_year=2016&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0016"> <div class="citation-journal">16. Novikova N, Hofmeyr GJ. <span class="citation-title">Tranexamic acid for preventing postpartum haemorrhage</span>. <span class="citation"> Cochrane Database of Systematic Reviews </span><span class="pubYear">2010</span>, Issue 7. Art. No: CD007872. [DOI: <a href="http://dx.doi.org/10.1002/14651858.CD007872.pub2" target="_blank"><span>10.1002/14651858.CD007872.pub2</span></a>] <ul class="citation-link-group"> <li> <a class="citation-link" href="https://doi.org/10.1002/14651858.CD007872.pub2" target="_blank"> <span>Link to article</span> </a> </li> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=Tranexamic+acid+for+preventing+postpartum+haemorrhage&amp;author=N+Novikova&amp;author=GJ+Hofmeyr&amp;publication_year=2010&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0017"> <div class="citation-journal">17. Novikova N, Hofmeyr J, Cluver C. <span class="citation-title">Tranexamic acid for preventing postpartum haemorrhage</span>. <span class="citation"> Cochrane Database of Systematic Reviews </span><span class="pubYear">2015</span>, Issue 6. Art. No: CD007872. [DOI: <a href="http://dx.doi.org/10.1002/14651858.CD007872.pub3" target="_blank"><span>10.1002/14651858.CD007872.pub3</span></a>] <ul class="citation-link-group"> <li> <a class="citation-link" href="https://doi.org/10.1002/14651858.CD007872.pub3" target="_blank"> <span>Link to article</span> </a> </li> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=Tranexamic+acid+for+preventing+postpartum+haemorrhage&amp;author=N+Novikova&amp;author=J+Hofmeyr&amp;author=C+Cluver&amp;publication_year=2015&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0018"> <div class="citation-journal">18. Murao S, Nakata H, Roberts I, Yamakawa K. <span class="citation-title">Effect of tranexamic acid on thrombotic events and seizures in bleeding patients: a systematic review and meta-analysis</span>. <span class="citation"> Critical Care (London, England) </span><span class="pubYear">2021</span>;<span class="volume">25</span>(1):380. <ul class="citation-link-group"> <li> <a class="citation-link" href="https://doi.org/10.1186/s13054-021-03799-9" target="_blank"> <span>Link to article</span> </a> </li> <li> <a class="citation-link" href="https://www.ncbi.nlm.nih.gov/pubmed/34724964" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=Effect+of+tranexamic+acid+on+thrombotic+events+and+seizures+in+bleeding+patients:+a+systematic+review+and+meta-analysis+&amp;author=S+Murao&amp;author=H+Nakata&amp;author=I+Roberts&amp;author=K+Yamakawa&amp;publication_year=2021&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0019"> <div class="citation-journal">19. CRASH-2 collaborators; Roberts I, Shakur H, Afolabi A, Brohi K, Coats T, Dewan Y, et al. <span class="citation-title">The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial</span>. <span class="citation"> Lancet </span><span class="pubYear">2011</span>;<span class="volume">26;377</span>(9771):1096-101, 1101.e1-2. <ul class="citation-link-group"> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=The+importance+of+early+treatment+with+tranexamic+acid+in+bleeding+trauma+patients:+an+exploratory+analysis+of+the+CRASH-2+randomised+controlled+trial+&amp;author=H+Shakur&amp;author=A+Afolabi&amp;author=K+Brohi&amp;author=T+Coats&amp;author=Y+Dewan&amp;publication_year=2011&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0020"> <div class="citation-other">20. Higgins J, Lasserson T, Chandler J, Tovey D, Thomas J, Flemyng E, Churchill R. <span class="citation-title">Methodological Expectations of Cochrane Intervention Reviews (MECIR) Standards for the conduct and reporting of new Cochrane Intervention Reviews, reporting of protocols and the planning, conduct and reporting of updates</span>. methods.cochrane.org/methodological-expectations-cochrane-intervention-reviews. <ul class="citation-link-group"> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0021"> <div class="citation-journal">21. Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. <span class="citation-title">The PRISMA 2020 statement: an updated guideline for reporting systematic reviews</span>. <span class="citation"> BMJ </span><span class="pubYear">2021</span>;<span class="volume">372</span>:n71. [DOI: 10.1136/bmj.n71] <ul class="citation-link-group"> <li> <a class="citation-link" href="https://www.ncbi.nlm.nih.gov/pubmed/33782057" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=The+PRISMA+2020+statement:+an+updated+guideline+for+reporting+systematic+reviews&amp;author=MJ+Page&amp;author=JE+McKenzie&amp;author=PM+Bossuyt&amp;author=I+Boutron&amp;author=TC+Hoffmann&amp;author=CD+Mulrow&amp;publication_year=2021&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0022"> <div class="citation-journal">22. Li. <span class="citation-title">Assessing research misconduct in randomized controlled trials</span>. <span class="citation"> Obstetrics and Gynecology </span><span class="pubYear">2021</span>;<span class="volume">138</span>(3):338-47. [DOI: <a href="http://dx.doi.org/10.1097/AOG.0000000000004513" target="_blank"><span>10.1097/AOG.0000000000004513</span></a>] <ul class="citation-link-group"> <li> <a class="citation-link" href="https://www.ncbi.nlm.nih.gov/pubmed/34352811" target="_blank"> <span>PubMed</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0023"> <div class="citation-journal">23. Ker K, Beecher D, Roberts I. <span class="citation-title">Topical application of tranexamic acid for the reduction of bleeding</span>. <span class="citation"> Cochrane Database of Systematic Reviews </span><span class="pubYear">2013</span>, Issue 7. Art. No: CD010562. [DOI: <a href="http://dx.doi.org/10.1002/14651858.CD010562.pub2" target="_blank"><span>10.1002/14651858.CD010562.pub2</span></a>] <ul class="citation-link-group"> <li> <a class="citation-link" href="https://doi.org/10.1002/14651858.CD010562" target="_blank"> <span>Link to article</span> </a> </li> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=Topical+application+of+tranexamic+acid+for+the+reduction+of+bleeding&amp;author=K+Ker&amp;author=D+Beecher&amp;author=I+Roberts&amp;publication_year=2013&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0024"> <div class="citation-other">24. Alfirevic Z, Kellie FJ, Weeks J, Stewart F, Jones L, Hampson L, on behalf of the Pregnancy and Childbirth Editorial Board. <span class="citation-title">Identifying and handling potentially untrustworthy trials - Trustworthiness Screening Tool (TST) developed by the Cochrane Pregnancy and Childbirth Group</span>. Cochrane Pregnancy and Childbirth Group. <ul class="citation-link-group"> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0025"> <div class="citation-journal">25. Carlisle JB. <span class="citation-title">Data fabrication and other reasons for non-random sampling in 5087 randomised, controlled trial in anaesthetic and general medical journals</span>. <span class="citation"> Anaesthesia </span><span class="pubYear">2017</span>;<span class="volume">72</span>:944-52. <ul class="citation-link-group"> <li> <a class="citation-link" href="https://doi.org/10.1111/anae.13938" target="_blank"> <span>Link to article</span> </a> </li> <li> <a class="citation-link" href="https://www.ncbi.nlm.nih.gov/pubmed/28580651" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=Data+fabrication+and+other+reasons+for+non-random+sampling+in+5087+randomised,+controlled+trial+in+anaesthetic+and+general+medical+journals+&amp;author=JB+Carlisle&amp;publication_year=2017&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0026"> <div class="citation-other">26. <span class="citation-title">Covidence systematic review software</span>. Version 01/08/2024. Melbourne, Australia: Veritas Health Innovation, <span class="pubYear">2024</span>. Available at www.covidence.org. <ul class="citation-link-group"> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0027"> <div class="citation-other">27. Higgins JP, Altman DG, Sterne JA, editor(s). <span class="citation-title">Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011</span>. Available from training.cochrane.org/handbook/archive/v5.1/. <ul class="citation-link-group"> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0028"> <div class="citation-other">28. Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). <span class="citation-title">Cochrane Handbook for Systematic Reviews of Interventions version 6.3 (updated February 2022). Cochrane, 2022</span>. Available from training.cochrane.org/handbook/archive/v6.3. <ul class="citation-link-group"> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0029"> <div class="citation-other">29. <span class="citation-title">Review Manager (RevMan)</span>. Version 7.12.0. The Cochrane Collaboration, <span class="pubYear">2024</span>. Available at https://revman.cochrane.org. <ul class="citation-link-group"> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0030"> <div class="citation-journal">30. Schunemann HJ. <span class="citation-title">GRADE: from grading the evidence to developing recommendations. A description of the system and a proposal regarding the transferability of the results of clinical research to clinical practice</span> [GRADE: von der Evidenz zur Empfehlung. Beschreibung des Systems und Losungsbeitrag zur Ubertragbarkeit von Studienergebnissen]. <span class="citation"> Zeitschrift fur Evidenz, Fortbildung und Qualitat Im Gesundheitswesen </span><span class="pubYear">2009</span>;<span class="volume">103</span>(6):391-400. [PMID: 19839216] <ul class="citation-link-group"> <li> <a class="citation-link" href="https://www.ncbi.nlm.nih.gov/pubmed/19839216" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=GRADE:+from+grading+the+evidence+to+developing+recommendations.+A+description+of+the+system+and+a+proposal+regarding+the+transferability+of+the+results+of+clinical+research+to+clinical+practice+&amp;author=HJ+Schunemann&amp;publication_year=2009&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0031"> <div class="citation-other">31. <span class="citation-title">GRADEpro GDT</span>. Version 01/08/2024. Hamilton (ON): McMaster University (developed by Evidence Prime), <span class="pubYear">2024</span>. Available at https://www.gradepro.org. <ul class="citation-link-group"> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0032"> <div class="citation-journal">32. Meher S, Cuthbert A, Kirkham JJ, Williamson P, Abalos E, Aflaifel N, et al. <span class="citation-title">Core outcome sets for prevention and treatment of postpartum haemorrhage: an international Delphi consensus study</span>. <span class="citation"> BJOG </span><span class="pubYear">2019</span>;<span class="volume">126</span>:83–93. <ul class="citation-link-group"> <li> <a class="citation-link" href="https://doi.org/10.1111/1471-0528.15335" target="_blank"> <span>Link to article</span> </a> </li> <li> <a class="citation-link" href="https://www.ncbi.nlm.nih.gov/pubmed/29920912" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=Core+outcome+sets+for+prevention+and+treatment+of+postpartum+haemorrhage:+an+international+Delphi+consensus+study+&amp;author=S+Meher&amp;author=A+Cuthbert&amp;author=JJ+Kirkham&amp;author=P+Williamson&amp;author=E+Abalos&amp;author=N+Aflaifel&amp;publication_year=2019&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0033"> <div class="citation-journal">33. Abdel-Aleem H, Alhusaini TK, Abdel-Aleem MA, Menoufy M, Gulmezoglu AM. <span class="citation-title">Effectiveness of tranexamic acid on blood loss in patients undergoing elective cesarean section: randomized clinical trial</span>. <span class="citation"> Journal of Maternal-Fetal &amp; Neonatal Medicine </span><span class="pubYear">2013</span>;<span class="volume">26</span>(17):1705-9. <a class="crsref citation-link central-link" data-crsref="26709973" href="" ref="info:x-wiley/crsRef/26709973" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="https://doi.org/10.3109/14767058.2013.794210" target="_blank"> <span>Link to article</span> </a> </li> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=Effectiveness+of+tranexamic+acid+on+blood+loss+in+patients+undergoing+elective+cesarean+section:+randomized+clinical+trial+&amp;author=H+Abdel-Aleem&amp;author=TK+Alhusaini&amp;author=MA+Abdel-Aleem&amp;author=M+Menoufy&amp;author=AM+Gulmezoglu&amp;publication_year=2013&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0034"> <div class="citation-other">34. ACTRN12612000313831. <span class="citation-title">The use of tranexamic acid to reduce blood loss during and after cesarean section</span>. Https://anzctr.org.au/ACTRN12612000313831.aspx (first received 2012). <a class="crsref citation-link central-link" data-crsref="26709972" href="" ref="info:x-wiley/crsRef/26709972" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0035"> <div class="citation-journal">35. Goswami U, Sarangi S, Gupta S, Babbar S. <span class="citation-title">Comparative evaluation of two doses of tranexamic acid used prophylactically in anemic parturients for lower segment cesarean section: a double-blind randomized case control prospective trial</span>. <span class="citation"> Saudi Journal of Anaesthesia </span><span class="pubYear">2013</span>;<span class="volume">7</span>(4):427-31. <a class="crsref citation-link central-link" data-crsref="26709991" href="" ref="info:x-wiley/crsRef/26709991" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="https://doi.org/10.4103/1658-354X.121077" target="_blank"> <span>Link to article</span> </a> </li> <li> <a class="citation-link" href="https://www.ncbi.nlm.nih.gov/pubmed/24348295" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=Comparative+evaluation+of+two+doses+of+tranexamic+acid+used+prophylactically+in+anemic+parturients+for+lower+segment+cesarean+section:+a+double-blind+randomized+case+control+prospective+trial+&amp;author=U+Goswami&amp;author=S+Sarangi&amp;author=S+Gupta&amp;author=S+Babbar&amp;publication_year=2013&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0036"> <div class="citation-journal">36. Gungorduk K, Yildirim G, Asicioglu O, Gungorduk OC, Sudolmus S, Ark C. <span class="citation-title">Efficacy of intravenous tranexamic acid in reducing blood loss after elective cesarean section: a prospective, randomized, double-blind, placebo-controlled study</span>. <span class="citation"> American Journal of Perinatology </span><span class="pubYear">2011</span>;<span class="volume">28</span>(3):233-40. <a class="crsref citation-link central-link" data-crsref="26709993" href="" ref="info:x-wiley/crsRef/26709993" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="https://doi.org/10.1055/s-0030-1268238" target="_blank"> <span>Link to article</span> </a> </li> <li> <a class="citation-link" href="https://www.ncbi.nlm.nih.gov/pubmed/20979013" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=Efficacy+of+intravenous+tranexamic+acid+in+reducing+blood+loss+after+elective+cesarean+section:+a+prospective,+randomized,+double-blind,+placebo-controlled+study+&amp;author=K+Gungorduk&amp;author=G+Yildirim&amp;author=O+Asicioglu&amp;author=OC+Gungorduk&amp;author=S+Sudolmus&amp;author=C+Ark&amp;publication_year=2011&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0037"> <div class="citation-journal">37. Gungorduk K, Asicioglu O, Yildirim G, Ark C, Tekirdag AI, Besimoglu B. <span class="citation-title">Can intravenous injection of tranexamic acid be used in routine practice with active management of the third stage of labor in vaginal delivery? A randomized controlled study</span>. <span class="citation"> American Journal of Perinatology </span><span class="pubYear">2013</span>;<span class="volume">30</span>(5):407-13. <a class="crsref citation-link central-link" data-crsref="26709995" href="" ref="info:x-wiley/crsRef/26709995" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="https://www.ncbi.nlm.nih.gov/pubmed/23023559" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=Can+intravenous+injection+of+tranexamic+acid+be+used+in+routine+practice+with+active+management+of+the+third+stage+of+labor+in+vaginal+delivery?+A+randomized+controlled+study+&amp;author=K+Gungorduk&amp;author=O+Asicioglu&amp;author=G+Yildirim&amp;author=C+Ark&amp;author=AI+Tekirdag&amp;author=B+Besimoglu&amp;publication_year=2013&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0038"> <div class="citation-journal">38. Mirghafourvand M, Alizadeh SM, Abasalizadeh F, Shirdel M. <span class="citation-title">The effect of intravenous tranexamic acid on hemoglobin and hematocrit levels after vaginal delivery: a randomized controlled trial</span>. <span class="citation"> Iranian Journal of Obstetrics, Gynecology and Infertility </span><span class="pubYear">2013</span>;<span class="volume">16</span>(60):1-8. <a class="crsref citation-link central-link" data-crsref="26710021" href="" ref="info:x-wiley/crsRef/26710021" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=The+effect+of+intravenous+tranexamic+acid+on+hemoglobin+and+hematocrit+levels+after+vaginal+delivery:+a+randomized+controlled+trial+&amp;author=M+Mirghafourvand&amp;author=SM+Alizadeh&amp;author=F+Abasalizadeh&amp;author=M+Shirdel&amp;publication_year=2013&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0039"> <div class="citation-other">39. Mirghafourvand M, Mohammad-Alizadeh S, Abasalizadeh F, Shirdel M. <span class="citation-title">The effect of prophylactic intravenous tranexamic acid on blood loss after vaginal delivery in low risk of postpartum haemorrhage women: a double-blind randomized controlled trial</span>. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology in press. <a class="crsref citation-link central-link" data-crsref="26710022" href="" ref="info:x-wiley/crsRef/26710022" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0040"> <div class="citation-journal">40. Movafegh A, Eslamian L, Dorabadi A. <span class="citation-title">Effect of intravenous tranexamic acid administration on blood loss during and after cesarean delivery</span>. <span class="citation"> International Journal of Gynaecology and Obstetrics </span><span class="pubYear">2011</span>;<span class="volume">115</span>(3):224-6. <a class="crsref citation-link central-link" data-crsref="26710024" href="" ref="info:x-wiley/crsRef/26710024" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="https://doi.org/10.1016/j.ijgo.2011.07.015" target="_blank"> <span>Link to article</span> </a> </li> <li> <a class="citation-link" href="https://www.ncbi.nlm.nih.gov/pubmed/21872857" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=Effect+of+intravenous+tranexamic+acid+administration+on+blood+loss+during+and+after+cesarean+delivery+&amp;author=A+Movafegh&amp;author=L+Eslamian&amp;author=A+Dorabadi&amp;publication_year=2011&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0041"> <div class="citation-other">41. NCT01085006. <span class="citation-title">The effect of tranexamic acid administration on postpartum hemorrhage during and after cesarean delivery</span>. Http://clinicaltrials.gov/show/NCT01085006 (first received 2009). [CENTRAL: CN-01067257] <a class="crsref citation-link central-link" data-crsref="26710025" href="" ref="info:x-wiley/crsRef/26710025" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0042"> <div class="citation-journal">42. Yang H, Zheng S, Shi C. <span class="citation-title">[Clinical study on the efficacy of tranexamic acid in reducing postpartum blood lose: a randomized comparative, multicenter trial] [Chinese]</span>. <span class="citation"> Chung-Hua Fu Chan Ko Tsa Chih [Chinese Journal of Obstetrics and Gynaecology] </span><span class="pubYear">2001</span>;<span class="volume">36</span>(10):590-2. <a class="crsref citation-link central-link" data-crsref="26710075" href="" ref="info:x-wiley/crsRef/26710075" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=[Clinical+study+on+the+efficacy+of+tranexamic+acid+in+reducing+postpartum+blood+lose:+a+randomized+comparative,+multicenter+trial]+[Chinese]+&amp;author=H+Yang&amp;author=S+Zheng&amp;author=C+Shi&amp;publication_year=2001&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0043"> <div class="citation-journal">43. Gai MY, Wu LF, Su QF, Tatsumoto K. <span class="citation-title">Clinical observation of blood loss reduced by tranexamic acid during and after caesarian section: a multi-center, randomized trial</span>. <span class="citation"> European Journal of Obstetrics &amp; Gynecology and Reproductive Biology </span><span class="pubYear">2004</span>;<span class="volume">112</span>:154-7. <a class="crsref citation-link central-link" data-crsref="26710094" href="" ref="info:x-wiley/crsRef/26710094" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="https://doi.org/10.1016/S0301-2115(03)00287-2" target="_blank"> <span>Link to article</span> </a> </li> <li> <a class="citation-link" href="https://www.ncbi.nlm.nih.gov/pubmed/14746950" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=Clinical+observation+of+blood+loss+reduced+by+tranexamic+acid+during+and+after+caesarian+section:+a+multi-center,+randomized+trial+&amp;author=MY+Gai&amp;author=LF+Wu&amp;author=QF+Su&amp;author=K+Tatsumoto&amp;publication_year=2004&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0044"> <div class="citation-journal">44. Shahid A, Khan A. <span class="citation-title">Tranexamic acid in decreasing blood loss during and after caesarean section</span>. <span class="citation"> Journal of the College of Physicians and Surgeons--Pakistan: JCPSP </span><span class="pubYear">2013</span>;<span class="volume">23</span>(7):459-62. <a class="crsref citation-link central-link" data-crsref="26710149" href="" ref="info:x-wiley/crsRef/26710149" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="https://www.ncbi.nlm.nih.gov/pubmed/23823946" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=Tranexamic+acid+in+decreasing+blood+loss+during+and+after+caesarean+section&amp;author=A+Shahid&amp;author=A+Khan&amp;publication_year=2013&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0045"> <div class="citation-journal">45. Xu J, Gao W, Ju Y. <span class="citation-title">Tranexamic acid for the prevention of postpartum hemorrhage after cesarean section: a double-blind randomization trial</span>. <span class="citation"> Archives of Gynecology and Obstetrics </span><span class="pubYear">2013</span>;<span class="volume">287</span>(3):463-8. <a class="crsref citation-link central-link" data-crsref="26710173" href="" ref="info:x-wiley/crsRef/26710173" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="https://doi.org/10.1007/s00404-012-2593-y" target="_blank"> <span>Link to article</span> </a> </li> <li> <a class="citation-link" href="https://www.ncbi.nlm.nih.gov/pubmed/23064441" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=Tranexamic+acid+for+the+prevention+of+postpartum+hemorrhage+after+cesarean+section:+a+double-blind+randomization+trial+&amp;author=J+Xu&amp;author=W+Gao&amp;author=Y+Ju&amp;publication_year=2013&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0046"> <div class="citation-journal">46. Yehia AH, Koleib MH, Abdelazim IA, Atik A. <span class="citation-title">Tranexamic acid reduces blood loss during and after cesarean section: A double blinded, randomized, controlled trial</span>. <span class="citation"> Asian Pacific Journal of Reproduction </span><span class="pubYear">2014</span>;<span class="volume">3</span>(1):53-6. <a class="crsref citation-link central-link" data-crsref="26710175" href="" ref="info:x-wiley/crsRef/26710175" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="https://doi.org/10.1016/S2305-0500(14)60002-6" target="_blank"> <span>Link to article</span> </a> </li> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=Tranexamic+acid+reduces+blood+loss+during+and+after+cesarean+section:+A+double+blinded,+randomized,+controlled+trial+&amp;author=AH+Yehia&amp;author=MH+Koleib&amp;author=IA+Abdelazim&amp;author=A+Atik&amp;publication_year=2014&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0047"> <div class="citation-journal">47. Ahmed MR, Sayed Ahmed WA, Madny EH, Arafa AM, Said MM. <span class="citation-title">Efficacy of tranexamic acid in decreasing blood loss in elective caesarean delivery</span>. <span class="citation"> Journal of Maternal-Fetal &amp; Neonatal Medicine </span><span class="pubYear">2015</span>;<span class="volume">28</span>(9):1014-8. [CENTRAL: CN-01086300] <a class="crsref citation-link central-link" data-crsref="26709976" href="" ref="info:x-wiley/crsRef/26709976" target="_blank"><span style="display: none;">CENTRAL</span></a> [EMBASE: 605117379] [PMID: 25068947] <ul class="citation-link-group"> <li> <a class="citation-link" href="https://doi.org/10.3109/14767058.2014.941283" target="_blank"> <span>Link to article</span> </a> </li> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=Efficacy+of+tranexamic+acid+in+decreasing+blood+loss+in+elective+caesarean+delivery&amp;author=MR+Ahmed&amp;author=WA+SayedAhmed&amp;author=EH+Madny&amp;author=AM+Arafa&amp;author=MM+Said&amp;publication_year=2015&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0048"> <div class="citation-journal">48. Maged AM, Helal, OM, Elsherbini MM, Eid MM, Elkomy RO, et al. <span class="citation-title">A randomized placebo-controlled trial of peroperative tranexmaic acid among women undergoing elective cesarean delivery</span>. <span class="citation"> Internatonal Journal Fo Gynecology and Obstetrics </span><span class="pubYear">2015</span>;<span class="volume">131</span>(3):265-8. <a class="crsref citation-link central-link" data-crsref="26709977" href="" ref="info:x-wiley/crsRef/26709977" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="https://doi.org/10.1016/j.ijgo.2015.05.027" target="_blank"> <span>Link to article</span> </a> </li> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=A+randomized+placebo-controlled+trial+of+peroperative+tranexmaic+acid+among+women+undergoing+elective+cesarean+delivery+&amp;author=AM+Maged&amp;author=MM+Elsherbini&amp;author=MM+Eid&amp;author=RO+Elkomy&amp;publication_year=2015&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0049"> <div class="citation-other">49. Ahmed MR, Sayed Ahmed WA, Madny EH, Arafa AM, Said MM. <span class="citation-title">Efficacy of tranexamic acid in decreasing blood loss in elective caesarean delivery</span>. Journal of Maternal-Fetal &amp; Neonatal Medicine 2014 Jul 28 {Epub ahead of print]. <a class="crsref citation-link central-link" data-crsref="26709975" href="" ref="info:x-wiley/crsRef/26709975" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0050"> <div class="citation-journal">50. Bhavana G, Abhishek MV, Suneeta M. <span class="citation-title">Efficacy of prophylactic tranexamic acid in reducing blood loss during and after caesarean section</span>. <span class="citation"> International Journal of Reproduction, Contraception, Obstetrics and Gynecology </span><span class="pubYear">2016</span>;<span class="volume">5</span>(6):2011-6. <a class="crsref citation-link central-link" data-crsref="26710085" href="" ref="info:x-wiley/crsRef/26710085" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=Efficacy+of+prophylactic+tranexamic+acid+in+reducing+blood+loss+during+and+after+caesarean+section+&amp;author=G+Bhavana&amp;author=MV+Abhishek&amp;author=M+Suneeta&amp;publication_year=2016&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0051"> <div class="citation-journal">51. Bhavana G, Mittal S. <span class="citation-title">Evaluation of efficacy of prophylactic injection tranexamic acid in decreasing blood loss before and after caesarean section</span>. <span class="citation"> BJOG </span><span class="pubYear">2013</span>;<span class="volume">120</span>(Suppl s1):32. <a class="crsref citation-link central-link" data-crsref="26710086" href="" ref="info:x-wiley/crsRef/26710086" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="https://www.ncbi.nlm.nih.gov/pubmed/23107369" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=Evaluation+of+efficacy+of+prophylactic+injection+tranexamic+acid+in+decreasing+blood+loss+before+and+after+caesarean+section+&amp;author=G+Bhavana&amp;author=S+Mittal&amp;publication_year=2013&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0052"> <div class="citation-other">52. <span class="citation-title">Tranexamic acid to prevent heavy bleeding after childbirth in women at higher risk (I'M-WOMAN)</span>. https://clinicaltrials.gov/ct2/show/NCT05562609. <a class="crsref citation-link central-link" data-crsref="26710179" href="" ref="info:x-wiley/crsRef/26710179" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0053"> <div class="citation-other">53. <span class="citation-title">Comparing tranexamic acid versus ecbolics in preventing hemorrhage during and after cesarean section</span>. https://clinicaltrials.gov/ct2/show/NCT06060327<span class="pubYear">2023</span>. <a class="crsref citation-link central-link" data-crsref="26710181" href="" ref="info:x-wiley/crsRef/26710181" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0054"> <div class="citation-other">54. <span class="citation-title">Tranexamic acid for preventing blood loss following a cesarean delivery in women with placenta previa (traaprevia)</span>. https://www.clinicaltrials.gov/ct2/show/NCT04304625. <a class="crsref citation-link central-link" data-crsref="26710183" href="" ref="info:x-wiley/crsRef/26710183" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0055"> <div class="citation-journal">55. Alam AQ, Barrett J, Callum J, Kaustov L, Au S, Fleet A, et al. <span class="citation-title">Tranexamic acid for the prevention of postpartum haemorrhage: the TAPPH-1 pilot randomized trial and lessons learned for trials in Canadian obstetrics</span>. <span class="citation"> Scientific Reports </span><span class="pubYear">2023</span>;<span class="volume">18;13</span>(1):4512. <a class="crsref citation-link central-link" data-crsref="26709953" href="" ref="info:x-wiley/crsRef/26709953" target="_blank"><span style="display: none;">CENTRAL</span></a> [DOI: <a href="http://dx.doi.org/10.1038/s41598-023-30947-8" target="_blank"><span>10.1038/s41598-023-30947-8</span></a>] [PMCID: PMC10024764.] [PMID: 36934142] <ul class="citation-link-group"> <li> <a class="citation-link" href="https://doi.org/10.1038/s41598-023-30947-8" target="_blank"> <span>Link to article</span> </a> </li> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=Tranexamic+acid+for+the+prevention+of+postpartum+haemorrhage:+the+TAPPH-1+pilot+randomized+trial+and+lessons+learned+for+trials+in+Canadian+obstetrics+&amp;author=AQ+Alam&amp;author=J+Barrett&amp;author=J+Callum&amp;author=L+Kaustov&amp;author=S+Au&amp;author=A+Fleet&amp;publication_year=2023&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0056"> <div class="citation-journal">56. Lee SH, Kwek ME-J, Tagore S, Wright A, Ku CW, Teong AC, et al. <span class="citation-title">Tranexamic acid, as an adjunct to oxytocin prophylaxis, in the prevention of postpartum haemorrhage in women undergoing elective caesarean section: a single-centre double-blind randomised controlled trial</span>. <span class="citation"> BJOG </span><span class="pubYear">2023</span>;<span class="volume">130</span>(9):1007-15. <a class="crsref citation-link central-link" data-crsref="26709955" href="" ref="info:x-wiley/crsRef/26709955" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="https://doi.org/10.1111/1471-0528.17445" target="_blank"> <span>Link to article</span> </a> </li> <li> <a class="citation-link" href="https://www.ncbi.nlm.nih.gov/pubmed/36852501" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=Tranexamic+acid,+as+an+adjunct+to+oxytocin+prophylaxis,+in+the+prevention+of+postpartum+haemorrhage+in+women+undergoing+elective+caesarean+section:+a+single-centre+double-blind+randomised+controlled+trial+&amp;author=SH+Lee&amp;author=S+Tagore&amp;author=A+Wright&amp;author=CW+Ku&amp;author=AC+Teong&amp;publication_year=2023&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0057"> <div class="citation-journal">57. Ogunkua OT, Duryea EL, Nelson DB, Eddins MM, Klucsarits SE, McIntire DD, et al. <span class="citation-title">Tranexamic acid for prevention of hemorrhage in elective repeat cesarean delivery - a randomized study</span>. <span class="citation"> American Journal of Obstetrics and Gynecology </span><span class="pubYear">2022</span>;<span class="volume">4</span>(2):100573. <a class="crsref citation-link central-link" data-crsref="26709957" href="" ref="info:x-wiley/crsRef/26709957" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=Tranexamic+acid+for+prevention+of+hemorrhage+in+elective+repeat+cesarean+delivery+-+a+randomized+study+&amp;author=OT+Ogunkua&amp;author=EL+Duryea&amp;author=DB+Nelson&amp;author=MM+Eddins&amp;author=SE+Klucsarits&amp;author=DD+McIntire&amp;publication_year=2022&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0058"> <div class="citation-journal">58. Pacheco LD, Clifton RG, Saade GR, Weiner SJ, Parry S, Thorp JM, et al, For the Eunice Kennedy Shriver National Institute of Child Health, Human Development Maternal-Fetal Medicine Units Network. <span class="citation-title">Tranexamic acid to prevent obstetrical hemorrhage after cesarean delivery</span>. <span class="citation"> New England Journal of Medicine </span><span class="pubYear">2023</span>;<span class="volume">388</span>(15):1365-75. <a class="crsref citation-link central-link" data-crsref="26709959" href="" ref="info:x-wiley/crsRef/26709959" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="https://doi.org/10.1056/NEJMoa2207419" target="_blank"> <span>Link to article</span> </a> </li> <li> <a class="citation-link" href="https://www.ncbi.nlm.nih.gov/pubmed/37043652" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=Tranexamic+acid+to+prevent+obstetrical+hemorrhage+after+cesarean+delivery&amp;author=LD+Pacheco&amp;author=RG+Clifton&amp;author=GR+Saade&amp;author=SJ+Weiner&amp;author=S+Parry&amp;author=JM+Thorp&amp;publication_year=2023&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0059"> <div class="citation-journal">59. Pacheco LD. <span class="citation-title">Tranexamic acid for the prevention of obstetrical hemorrhage after cesarean delivery: a randomized controlled trial</span>. <span class="citation"> American Journal of Obstetrics and Gynecology </span><span class="pubYear">2022</span>;<span class="volume">226</span>(1):S779?S780. <a class="crsref citation-link central-link" data-crsref="26709960" href="" ref="info:x-wiley/crsRef/26709960" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="https://doi.org/10.1016/j.ajog.2021.12.020" target="_blank"> <span>Link to article</span> </a> </li> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=Tranexamic+acid+for+the+prevention+of+obstetrical+hemorrhage+after+cesarean+delivery:+a+randomized+controlled+trial+&amp;author=LD+Pacheco&amp;publication_year=2022&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0060"> <div class="citation-journal">60. Sentilhes L, Senat MV, Le Lous M, Winer N, Rozenberg P, Kayem G, et al. <span class="citation-title">Tranexamic acid for the prevention of blood loss after cesarean delivery</span>. <span class="citation"> New England Journal of Medicine </span><span class="pubYear">2021</span>;<span class="volume">384</span>(17):1623-34. [CENTRAL: CN-02268529] <a class="crsref citation-link central-link" data-crsref="26709965" href="" ref="info:x-wiley/crsRef/26709965" target="_blank"><span style="display: none;">CENTRAL</span></a> [PMID: 33913639] <ul class="citation-link-group"> <li> <a class="citation-link" href="https://doi.org/10.1056/NEJMoa2028788" target="_blank"> <span>Link to article</span> </a> </li> <li> <a class="citation-link" href="https://www.ncbi.nlm.nih.gov/pubmed/33913639" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=Tranexamic+acid+for+the+prevention+of+blood+loss+after+cesarean+delivery&amp;author=L+Sentilhes&amp;author=MV+Senat&amp;author=M+LeLous&amp;author=N+Winer&amp;author=P+Rozenberg&amp;author=G+Kayem&amp;publication_year=2021&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0061"> <div class="citation-journal">61. Sentilhes L, Senat MV, Le Lous M, Winer N, Rozenberg P, Kayem G, et al. <span class="citation-title">Tranexamic acid for the prevention of postpartum hemorrhage after cesarean delivery: the TRAAP2 trial</span>. <span class="citation"> American Journal of Obstetrics &amp; Gynecology </span><span class="pubYear">2021</span>;<span class="volume">224</span>(2):S1. [CENTRAL: CN-02247791] <a class="crsref citation-link central-link" data-crsref="26709966" href="" ref="info:x-wiley/crsRef/26709966" target="_blank"><span style="display: none;">CENTRAL</span></a> [EMBASE: 2010867550] <ul class="citation-link-group"> <li> <a class="citation-link" href="https://doi.org/10.1016/j.ajog.2020.12.103" target="_blank"> <span>Link to article</span> </a> </li> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=Tranexamic+acid+for+the+prevention+of+postpartum+hemorrhage+after+cesarean+delivery:+the+TRAAP2+trial+&amp;author=L+Sentilhes&amp;author=MV+Senat&amp;author=M+LeLous&amp;author=N+Winer&amp;author=P+Rozenberg&amp;author=G+Kayem&amp;publication_year=2021&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0062"> <div class="citation-journal">62. Sentilhes L, Daniel V, Deneux-Tharaux C. <span class="citation-title">TRAAP2 - TRAnexamic Acid for Preventing postpartum hemorrhage after cesarean delivery: a multicenter randomized, doubleblind, placebo-controlled trial - a study protocol</span>. <span class="citation"> BMC Pregnancy and Childbirth </span><span class="pubYear">2020</span>;<span class="volume">20</span>(1):63. [CENTRAL: CN-02085587] <a class="crsref citation-link central-link" data-crsref="26709964" href="" ref="info:x-wiley/crsRef/26709964" target="_blank"><span style="display: none;">CENTRAL</span></a> [EMBASE: 630806397] [PMID: 32005192] <ul class="citation-link-group"> <li> <a class="citation-link" href="https://doi.org/10.1186/s12884-019-2718-4" target="_blank"> <span>Link to article</span> </a> </li> <li> <a class="citation-link" href="https://www.ncbi.nlm.nih.gov/pubmed/32005192" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=TRAAP2+-+TRAnexamic+Acid+for+Preventing+postpartum+hemorrhage+after+cesarean+delivery:+a+multicenter+randomized,+doubleblind,+placebo-controlled+trial+-+a+study+protocol+&amp;author=L+Sentilhes&amp;author=V+Daniel&amp;author=C+Deneux-Tharaux&amp;publication_year=2020&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0063"> <div class="citation-other">63. EUCTR2017-001144-36-FR. <span class="citation-title">Tranexamic acid for preventing postpartum hemorrhage following a cesarean delivery</span> [TRAnexamic Acid for Preventing postpartum hemorrhage following a Cesarean Delivery: a multicenter randomised, double blind placebo controlled trial (TRAAP2) - TRAAP2]. www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2017-001144-36-FR. [CENTRAL: CN-02067652] <a class="crsref citation-link central-link" data-crsref="26709962" href="" ref="info:x-wiley/crsRef/26709962" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0064"> <div class="citation-other">64. NCT03742947. <span class="citation-title">Haemostasis and tranexamic acid in caesarean delivery</span> [Study of peripartum haemostasis and effects of tranexamic acid in caesarean delivery: biologic ancillary study in TRAAP2 patients recruited at the Bordeaux University Hospital: BIO-TRAAP]. clinicaltrials.gov/show/NCT03742947 (first received 15 November 2018). [CENTRAL: CN-01918391] <a class="crsref citation-link central-link" data-crsref="26709963" href="" ref="info:x-wiley/crsRef/26709963" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0065"> <div class="citation-journal">65. Shakur-Still H, Roberts I, Grassin-Delyle S, Chaudhri R, Geer A, Arribas M, et al. <span class="citation-title">Alternative routes for tranexamic acid treatment in obstetric bleeding (WOMAN-PharmacoTXA trial): a randomised trial and pharmacological study in caesarean section births</span>. <span class="citation"> British Journal of Obstetrics and Gynaecology </span><span class="pubYear">2023</span>;<span class="volume">130</span>(10):1177-18. <a class="crsref citation-link central-link" data-crsref="26709968" href="" ref="info:x-wiley/crsRef/26709968" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="https://doi.org/10.1111/1471-0528.17455" target="_blank"> <span>Link to article</span> </a> </li> <li> <a class="citation-link" href="https://www.ncbi.nlm.nih.gov/pubmed/37019443" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=Alternative+routes+for+tranexamic+acid+treatment+in+obstetric+bleeding+(WOMAN-PharmacoTXA+trial):+a+randomised+trial+and+pharmacological+study+in+caesarean+section+births+&amp;author=H+Shakur-Still&amp;author=I+Roberts&amp;author=S+Grassin-Delyle&amp;author=R+Chaudhri&amp;author=A+Geer&amp;author=M+Arribas&amp;publication_year=2023&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0066"> <div class="citation-journal">66. Igboke FN, Obi VO, Dimejesi BI, Lawani LO. <span class="citation-title">Tranexamic acid for reducing blood loss following vaginal delivery: a double-blind randomized controlled trial</span>. <span class="citation"> BioMed Central Pregnancy and Childbirth </span><span class="pubYear">2022</span>;<span class="volume">22</span>(178):1. <a class="crsref citation-link central-link" data-crsref="26710001" href="" ref="info:x-wiley/crsRef/26710001" target="_blank"><span style="display: none;">CENTRAL</span></a> [DOI: <a href="http://dx.doi.org/10.1186/s12884-022-04462-z" target="_blank"><span>10.1186/s12884-022-04462-z</span></a>] <ul class="citation-link-group"> <li> <a class="citation-link" href="https://doi.org/10.1186/s12884-022-04462-z" target="_blank"> <span>Link to article</span> </a> </li> <li> <a class="citation-link" href="https://www.ncbi.nlm.nih.gov/pubmed/34979996" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=Tranexamic+acid+for+reducing+blood+loss+following+vaginal+delivery:+a+double-blind+randomized+controlled+trial+&amp;author=FN+Igboke&amp;author=VO+Obi&amp;author=BI+Dimejesi&amp;author=LO+Lawani&amp;publication_year=2022&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0067"> <div class="citation-journal">67. Ismail AM, Abbas AM, Shahat MA, Ali MK. <span class="citation-title">Evaluation of subendometrial and intramyometrial blood flow after intravenous tranexamic acid for prevention of postpartum hemorrhage in vaginal delivery: a randomized controlled study</span>. <span class="citation"> Journal of Gynecological Research and Obstetrics </span><span class="pubYear">2017</span>;<span class="volume">3</span>(2):046-52. [CENTRAL: CN-01609034] <a class="crsref citation-link central-link" data-crsref="26710003" href="" ref="info:x-wiley/crsRef/26710003" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=Evaluation+of+subendometrial+and+intramyometrial+blood+flow+after+intravenous+tranexamic+acid+for+prevention+of+postpartum+hemorrhage+in+vaginal+delivery:+a+randomized+controlled+study+&amp;author=AM+Ismail&amp;author=AM+Abbas&amp;author=MA+Shahat&amp;author=MK+Ali&amp;publication_year=2017&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0068"> <div class="citation-journal">68. Jafarbegloo E, Faridnyia F, Ahangari R, Mohammadbeigi A. <span class="citation-title">Prophylactic use of tranexamic acid on blood loss in cesarean delivery: a randomized controlled- clinical trial</span>. <span class="citation"> Trauma Monthly </span><span class="pubYear">2021</span>;<span class="volume">26</span>(1):19-24. <a class="crsref citation-link central-link" data-crsref="26710005" href="" ref="info:x-wiley/crsRef/26710005" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=Prophylactic+use+of+tranexamic+acid+on+blood+loss+in+cesarean+delivery:+a+randomized+controlled-+clinical+trial+&amp;author=E+Jafarbegloo&amp;author=F+Faridnyia&amp;author=R+Ahangari&amp;author=A+Mohammadbeigi&amp;publication_year=2021&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0069"> <div class="citation-journal">69. Milani F, Sharami SH, Farzadi S, Haryalchi K, Atrkarroshan Z. <span class="citation-title">Prophylactic effect of tranexamic acid on hemorrhage during and after the cesarean section</span>. <span class="citation"> International Journal of Women's Health and Reproduction Sciences </span><span class="pubYear">2019</span>;<span class="volume">7</span>(1):74-8. [CENTRAL: CN-01793985] <a class="crsref citation-link central-link" data-crsref="26710019" href="" ref="info:x-wiley/crsRef/26710019" target="_blank"><span style="display: none;">CENTRAL</span></a> [EMBASE: 625996781] <ul class="citation-link-group"> <li> <a class="citation-link" href="https://doi.org/10.15296/ijwhr.2019.12" target="_blank"> <span>Link to article</span> </a> </li> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=Prophylactic+effect+of+tranexamic+acid+on+hemorrhage+during+and+after+the+cesarean+section+&amp;author=F+Milani&amp;author=SH+Sharami&amp;author=S+Farzadi&amp;author=K+Haryalchi&amp;author=Z+Atrkarroshan&amp;publication_year=2019&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0070"> <div class="citation-journal">70. Naeiji Z, Delshadiyan N, Saleh S, Moridi A, Rahmati N, Fathi M. <span class="citation-title">Prophylactic use of tranexamic acid for decreasing the blood loss in elective cesarean section: a placebo-controlled randomized clinical trial</span>. <span class="citation"> Journal of Gynecology Obstetrics and Human Reproduction </span><span class="pubYear">2020</span>;<span class="volume">50</span>(1):101973. [CENTRAL: CN-02210140] <a class="crsref citation-link central-link" data-crsref="26710027" href="" ref="info:x-wiley/crsRef/26710027" target="_blank"><span style="display: none;">CENTRAL</span></a> [EMBASE: 2010158550] [PMID: 33221559] <ul class="citation-link-group"> <li> <a class="citation-link" href="https://doi.org/10.1016/j.jogoh.2020.101973" target="_blank"> <span>Link to article</span> </a> </li> <li> <a class="citation-link" href="https://www.ncbi.nlm.nih.gov/pubmed/33221559" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=Prophylactic+use+of+tranexamic+acid+for+decreasing+the+blood+loss+in+elective+cesarean+section:+a+placebo-controlled+randomized+clinical+trial+&amp;author=Z+Naeiji&amp;author=N+Delshadiyan&amp;author=S+Saleh&amp;author=A+Moridi&amp;author=N+Rahmati&amp;author=M+Fathi&amp;publication_year=2020&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0071"> <div class="citation-journal">71. Pakniat H, Chegini V, Shojaei A, Khezri MB, Ansari I. <span class="citation-title">Comparison of the effect of intravenous tranexamic acid and sublingual misoprostol on reducing bleeding after cesarean section: a double-blind randomized clinical trial</span>. <span class="citation"> Journal of Obstetrics and Gynaecology of India </span><span class="pubYear">2019</span>;<span class="volume">69</span>(3):239-45. [CENTRAL: CN-02004087] <a class="crsref citation-link central-link" data-crsref="26710033" href="" ref="info:x-wiley/crsRef/26710033" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="https://doi.org/10.1007/s13224-018-1181-x" target="_blank"> <span>Link to article</span> </a> </li> <li> <a class="citation-link" href="https://www.ncbi.nlm.nih.gov/pubmed/31178639" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=Comparison+of+the+effect+of+intravenous+tranexamic+acid+and+sublingual+misoprostol+on+reducing+bleeding+after+cesarean+section:+a+double-blind+randomized+clinical+trial+&amp;author=H+Pakniat&amp;author=V+Chegini&amp;author=A+Shojaei&amp;author=MB+Khezri&amp;author=I+Ansari&amp;publication_year=2019&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0072"> <div class="citation-journal">72. Samimi M, Moravveji SA, Heidari-Shirazi F. <span class="citation-title">The effect of tranexamic acid on pregnancy outcome and vaginal post-parturition hemodynamics</span>. <span class="citation"> Feyz: Journal of Kashan University of Medical Sciences </span><span class="pubYear">2013</span>;<span class="volume">17</span>(2):114-22. [CENTRAL: CN-02134955] <a class="crsref citation-link central-link" data-crsref="26710045" href="" ref="info:x-wiley/crsRef/26710045" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=The+effect+of+tranexamic+acid+on+pregnancy+outcome+and+vaginal+post-parturition+hemodynamics&amp;author=M+Samimi&amp;author=SA+Moravveji&amp;author=F+Heidari-Shirazi&amp;publication_year=2013&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0073"> <div class="citation-journal">73. Sujita A, Songthamwat S, Songthamwat M. <span class="citation-title">Effectiveness of tranexamic acid for reducing postpartum blood loss in the first two hours after vaginal delivery: a randomised controlled trial</span>. <span class="citation"> Journal of Clinical and Diagnostic Research </span><span class="pubYear">2018</span>;<span class="volume">12</span>(3):QC01-4. [CENTRAL: CN-01572688] <a class="crsref citation-link central-link" data-crsref="26710069" href="" ref="info:x-wiley/crsRef/26710069" target="_blank"><span style="display: none;">CENTRAL</span></a> [EMBASE: 621390430] <ul class="citation-link-group"> <li> <a class="citation-link" href="https://doi.org/10.7860/JCDR/2018/32494.11248" target="_blank"> <span>Link to article</span> </a> </li> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=Effectiveness+of+tranexamic+acid+for+reducing+postpartum+blood+loss+in+the+first+two+hours+after+vaginal+delivery:+a+randomised+controlled+trial+&amp;author=A+Sujita&amp;author=S+Songthamwat&amp;author=M+Songthamwat&amp;publication_year=2018&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0074"> <div class="citation-journal">74. Sujita A, Songthamwat M, Songthamwat S. <span class="citation-title">Efficacy of tranexamic acid for reducing blood loss after vaginal delivery: a randomized control trial, double blind</span>. <span class="citation"> Journal of Obstetrics and Gynaecology Research </span><span class="pubYear">2017</span>;<span class="volume">43</span>:41. [CENTRAL: CN-01744328] <a class="crsref citation-link central-link" data-crsref="26710068" href="" ref="info:x-wiley/crsRef/26710068" target="_blank"><span style="display: none;">CENTRAL</span></a> [EMBASE: 616813318] <ul class="citation-link-group"> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=Efficacy+of+tranexamic+acid+for+reducing+blood+loss+after+vaginal+delivery:+a+randomized+control+trial,+double+blind+&amp;author=A+Sujita&amp;author=M+Songthamwat&amp;author=S+Songthamwat&amp;publication_year=2017&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0075"> <div class="citation-journal">75. Abbas AM, Shady NW, Sallam HF. <span class="citation-title">Bilateral uterine artery ligation plus intravenous tranexamic acid during cesarean delivery for placenta previa: a randomized double-blind controlled trial</span>. <span class="citation"> Journal of Gynecology Obstetrics and Human Reproduction </span><span class="pubYear">2019</span>;<span class="volume">48</span>(2):115-9. [CENTRAL: CN-01930043] <a class="crsref citation-link central-link" data-crsref="26709970" href="" ref="info:x-wiley/crsRef/26709970" target="_blank"><span style="display: none;">CENTRAL</span></a> [PMID: 30412786] <ul class="citation-link-group"> <li> <a class="citation-link" href="https://doi.org/10.1016/j.jogoh.2018.10.023" target="_blank"> <span>Link to article</span> </a> </li> <li> <a class="citation-link" href="https://www.ncbi.nlm.nih.gov/pubmed/30412786" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=Bilateral+uterine+artery+ligation+plus+intravenous+tranexamic+acid+during+cesarean+delivery+for+placenta+previa:+a+randomized+double-blind+controlled+trial+&amp;author=AM+Abbas&amp;author=NW+Shady&amp;author=HF+Sallam&amp;publication_year=2019&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0076"> <div class="citation-journal">76. Bose D, Beegum R. <span class="citation-title">Sublingual misoprostol vs intravenous tranexamic acid in reducing blood loss during cesarean section: a prospective randomized study</span>. <span class="citation"> Journal of SAFOG </span><span class="pubYear">2017</span>;<span class="volume">9</span>(1):9-13. [CENTRAL: CN-01430856] <a class="crsref citation-link central-link" data-crsref="26709981" href="" ref="info:x-wiley/crsRef/26709981" target="_blank"><span style="display: none;">CENTRAL</span></a> [EMBASE: 619028533] <ul class="citation-link-group"> <li> <a class="citation-link" href="https://doi.org/10.5005/jp-journals-10006-1448" target="_blank"> <span>Link to article</span> </a> </li> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=Sublingual+misoprostol+vs+intravenous+tranexamic+acid+in+reducing+blood+loss+during+cesarean+section:+a+prospective+randomized+study+&amp;author=D+Bose&amp;author=R+Beegum&amp;publication_year=2017&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0077"> <div class="citation-journal">77. Ray I, Bhattacharya R, Chakraborty S, Bagchi C, Mukhopadhyay S. <span class="citation-title">Role of intravenous tranexamic acid on caesarean blood loss: a prospective randomised study</span>. <span class="citation"> Journal of Obstetrics and Gynaecology of India </span><span class="pubYear">2016</span>;<span class="volume">66</span>(Suppl 1):S347-52. [CENTRAL: CN-01761234] <a class="crsref citation-link central-link" data-crsref="26710037" href="" ref="info:x-wiley/crsRef/26710037" target="_blank"><span style="display: none;">CENTRAL</span></a> [EMBASE: 610988100] [PMID: 27651628] <ul class="citation-link-group"> <li> <a class="citation-link" href="https://doi.org/10.1007/s13224-016-0915-x" target="_blank"> <span>Link to article</span> </a> </li> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=Role+of+intravenous+tranexamic+acid+on+caesarean+blood+loss:+a+prospective+randomised+study+&amp;author=I+Ray&amp;author=R+Bhattacharya&amp;author=S+Chakraborty&amp;author=C+Bagchi&amp;author=S+Mukhopadhyay&amp;publication_year=2016&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0078"> <div class="citation-journal">78. Chandak AV, Gupta I, Sreemayi C. <span class="citation-title">Efficacy of tranexamic acid in decreasing blood loss during and after cesarean section: a randomized case controlled prospective study</span>. <span class="citation"> International Journal of Science and Research </span><span class="pubYear">2017</span>;<span class="volume">6</span>(1):1321-3. <a class="crsref citation-link central-link" data-crsref="26709983" href="" ref="info:x-wiley/crsRef/26709983" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=Efficacy+of+tranexamic+acid+in+decreasing+blood+loss+during+and+after+cesarean+section:+a+randomized+case+controlled+prospective+study+&amp;author=AV+Chandak&amp;author=I+Gupta&amp;author=C+Sreemayi&amp;publication_year=2017&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0079"> <div class="citation-journal">79. Gohel M, Patel P, Gupta A, Desai P. <span class="citation-title">Efficacy of tranexamic acid in decreasing blood loss during and after cesarean section: a randomized case controlled prospective study</span>. <span class="citation"> Journal of Obstetrics and Gynaecology of India </span><span class="pubYear">2007</span>;<span class="volume">57</span>(3):228-30. <a class="crsref citation-link central-link" data-crsref="26709989" href="" ref="info:x-wiley/crsRef/26709989" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=Efficacy+of+tranexamic+acid+in+decreasing+blood+loss+during+and+after+cesarean+section:+a+randomized+case+controlled+prospective+study+&amp;author=M+Gohel&amp;author=P+Patel&amp;author=A+Gupta&amp;author=P+Desai&amp;publication_year=2007&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0080"> <div class="citation-journal">80. Sekhavat L, Tabatabaii A, Dalili M, Farajkhoda T, Tafti AD. <span class="citation-title">Efficacy of tranexamic acid in reducing blood loss after cesarean section</span>. <span class="citation"> Journal of Maternal-Fetal &amp; Neonatal Medicine </span><span class="pubYear">2009</span>;<span class="volume">22</span>(1):72-5. <a class="crsref citation-link central-link" data-crsref="26710047" href="" ref="info:x-wiley/crsRef/26710047" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="https://doi.org/10.1080/14767050802353580" target="_blank"> <span>Link to article</span> </a> </li> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=Efficacy+of+tranexamic+acid+in+reducing+blood+loss+after+cesarean+section&amp;author=L+Sekhavat&amp;author=A+Tabatabaii&amp;author=M+Dalili&amp;author=T+Farajkhoda&amp;author=AD+Tafti&amp;publication_year=2009&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0081"> <div class="citation-journal">81. Ducloy-Bouthors A-S, Jeanpierre E, Saidi I, Baptiste A-S, Simon E, Lannoy D, et al. <span class="citation-title">TRAnexamic acid in hemorrhagic CESarean section (TRACES) randomized placebo controlled dose-ranging pharmacobiological ancillary trial: study protocol for a randomized controlled trial</span>. <span class="citation"> Trials </span><span class="pubYear">2018</span>;<span class="volume">19</span>(1):149. [CENTRAL: CN-01464518] <a class="crsref citation-link central-link" data-crsref="26709987" href="" ref="info:x-wiley/crsRef/26709987" target="_blank"><span style="display: none;">CENTRAL</span></a> [EMBASE: 620904152] <ul class="citation-link-group"> <li> <a class="citation-link" href="https://www.ncbi.nlm.nih.gov/pubmed/29490690" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=TRAnexamic+acid+in+hemorrhagic+CESarean+section+(TRACES)+randomized+placebo+controlled+dose-ranging+pharmacobiological+ancillary+trial:+study+protocol+for+a+randomized+controlled+trial+&amp;author=E+Jeanpierre&amp;author=I+Saidi&amp;author=E+Simon&amp;author=D+Lannoy&amp;publication_year=2018&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0082"> <div class="citation-other">82. Bouthors A-S, Hennart B, Jeanpierre E, Baptiste A-S, Saidi I, Simon E, et al. <span class="citation-title">Therapeutic and pharmaco-biological, dose-ranging multicentre trial to determine the optimal dose of TRAnexamic acid to reduce blood loss in haemorrhagic CESarean delivery (TRACES): study protocol for a randomised, double-blind, placebo-controlled trial</span>. Trials<span class="pubYear">2018</span>;<span class="volume">19</span>(1):148. [CENTRAL: CN-01464283] <a class="crsref citation-link central-link" data-crsref="26709985" href="" ref="info:x-wiley/crsRef/26709985" target="_blank"><span style="display: none;">CENTRAL</span></a> [EMBASE: 620904151] <ul class="citation-link-group"> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=Therapeutic+and+pharmaco-biological,+dose-ranging+multicentre+trial+to+determine+the+optimal+dose+of+TRAnexamic+acid+to+reduce+blood+loss+in+haemorrhagic+CESarean+delivery+(TRACES):+study+protocol+for+a+randomised,+double-blind,+placebo-controlled+trial+&amp;author=B+Hennart&amp;author=E+Jeanpierre&amp;author=I+Saidi&amp;author=E+Simon&amp;publication_year=2018&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0083"> <div class="citation-journal">83. Ducloy-Bouthors A-S, Jeanpierre E, Hennart B, Baptiste A-S, Giovannoni S, Saidi I, et al. <span class="citation-title">TRAnexamic acid to reduce blood loss in haemorrhagic CESarean delivery: therapeutic and pharmaco-biological dose-ranging multicentre randomised double-blind placebo-controlled study: TRACES trial methodology</span> [Tranexamic Acid to Reduce Blood Loss in Hemorrhagic Caesarean Delivery: a Multicenter Randomized Double Blind Placebo Controlled Therapeutic and Pharmaco-biological Dose Ranging Study (TRACES) for Its Optimal Benefit/Risk]. <span class="citation"> Transfusion Medicine (Oxford, England) </span><span class="pubYear">2017</span>;<span class="volume">27</span>:61-62, Abstract no: P95. [CENTRAL: CN-01558936] <a class="crsref citation-link central-link" data-crsref="26709986" href="" ref="info:x-wiley/crsRef/26709986" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=TRAnexamic+acid+to+reduce+blood+loss+in+haemorrhagic+CESarean+delivery:+therapeutic+and+pharmaco-biological+dose-ranging+multicentre+randomised+double-blind+placebo-controlled+study:+TRACES+trial+methodology+&amp;author=E+Jeanpierre&amp;author=B+Hennart&amp;author=S+Giovannoni&amp;author=I+Saidi&amp;publication_year=2017&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0084"> <div class="citation-journal">84. Hunt BJ. <span class="citation-title">Tranexamic acid for the treatment of postpartum haemorrhage-preliminary results of the woman trial</span>. <span class="citation"> Transfusion Medicine (Oxford, England) </span><span class="pubYear">2013</span>;<span class="volume">23</span>(Suppl 1):7. <a class="crsref citation-link central-link" data-crsref="26709999" href="" ref="info:x-wiley/crsRef/26709999" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=Tranexamic+acid+for+the+treatment+of+postpartum+haemorrhage-preliminary+results+of+the+woman+trial+&amp;author=BJ+Hunt&amp;publication_year=2013&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0085"> <div class="citation-other">85. Javadi EH, Sadeghipour Z, Barikani A, Javadi M. <span class="citation-title">Tranexamic acid in the control of uterine atony during labor</span>. Biotechnology and Health Sciences<span class="pubYear">2015</span>;<span class="volume">2</span>(2):e26898. <a class="crsref citation-link central-link" data-crsref="26710007" href="" ref="info:x-wiley/crsRef/26710007" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=Tranexamic+acid+in+the+control+of+uterine+atony+during+labor&amp;author=EH+Javadi&amp;author=Z+Sadeghipour&amp;author=A+Barikani&amp;author=M+Javadi&amp;publication_year=2015&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0086"> <div class="citation-journal">86. Sahhaf F, Abbasalizadeh S, Ghojazadeh M, Velayati A, Khandanloo R, Saleh P, et al. <span class="citation-title">Comparison effect of intravenous tranexamic acid and misoprostol for postpartum haemorrhage</span>. <span class="citation"> Nigerian Medical Journal </span><span class="pubYear">2014</span>;<span class="volume">55</span>(4):348-53. [CENTRAL: CN-01076651] <a class="crsref citation-link central-link" data-crsref="26710039" href="" ref="info:x-wiley/crsRef/26710039" target="_blank"><span style="display: none;">CENTRAL</span></a> [PMCID:: PMC4124551] [PMID: 25114373] <ul class="citation-link-group"> <li> <a class="citation-link" href="https://www.ncbi.nlm.nih.gov/pubmed/25114373" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=Comparison+effect+of+intravenous+tranexamic+acid+and+misoprostol+for+postpartum+haemorrhage&amp;author=F+Sahhaf&amp;author=S+Abbasalizadeh&amp;author=M+Ghojazadeh&amp;author=A+Velayati&amp;author=R+Khandanloo&amp;author=P+Saleh&amp;publication_year=2014&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0087"> <div class="citation-journal">87. Zargar M, Nikbakht R, Ahmadi M. <span class="citation-title">The effect of tranexamic acid on preventing post-partum hemorrhage due to uterine atony: a triple-blind randomized clinical trial</span>. <span class="citation"> Current Clinical Pharmacology </span><span class="pubYear">2018</span>;<span class="volume">13</span>(2):136-9. [CENTRAL: CN-01649688] <a class="crsref citation-link central-link" data-crsref="26710077" href="" ref="info:x-wiley/crsRef/26710077" target="_blank"><span style="display: none;">CENTRAL</span></a> [EMBASE: 624513891] [PMID: 29732978] <ul class="citation-link-group"> <li> <a class="citation-link" href="https://doi.org/10.2174/1574884713666180507101002" target="_blank"> <span>Link to article</span> </a> </li> <li> <a class="citation-link" href="https://www.ncbi.nlm.nih.gov/pubmed/29732978" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=The+effect+of+tranexamic+acid+on+preventing+post-partum+hemorrhage+due+to+uterine+atony:+a+triple-blind+randomized+clinical+trial+&amp;author=M+Zargar&amp;author=R+Nikbakht&amp;author=M+Ahmadi&amp;publication_year=2018&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0088"> <div class="citation-journal">88. Bhatia SK, Deshpande H. <span class="citation-title">Role of tranexamic acid in reducing blood loss during and after caesarean section</span>. <span class="citation"> Medical Journal of Dr D.Y. Patil University </span><span class="pubYear">2015</span>;<span class="volume">8</span>(1):21-5. <a class="crsref citation-link central-link" data-crsref="26709979" href="" ref="info:x-wiley/crsRef/26709979" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="https://doi.org/10.4103/0975-2870.148830" target="_blank"> <span>Link to article</span> </a> </li> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=Role+of+tranexamic+acid+in+reducing+blood+loss+during+and+after+caesarean+section&amp;author=SK+Bhatia&amp;author=H+Deshpande&amp;publication_year=2015&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0089"> <div class="citation-journal">89. Halder S, Samanta B, Sardar R, Chattopadhyay S. <span class="citation-title">Tranexamic acid used before caesarean section reduces blood loss based on pre- and postoperative hemoglobin level: a case-control study</span>. <span class="citation"> Journal of the Indian Medical Association </span><span class="pubYear">2013</span>;<span class="volume">111</span>(3):184-6. <a class="crsref citation-link central-link" data-crsref="26709997" href="" ref="info:x-wiley/crsRef/26709997" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="https://www.ncbi.nlm.nih.gov/pubmed/24592760" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=Tranexamic+acid+used+before+caesarean+section+reduces+blood+loss+based+on+pre-+and+postoperative+hemoglobin+level:+a+case-control+study+&amp;author=S+Halder&amp;author=B+Samanta&amp;author=R+Sardar&amp;author=S+Chattopadhyay&amp;publication_year=2013&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0090"> <div class="citation-journal">90. Rashmi PS, Sudha TR, Prabhudev P, Patil R, Vijayanath V. <span class="citation-title">Role of tranexamic acid in reducing blood loss during and after cesarean section. A randomized case control prospective study</span>. <span class="citation"> Journal of Medical Research and Practice </span><span class="pubYear">2012</span>;<span class="volume">1</span>(2):40-3. <a class="crsref citation-link central-link" data-crsref="26710035" href="" ref="info:x-wiley/crsRef/26710035" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=Role+of+tranexamic+acid+in+reducing+blood+loss+during+and+after+cesarean+section.+A+randomized+case+control+prospective+study+&amp;author=PS+Rashmi&amp;author=TR+Sudha&amp;author=P+Prabhudev&amp;author=R+Patil&amp;author=V+Vijayanath&amp;publication_year=2012&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0091"> <div class="citation-journal">91. Sahu J, Mishra N. <span class="citation-title">Role of intravenous tranexamic acid in reducing blood loss during caesarean section: study at tribal-dominated area hospital in Chhattisgarh, India</span> [Role of intravenous tranexamic acid in reducing blood loss during caesarean section: study at tribal-dominated area hospital in Chhattisgarh, India]. <span class="citation"> Journal of Obstetrics and Gynaecology Research </span><span class="pubYear">2019</span>;<span class="volume">45</span>(4):841-8. [CENTRAL: CN-01932139] <a class="crsref citation-link central-link" data-crsref="26710041" href="" ref="info:x-wiley/crsRef/26710041" target="_blank"><span style="display: none;">CENTRAL</span></a> [EMBASE: 626068178] <ul class="citation-link-group"> <li> <a class="citation-link" href="https://doi.org/10.1111/jog.13915" target="_blank"> <span>Link to article</span> </a> </li> <li> <a class="citation-link" href="https://www.ncbi.nlm.nih.gov/pubmed/30663200" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=Role+of+intravenous+tranexamic+acid+in+reducing+blood+loss+during+caesarean+section:+study+at+tribal-dominated+area+hospital+in+Chhattisgarh,+India+&amp;author=J+Sahu&amp;author=N+Mishra&amp;publication_year=2019&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0092"> <div class="citation-journal">92. Singh T, Burute SB, Deshpande HG, Jethani S, Ratwani K. <span class="citation-title">Efficacy of tranexamic acid in decreasing blood loss during and after caesarean section: a randomized case control prospective study</span>. <span class="citation"> Journal of Evolution of Medical and Dental Sciences </span><span class="pubYear">2014</span>;<span class="volume">3</span>:2780-8. <a class="crsref citation-link central-link" data-crsref="26710063" href="" ref="info:x-wiley/crsRef/26710063" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="https://doi.org/10.14260/jemds/2014/2209" target="_blank"> <span>Link to article</span> </a> </li> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=Efficacy+of+tranexamic+acid+in+decreasing+blood+loss+during+and+after+caesarean+section:+a+randomized+case+control+prospective+study+&amp;author=T+Singh&amp;author=SB+Burute&amp;author=HG+Deshpande&amp;author=S+Jethani&amp;author=K+Ratwani&amp;publication_year=2014&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0093"> <div class="citation-other">93. NCT03778242. <span class="citation-title">Oxytocin and tranexamic acid in pregnant women with twin pregnancy undergoing cesarean section</span> [Effects of Co-administered Oxytocin and Intravenous Tranexamic Acid on Prevention of Postpartum Hemorrhage in Pregnant Women With Twin Pregnancy Undergoing Elective Cesarean Section: a Double-Blind Randomized Clinical Trial]. Https://clinicaltrials.gov/show/nct03778242 (first received 2018 Dec 18). [CENTRAL: CN-01918664] <a class="crsref citation-link central-link" data-crsref="26710043" href="" ref="info:x-wiley/crsRef/26710043" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0094"> <div class="citation-journal">94. The WOMAN-2 Trial Collaborators. <span class="citation-title">Tranexamic acid for the prevention of postpartum bleeding in women with anaemia: study protocol for an international, randomised, double-blind, placebo-controlled trial</span>. <span class="citation"> Trials </span><span class="pubYear">2018</span>;<span class="volume">19</span>(712):https://doi.org/10.1186/s13063-018-3081-x. <a class="crsref citation-link central-link" data-crsref="26710011" href="" ref="info:x-wiley/crsRef/26710011" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0095"> <div class="citation-other">95. <span class="citation-title">World maternal antifibrinolytic trial_2 (WOMAN-2)</span>. https://clinicaltrials.gov/ct2/show/NCT03475342. <a class="crsref citation-link central-link" data-crsref="26710012" href="" ref="info:x-wiley/crsRef/26710012" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0096"> <div class="citation-journal">96. Ker K, Roberts I, Chaudhri R, Fawole B, Beaumont D, Balogun E, et al. <span class="citation-title">Tranexamic acid for the prevention of postpartum bleeding in women with anaemia: study protocol for an international, randomised, double-blind, placebo-controlled trial</span>. <span class="citation"> Trials </span><span class="pubYear">2018</span>;<span class="volume">19</span>(1):712. [CENTRAL: CN-01792461] <a class="crsref citation-link central-link" data-crsref="26710010" href="" ref="info:x-wiley/crsRef/26710010" target="_blank"><span style="display: none;">CENTRAL</span></a> [EMBASE: 625692661] [PMID: 30594227] <ul class="citation-link-group"> <li> <a class="citation-link" href="https://doi.org/10.1186/s13063-018-3081-x" target="_blank"> <span>Link to article</span> </a> </li> <li> <a class="citation-link" href="https://www.ncbi.nlm.nih.gov/pubmed/30594227" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=Tranexamic+acid+for+the+prevention+of+postpartum+bleeding+in+women+with+anaemia:+study+protocol+for+an+international,+randomised,+double-blind,+placebo-controlled+trial+&amp;author=K+Ker&amp;author=I+Roberts&amp;author=R+Chaudhri&amp;author=B+Fawole&amp;author=D+Beaumont&amp;author=E+Balogun&amp;publication_year=2018&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0097"> <div class="citation-other">97. ISRCTN62396133. <span class="citation-title">World maternal antifibrinolytic trial-2</span> [Tranexamic acid for the prevention of postpartum bleeding in Women with anaemia: an international, randomised, double-blind, placebo controlled trial]. Http://www.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN62396133 (first received 2017). [CENTRAL: CN-01885095] <a class="crsref citation-link central-link" data-crsref="26710009" href="" ref="info:x-wiley/crsRef/26710009" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0098"> <div class="citation-other">98. Mei LL, Ruey S, Wen EP, Ghani NA, Wahab AV. <span class="citation-title">Tranexamic acid usage in third stage labour in reducing post-partum haemorrhage in high risk mothers following a vaginal delivery: a randomised prospective, double-blinded clinical trial</span>. In: Medical Journal of Malaysia. Vol. 74. Malaysian Medical Association, <span class="pubYear">2019</span>:2. [CENTRAL: CN-02205541] <a class="crsref citation-link central-link" data-crsref="26710017" href="" ref="info:x-wiley/crsRef/26710017" target="_blank"><span style="display: none;">CENTRAL</span></a> [EMBASE: 633276952] <ul class="citation-link-group"> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=Tranexamic+acid+usage+in+third+stage+labour+in+reducing+post-partum+haemorrhage+in+high+risk+mothers+following+a+vaginal+delivery:+a+randomised+prospective,+double-blinded+clinical+trial+&amp;author=LL+Mei&amp;author=S+Ruey&amp;author=EP+Wen&amp;author=NA+Ghani&amp;author=AV+Wahab&amp;publication_year=2019&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0099"> <div class="citation-journal">99. Sentilhes L, Daniel V, Darsonval A, Deruelle P, Vardon D, Perrotin F, et al. <span class="citation-title">Study protocol. TRAAP - TRAnexamic Acid for Preventing postpartum hemorrhage after vaginal delivery: a multicenter randomized, double-blind, placebo-controlled trial</span>. <span class="citation"> BMC Pregnancy and Childbirth </span><span class="pubYear">2015</span>;<span class="volume">15</span>(1):135. [CENTRAL: CN-01076658] <a class="crsref citation-link central-link" data-crsref="27540401" href="" ref="info:x-wiley/crsRef/27540401" target="_blank"><span style="display: none;">CENTRAL</span></a> [EMBASE: 2015125583] [PMCID:: PMC4465316] [PMID: 26071040] <ul class="citation-link-group"> <li> <a class="citation-link" href="https://doi.org/10.1186/s12884-015-0573-5" target="_blank"> <span>Link to article</span> </a> </li> <li> <a class="citation-link" href="https://www.ncbi.nlm.nih.gov/pubmed/26071040" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=Study+protocol.+TRAAP+-+TRAnexamic+Acid+for+Preventing+postpartum+hemorrhage+after+vaginal+delivery:+a+multicenter+randomized,+double-blind,+placebo-controlled+trial+&amp;author=L+Sentilhes&amp;author=V+Daniel&amp;author=A+Darsonval&amp;author=P+Deruelle&amp;author=D+Vardon&amp;author=F+Perrotin&amp;publication_year=2015&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0100"> <div class="citation-journal">100. Durand-Zaleski I, Deneux-Tharaux C, Seco A, Malki M, Frenkiel J, Sentilhes L. <span class="citation-title">An economic evaluation of tranexamic acid to prevent postpartum haemorrhage in women with vaginal delivery: the randomised controlled TRAAP trial</span>. <span class="citation"> BJOG </span><span class="pubYear">2021</span>;<span class="volume">128</span>(1):114-20. [CENTRAL: CN-02178159] <a class="crsref citation-link central-link" data-crsref="26710049" href="" ref="info:x-wiley/crsRef/26710049" target="_blank"><span style="display: none;">CENTRAL</span></a> [EMBASE: 2006051932] [PMID: 32770781] <ul class="citation-link-group"> <li> <a class="citation-link" href="https://doi.org/10.1111/1471-0528.16456" target="_blank"> <span>Link to article</span> </a> </li> <li> <a class="citation-link" href="https://www.ncbi.nlm.nih.gov/pubmed/32770781" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=An+economic+evaluation+of+tranexamic+acid+to+prevent+postpartum+haemorrhage+in+women+with+vaginal+delivery:+the+randomised+controlled+TRAAP+trial+&amp;author=I+Durand-Zaleski&amp;author=C+Deneux-Tharaux&amp;author=A+Seco&amp;author=M+Malki&amp;author=J+Frenkiel&amp;author=L+Sentilhes&amp;publication_year=2021&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0101"> <div class="citation-journal">101. Sentilhes L, Winer N, Azria E, Senat MV, Le Ray C, Vardon D, et al. <span class="citation-title">Tranexamic acid for the prevention of blood loss after vaginal delivery</span>. <span class="citation"> New England Journal of Medicine </span><span class="pubYear">2018</span>;<span class="volume">379</span>(8):731-42. [CENTRAL: CN-01626893] <a class="crsref citation-link central-link" data-crsref="26710055" href="" ref="info:x-wiley/crsRef/26710055" target="_blank"><span style="display: none;">CENTRAL</span></a> [PMID: 30134136] <ul class="citation-link-group"> <li> <a class="citation-link" href="https://doi.org/10.1056/NEJMoa1800942" target="_blank"> <span>Link to article</span> </a> </li> <li> <a class="citation-link" href="https://www.ncbi.nlm.nih.gov/pubmed/30134136" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=Tranexamic+acid+for+the+prevention+of+blood+loss+after+vaginal+delivery&amp;author=L+Sentilhes&amp;author=N+Winer&amp;author=E+Azria&amp;author=MV+Senat&amp;author=C+LeRay&amp;author=D+Vardon&amp;publication_year=2018&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0102"> <div class="citation-other">102. EUCTR2014-001748-39-FR. <span class="citation-title">Impact de l'injection d'acide tranexamique en prevention de l'hemorragie du post partum apres un accouchement par voie basse</span> [TRAnexamic Acid for Preventing postpartum hemorrhage following a vaginal delivery: a multicenter randomised, double blind placebo controlled trial - TRAAP]. Http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2014-001748-39-FR (first received 2015). [CENTRAL: CN-01864814] <a class="crsref citation-link central-link" data-crsref="26710050" href="" ref="info:x-wiley/crsRef/26710050" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0103"> <div class="citation-journal">103. Sentilhes L, Winer N, Azria E, Senat M-V, Le Ray C, Vardon D, et al. <span class="citation-title">Tranexamic acid for the prevention of postpartum hemorrhage after vaginal delivery: the TRAAP trial</span>. <span class="citation"> American Journal of Obstetrics and Gynecology </span><span class="pubYear">2018</span>;<span class="volume">218</span>(1 Supplement 1):S2-3. [CENTRAL: CN-01450841] <a class="crsref citation-link central-link" data-crsref="26710054" href="" ref="info:x-wiley/crsRef/26710054" target="_blank"><span style="display: none;">CENTRAL</span></a> [EMBASE: 620309567] <ul class="citation-link-group"> <li> <a class="citation-link" href="https://doi.org/10.1016/j.ajog.2017.10.412" target="_blank"> <span>Link to article</span> </a> </li> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=Tranexamic+acid+for+the+prevention+of+postpartum+hemorrhage+after+vaginal+delivery:+the+TRAAP+trial+&amp;author=L+Sentilhes&amp;author=N+Winer&amp;author=E+Azria&amp;author=C+LeRay&amp;author=D+Vardon&amp;publication_year=2018&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0104"> <div class="citation-journal">104. Sentilhes L, Daniel V, Darsonval A, Deruelle P, Vardon D, Perrotin F, et al. <span class="citation-title">Study protocol. TRAAP - TRAnexamic Acid for Preventing postpartum hemorrhage after vaginal delivery: a multicenter randomized, double-blind, placebo-controlled trial</span>. <span class="citation"> BMC Pregnancy and Childbirth </span><span class="pubYear">2015</span>;<span class="volume">15</span>:135. [CENTRAL: CN-01257586] <a class="crsref citation-link central-link" data-crsref="17960268" href="" ref="info:x-wiley/crsRef/17960268" target="_blank"><span style="display: none;">CENTRAL</span></a> [PMID: 26071040] <ul class="citation-link-group"> <li> <a class="citation-link" href="https://doi.org/10.1186/s12884-015-0573-5" target="_blank"> <span>Link to article</span> </a> </li> <li> <a class="citation-link" href="https://www.ncbi.nlm.nih.gov/pubmed/26071040" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=Study+protocol.+TRAAP+-+TRAnexamic+Acid+for+Preventing+postpartum+hemorrhage+after+vaginal+delivery:+a+multicenter+randomized,+double-blind,+placebo-controlled+trial+&amp;author=L+Sentilhes&amp;author=V+Daniel&amp;author=A+Darsonval&amp;author=P+Deruelle&amp;author=D+Vardon&amp;author=F+Perrotin&amp;publication_year=2015&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0105"> <div class="citation-other">105. NCT02302456. <span class="citation-title">Tranexamic acid for preventing postpartum haemorrhage following a vaginal delivery (TRAAP)</span>. Clinicaltrials.gov/ct2/show/NCT02302456 (first received Date first received: 17 November 2014). <a class="crsref citation-link central-link" data-crsref="26710051" href="" ref="info:x-wiley/crsRef/26710051" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0106"> <div class="citation-journal">106. Shady NW, Sallam HF, Elsayed AH, Abdelkader AM, Ali SS, Alanwar A, et al. <span class="citation-title">The effect of prophylactic oral tranexamic acid plus buccal misoprostol on blood loss after vaginal delivery: a randomized controlled trial</span>. <span class="citation"> Journal of Maternal-Fetal &amp; Neonatal Medicine </span><span class="pubYear">2017</span>;<span class="volume">27</span>:1-7. [CENTRAL: CN-01440910] <a class="crsref citation-link central-link" data-crsref="26710057" href="" ref="info:x-wiley/crsRef/26710057" target="_blank"><span style="display: none;">CENTRAL</span></a> [EMBASE: 619981098] <ul class="citation-link-group"> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=The+effect+of+prophylactic+oral+tranexamic+acid+plus+buccal+misoprostol+on+blood+loss+after+vaginal+delivery:+a+randomized+controlled+trial+&amp;author=NW+Shady&amp;author=HF+Sallam&amp;author=AH+Elsayed&amp;author=AM+Abdelkader&amp;author=SS+Ali&amp;author=A+Alanwar&amp;publication_year=2017&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0107"> <div class="citation-journal">107. Shady NW, Sallam HF, Elsayed AH, Abdelkader AM, Ali SS, Alanwar A, et al. <span class="citation-title">The effect of prophylactic oral tranexamic acid plus buccal misoprostol on blood loss after vaginal delivery: a randomized controlled trial</span>. <span class="citation"> Journal of Maternal-Fetal &amp; Neonatal Medicine </span><span class="pubYear">2019</span>;<span class="volume">32</span>(11):1806-12. [CENTRAL: CN-01944542] <a class="crsref citation-link central-link" data-crsref="26710059" href="" ref="info:x-wiley/crsRef/26710059" target="_blank"><span style="display: none;">CENTRAL</span></a> [PMID: 29241383] <ul class="citation-link-group"> <li> <a class="citation-link" href="https://doi.org/10.1080/14767058.2017.1418316" target="_blank"> <span>Link to article</span> </a> </li> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=The+effect+of+prophylactic+oral+tranexamic+acid+plus+buccal+misoprostol+on+blood+loss+after+vaginal+delivery:+a+randomized+controlled+trial+&amp;author=NW+Shady&amp;author=HF+Sallam&amp;author=AH+Elsayed&amp;author=AM+Abdelkader&amp;author=SS+Ali&amp;author=A+Alanwar&amp;publication_year=2019&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0108"> <div class="citation-other">108. <span class="citation-title">Tranexamic acid along with AMTSL for preventing PPH in vaginal delivery: TAAPP-V</span>. CTRI/2021/05/033500. <a class="crsref citation-link central-link" data-crsref="26710071" href="" ref="info:x-wiley/crsRef/26710071" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0109"> <div class="citation-journal">109. Tali K, Ignacio Alensuela A. <span class="citation-title">The effect of prophylactic intravenous tranexamic acid in reducing blood loss after vaginal delivery in women at low risk of postpartum haemorrhage: a prospective, randomised, double-blind, placebo-controlled study</span>. <span class="citation"> Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology </span><span class="pubYear">2016</span>;<span class="volume">56</span>(Suppl 1):61. [CENTRAL: CN-01252518] <a class="crsref citation-link central-link" data-crsref="26710073" href="" ref="info:x-wiley/crsRef/26710073" target="_blank"><span style="display: none;">CENTRAL</span></a> [EMBASE: 613101716] <ul class="citation-link-group"> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=The+effect+of+prophylactic+intravenous+tranexamic+acid+in+reducing+blood+loss+after+vaginal+delivery+in+women+at+low+risk+of+postpartum+haemorrhage:+a+prospective,+randomised,+double-blind,+placebo-controlled+study+&amp;author=K+Tali&amp;author=A+IgnacioAlensuela&amp;publication_year=2016&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0110"> <div class="citation-journal">110. Zheng SR, Li MZ, Chi GZ. <span class="citation-title">Effects of tranexamic acid on decreasing blood loss within two hours after delivery. A multicenter randomized comparative study</span>. <span class="citation"> Blood </span><span class="pubYear">2000</span>;<span class="volume">96</span>(11):846a. [CENTRAL: CN-00486589] <a class="crsref citation-link central-link" data-crsref="26710079" href="" ref="info:x-wiley/crsRef/26710079" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=Effects+of+tranexamic+acid+on+decreasing+blood+loss+within+two+hours+after+delivery.+A+multicenter+randomized+comparative+study+&amp;author=SR+Zheng&amp;author=MZ+Li&amp;author=GZ+Chi&amp;publication_year=2000&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0111"> <div class="citation-other">111. ACTRN12615000312549. <span class="citation-title">Efficiency and safety of preoperative Tranexamic acid in reducing perioperative blood loss in elective cesarean section</span>. Https://anzctr.org.au/ACTRN12615000312549.aspx (first received 2015). <a class="crsref citation-link central-link" data-crsref="26710014" href="" ref="info:x-wiley/crsRef/26710014" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0112"> <div class="citation-journal">112. Maged AM, Helal OM, Elsherbini MM, Eid MM, Elkomy RO, Dahab S, et al. <span class="citation-title">A randomized placebo-controlled trial of preoperative tranexamic acid among women undergoing elective cesarean delivery</span>. <span class="citation"> International Journal of Gynaecology and Obstetrics </span><span class="pubYear">2015</span>;<span class="volume">131</span>(3):265-8. [CENTRAL: CN-01140746] <a class="crsref citation-link central-link" data-crsref="26710015" href="" ref="info:x-wiley/crsRef/26710015" target="_blank"><span style="display: none;">CENTRAL</span></a> [EMBASE: 2015345374] [PMID: 26341174] <ul class="citation-link-group"> <li> <a class="citation-link" href="https://doi.org/10.1016/j.ijgo.2015.05.027" target="_blank"> <span>Link to article</span> </a> </li> <li> <a class="citation-link" href="https://www.ncbi.nlm.nih.gov/pubmed/26341174" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=A+randomized+placebo-controlled+trial+of+preoperative+tranexamic+acid+among+women+undergoing+elective+cesarean+delivery+&amp;author=AM+Maged&amp;author=OM+Helal&amp;author=MM+Elsherbini&amp;author=MM+Eid&amp;author=RO+Elkomy&amp;author=S+Dahab&amp;publication_year=2015&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0113"> <div class="citation-other">113. NCT02350179. <span class="citation-title">Efficacy of tranexamic acid in reducing blood loss during and after caesarean section</span> [Efficacy of Tranexamic Acid in Reducing Blood Loss During and After Caesarean Section]. Https://clinicaltrials.gov/show/NCT02350179 (first received 2015 Jan 1). [CENTRAL: CN-01551809] <a class="crsref citation-link central-link" data-crsref="26710029" href="" ref="info:x-wiley/crsRef/26710029" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0114"> <div class="citation-other">114. NCT02688127. <span class="citation-title">Efficacy of tranexamic acid in reducing blood loss during cesarean section because of placenta previa</span> [Efficacy of Tranexamic Acid In Reducing Blood Loss Among Pregnant Women During Cesarean Section Because Of Placenta Previa]. Https://clinicaltrials.gov/show/NCT02688127 (first received 2016 February 23). [CENTRAL: CN-01555966] <a class="crsref citation-link central-link" data-crsref="26710031" href="" ref="info:x-wiley/crsRef/26710031" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0115"> <div class="citation-other">115. IRCT201204079399N1. <span class="citation-title">A placebo-controlled clinical trial to assess efficacy of tranexamic acid in reducing hemorrhage after vaginal delivery</span>. Http://www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT201204079399N1 (first received 2012). [CENTRAL: CN-01864636] <a class="crsref citation-link central-link" data-crsref="26710061" href="" ref="info:x-wiley/crsRef/26710061" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0116"> <div class="citation-journal">116. Sujata N, Tobin R, Kaur R, Aneja A, Khanna M, Hanjoora VM. <span class="citation-title">Randomized controlled trial of tranexamic acid among parturients at increased risk for postpartum hemorrhage undergoing cesarean delivery</span>. <span class="citation"> International Journal of Gynaecology and Obstetrics </span><span class="pubYear">2016</span>;<span class="volume">133</span>(3):312-5. [CENTRAL: CN-01158811] <a class="crsref citation-link central-link" data-crsref="26710066" href="" ref="info:x-wiley/crsRef/26710066" target="_blank"><span style="display: none;">CENTRAL</span></a> [EMBASE: 20160186494] [PMID: 26952346] <ul class="citation-link-group"> <li> <a class="citation-link" href="https://doi.org/10.1016/j.ijgo.2015.09.032" target="_blank"> <span>Link to article</span> </a> </li> <li> <a class="citation-link" href="https://www.ncbi.nlm.nih.gov/pubmed/26952346" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=Randomized+controlled+trial+of+tranexamic+acid+among+parturients+at+increased+risk+for+postpartum+hemorrhage+undergoing+cesarean+delivery+&amp;author=N+Sujata&amp;author=R+Tobin&amp;author=R+Kaur&amp;author=A+Aneja&amp;author=M+Khanna&amp;author=VM+Hanjoora&amp;publication_year=2016&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0117"> <div class="citation-other">117. CTRI/2015/05/005752. <span class="citation-title">Tranexamic acid to reduce bleeding after cesarean section in high risk patients</span> [Role of Tranexamic acid in reducing the use of uterotonic drugs in parturients at increased risk for obstetric haemorrhage undergoing cesarean section]. Http://www.who.int/trialsearch/Trial2.aspx?TrialID=CTRI/2015/05/005752 (first received 2015). [CENTRAL: CN-01847694] <a class="crsref citation-link central-link" data-crsref="26710065" href="" ref="info:x-wiley/crsRef/26710065" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0118"> <div class="citation-journal">118. Al-Nasrawi H. <span class="citation-title">Evaluation of the role of tranexamic acid in prevention of postpartum bleeding: a case control study</span>. <span class="citation"> Indian Journal of Forensic Medicine and Toxicology </span><span class="pubYear">2019</span>;<span class="volume">13</span>(4):895-900. [CENTRAL: CN-02077566] <a class="crsref citation-link central-link" data-crsref="26710081" href="" ref="info:x-wiley/crsRef/26710081" target="_blank"><span style="display: none;">CENTRAL</span></a> [EMBASE: 2003259860] <ul class="citation-link-group"> <li> <a class="citation-link" href="https://doi.org/10.5958/0973-9130.2019.00409.2" target="_blank"> <span>Link to article</span> </a> </li> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=Evaluation+of+the+role+of+tranexamic+acid+in+prevention+of+postpartum+bleeding:+a+case+control+study+&amp;author=H+Al-Nasrawi&amp;publication_year=2019&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0119"> <div class="citation-journal">119. Bangash, AG, Riaz, S, Akhtar, Z, et al. <span class="citation-title">Tranexamic acid plus oxytocin prophylaxis in reducing blood loss and preventing postpartum hemorrhage during cesarean section</span>. <span class="citation"> Journal of Medical Sciences (Taipei, Taiwan) </span><span class="pubYear">2023</span>;<span class="volume">31</span>(3):203�207. <a class="crsref citation-link central-link" data-crsref="26710083" href="" ref="info:x-wiley/crsRef/26710083" target="_blank"><span style="display: none;">CENTRAL</span></a> [DOI: <a href="http://dx.doi.org/10.52764/jms.23.31.3.8" target="_blank"><span>10.52764/jms.23.31.3.8</span></a>] <ul class="citation-link-group"> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0120"> <div class="citation-journal">120. Dawoud M, Al-Husseiny M, Helal O, Elsherbini M, Abdel-Rasheed M, Sediek M. <span class="citation-title">Intravenous tranexamic acid vs. sublingual misoprostol in high-risk women for postpartum haemorrhage following cesarean delivery; a randomised clinical trial</span>. <span class="citation"> BioMed Central Pregnancy and Childbirth </span><span class="pubYear">2023</span>;<span class="volume">23</span>(1):611. <a class="crsref citation-link central-link" data-crsref="26710088" href="" ref="info:x-wiley/crsRef/26710088" target="_blank"><span style="display: none;">CENTRAL</span></a> [DOI: 10.1186/s12884-023-05935-5]] <ul class="citation-link-group"> <li> <a class="citation-link" href="https://doi.org/10.1186/s12884-023-05935-5" target="_blank"> <span>Link to article</span> </a> </li> <li> <a class="citation-link" href="https://www.ncbi.nlm.nih.gov/pubmed/37626292" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=Intravenous+tranexamic+acid+vs.+sublingual+misoprostol+in+high-risk+women+for+postpartum+haemorrhage+following+cesarean+delivery;+a+randomised+clinical+trial+&amp;author=M+Dawoud&amp;author=M+Al-Husseiny&amp;author=O+Helal&amp;author=M+Elsherbini&amp;author=M+Abdel-Rasheed&amp;author=M+Sediek&amp;publication_year=2023&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0121"> <div class="citation-other">121. Diab KM, Mohamed andAG Abdelhay RM. <span class="citation-title">The Efficacy of Intravenous Tranexamic Acid in Reduction of Blood Loss in Women at High Risk of Postpartum Hemorrhage</span>. In: From the Department of Obstetrics and Gynecology, Faculty of Medicine Ain Shams University, Cairo, Egypt. <span class="pubYear">2020</span>. <a class="crsref citation-link central-link" data-crsref="26710090" href="" ref="info:x-wiley/crsRef/26710090" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=The+Efficacy+of+Intravenous+Tranexamic+Acid+in+Reduction+of+Blood+Loss+in+Women+at+High+Risk+of+Postpartum+Hemorrhage+&amp;author=KM+Diab&amp;author=RM+MohamedandAGAbdelhay&amp;publication_year=2020&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0122"> <div class="citation-journal">122. Farhadifar F, Shahgheibi S, Zare S, Rezaie M, Seyedolshohadae F, Sharami SR, et al. <span class="citation-title">Investigation of prophylactic effect of tranexamic acid in preventing postpartum hemorrhage in besat hospital in sanandaj</span>. <span class="citation"> Pakistan Journal of Medical and Health Sciences </span><span class="pubYear">2021</span>;<span class="volume">15</span>(3):966-9. [CENTRAL: CN-02275027] <a class="crsref citation-link central-link" data-crsref="26710092" href="" ref="info:x-wiley/crsRef/26710092" target="_blank"><span style="display: none;">CENTRAL</span></a> [EMBASE: 2011993833] <ul class="citation-link-group"> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=Investigation+of+prophylactic+effect+of+tranexamic+acid+in+preventing+postpartum+hemorrhage+in+besat+hospital+in+sanandaj+&amp;author=F+Farhadifar&amp;author=S+Shahgheibi&amp;author=S+Zare&amp;author=M+Rezaie&amp;author=F+Seyedolshohadae&amp;author=SR+Sharami&amp;publication_year=2021&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0123"> <div class="citation-journal">123. Ghosh A, Chaudhurib P, Muhuri B. <span class="citation-title">Efficacy of intravenous tranexamic acid before cesarean section in preventing post partum hemorrhagea prospective randomised double blind placebo controlled study</span>. <span class="citation"> International Journal of Biological &amp; Medical Research </span><span class="pubYear">2014</span>;<span class="volume">5</span>(4):4461-4. <a class="crsref citation-link central-link" data-crsref="26710096" href="" ref="info:x-wiley/crsRef/26710096" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=Efficacy+of+intravenous+tranexamic+acid+before+cesarean+section+in+preventing+post+partum+hemorrhagea+prospective+randomised+double+blind+placebo+controlled+study+&amp;author=A+Ghosh&amp;author=P+Chaudhurib&amp;author=B+Muhuri&amp;publication_year=2014&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0124"> <div class="citation-other">124. Gobbur VR, Reddy SV, Bijapur UJ. <span class="citation-title">Efficacy of tranexamic acid in reducing blood loss during lower segment caesarean section</span>. In: 54th All India Congress of Obstetrics and Gynaecology; 2011 January 5-9; Hyderabad, Andhra Pradesh, India. <span class="pubYear">2011</span>:92. <a class="crsref citation-link central-link" data-crsref="26710098" href="" ref="info:x-wiley/crsRef/26710098" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=Efficacy+of+tranexamic+acid+in+reducing+blood+loss+during+lower+segment+caesarean+section+&amp;author=VR+Gobbur&amp;author=SV+Reddy&amp;author=UJ+Bijapur&amp;publication_year=2011&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0125"> <div class="citation-journal">125. Gobbur VR, Shiragur SS, Jhanwar UR, Tehalia MJ. <span class="citation-title">Efficacy of tranexamic acid in reducing blood loss during lower segment caesarean section</span>. <span class="citation"> International Journal of Reproduction, Contraception, Obstetrics and Gynecology </span><span class="pubYear">2014</span>;<span class="volume">3</span>(2):414-7. [CENTRAL: CN-02272414] <a class="crsref citation-link central-link" data-crsref="26710100" href="" ref="info:x-wiley/crsRef/26710100" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="https://doi.org/10.5455/2320-1770.ijrcog20140626" target="_blank"> <span>Link to article</span> </a> </li> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=Efficacy+of+tranexamic+acid+in+reducing+blood+loss+during+lower+segment+caesarean+section+&amp;author=VR+Gobbur&amp;author=SS+Shiragur&amp;author=UR+Jhanwar&amp;author=MJ+Tehalia&amp;publication_year=2014&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0126"> <div class="citation-other">126. Gwanzura. <span class="citation-title">Efficacy of tranexamic acid in preventing postpartum haemorrhage after elective caesarean section</span>. Clinical Trials.gov (https://Clinicaltrials.gov/Study/NCT03463993) Last updated: 01/06/2022. <a class="crsref citation-link central-link" data-crsref="26710102" href="" ref="info:x-wiley/crsRef/26710102" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0127"> <div class="citation-other">127. <span class="citation-title">The efficacy of tranexamic acid in preventing postpartum haemorrhage after caesarean section (ETAPPH)</span>. https://clinicaltrials.gov/ct2/show/study/NCT04733157. <a class="crsref citation-link central-link" data-crsref="26710104" href="" ref="info:x-wiley/crsRef/26710104" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0128"> <div class="citation-journal">128. Hemapriya L, More G, Kumar A. <span class="citation-title">Efficacy of tranexamic acid in reducing blood loss in lower segment cesearean section: a randomised controlled study</span>. <span class="citation"> Journal of Obstetrics and Gynaecology of India </span><span class="pubYear">2020</span>;<span class="volume">70</span>(6):479-84. [CENTRAL: CN-02178207] <a class="crsref citation-link central-link" data-crsref="26710106" href="" ref="info:x-wiley/crsRef/26710106" target="_blank"><span style="display: none;">CENTRAL</span></a> [EMBASE: 2006073040] [PMID: 33417631] <ul class="citation-link-group"> <li> <a class="citation-link" href="https://doi.org/10.1007/s13224-020-01351-3" target="_blank"> <span>Link to article</span> </a> </li> <li> <a class="citation-link" href="https://www.ncbi.nlm.nih.gov/pubmed/33417631" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=Efficacy+of+tranexamic+acid+in+reducing+blood+loss+in+lower+segment+cesearean+section:+a+randomised+controlled+study+&amp;author=L+Hemapriya&amp;author=G+More&amp;author=A+Kumar&amp;publication_year=2020&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0129"> <div class="citation-journal">129. Ifunanya NJ, Chukwu IC, Nobert OC, Blessing O, Chibuzor U, Uchenna O. <span class="citation-title">Tranexamic acid versus placebo for prevention of primary postpartum haemorrhage among high risk women undergoing caesarean section in Abakaliki: a randomized controlled trial</span>. <span class="citation"> Open Journal of Obstetrics and Gynecology </span><span class="pubYear">2019</span>;<span class="volume">9</span>(6):914-22. <a class="crsref citation-link central-link" data-crsref="26710108" href="" ref="info:x-wiley/crsRef/26710108" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="https://doi.org/10.4236/ojog.2019.96089" target="_blank"> <span>Link to article</span> </a> </li> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=Tranexamic+acid+versus+placebo+for+prevention+of+primary+postpartum+haemorrhage+among+high+risk+women+undergoing+caesarean+section+in+Abakaliki:+a+randomized+controlled+trial+&amp;author=NJ+Ifunanya&amp;author=IC+Chukwu&amp;author=OC+Nobert&amp;author=O+Blessing&amp;author=U+Chibuzor&amp;author=O+Uchenna&amp;publication_year=2019&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0130"> <div class="citation-journal">130. Kafayat H, Janjua M, Naheed I, Iqbal T. <span class="citation-title">To assess the prophylactic role of tranexamic acid in reducing blood loss during and after two hours of caesarean section</span>. <span class="citation"> Pakistan Journal of Medical and Health Sciences </span><span class="pubYear">2019</span>;<span class="volume">12</span>(4):1662-5. [CENTRAL: CN-01914956] <a class="crsref citation-link central-link" data-crsref="26710110" href="" ref="info:x-wiley/crsRef/26710110" target="_blank"><span style="display: none;">CENTRAL</span></a> [EMBASE: 2001674035] <ul class="citation-link-group"> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=To+assess+the+prophylactic+role+of+tranexamic+acid+in+reducing+blood+loss+during+and+after+two+hours+of+caesarean+section+&amp;author=H+Kafayat&amp;author=M+Janjua&amp;author=I+Naheed&amp;author=T+Iqbal&amp;publication_year=2019&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0131"> <div class="citation-journal">131. Kremer M, Cortez C. <span class="citation-title">Perioperative administration of tranexamic acid for placenta previa and accreta study (TAPPAS): a randomized trial</span>. <span class="citation"> Obstetrics and Gynecology </span><span class="pubYear">2019</span>;<span class="volume">133</span>(Suppl 1):1. [CENTRAL: CN-02228782] <a class="crsref citation-link central-link" data-crsref="26710112" href="" ref="info:x-wiley/crsRef/26710112" target="_blank"><span style="display: none;">CENTRAL</span></a> [EMBASE: 633844323] <ul class="citation-link-group"> <li> <a class="citation-link" href="https://doi.org/10.1097/01.AOG.0000559014.96155.77" target="_blank"> <span>Link to article</span> </a> </li> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=Perioperative+administration+of+tranexamic+acid+for+placenta+previa+and+accreta+study+(TAPPAS):+a+randomized+trial+&amp;author=M+Kremer&amp;author=C+Cortez&amp;publication_year=2019&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0132"> <div class="citation-other">132. NCT02806024. <span class="citation-title">Perioperative administration of tranexamic acid for placenta previa and accreta study</span> [Perioperative Administration of Tranexamic Acid for Placenta Previa and Accreta Study (TAPPAS): a Randomized, Placebo-controlled Double Blind Trial]. Https://clinicaltrials.gov/show/NCT02806024 (first received 2016 June 20). [CENTRAL: CN-01559173] <a class="crsref citation-link central-link" data-crsref="26710113" href="" ref="info:x-wiley/crsRef/26710113" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0133"> <div class="citation-journal">133. Lakshmi SJ, Abraham R. <span class="citation-title">Role of prophylactic tranexamic acid in reducing blood loss during elective caesarean section: a randomized controlled study</span>. <span class="citation"> Journal of Clinical and Diagnostic Research </span><span class="pubYear">2016</span>;<span class="volume">10</span>(12):OC17-21. [CENTRAL: CN-01286685] <a class="crsref citation-link central-link" data-crsref="26710115" href="" ref="info:x-wiley/crsRef/26710115" target="_blank"><span style="display: none;">CENTRAL</span></a> [EMBASE: 613547126] <ul class="citation-link-group"> <li> <a class="citation-link" href="https://doi.org/10.7860/JCDR/2016/21702.9050" target="_blank"> <span>Link to article</span> </a> </li> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=Role+of+prophylactic+tranexamic+acid+in+reducing+blood+loss+during+elective+caesarean+section:+a+randomized+controlled+study+&amp;author=SJ+Lakshmi&amp;author=R+Abraham&amp;publication_year=2016&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0134"> <div class="citation-journal">134. Malathi P, Anupama D, Habitha P. <span class="citation-title">Effect of injection tranexamic acid on peri-operative blood loss during cesarean section</span>. <span class="citation"> International Archives of Integrated Medicine </span><span class="pubYear">2016</span>;<span class="volume">3</span>(10):280-9. <a class="crsref citation-link central-link" data-crsref="26710117" href="" ref="info:x-wiley/crsRef/26710117" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=Effect+of+injection+tranexamic+acid+on+peri-operative+blood+loss+during+cesarean+section&amp;author=P+Malathi&amp;author=D+Anupama&amp;author=P+Habitha&amp;publication_year=2016&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0135"> <div class="citation-other">135. Markley JC, Tsen LC, Varelmann DJ, Farber MK. <span class="citation-title">The influence of prophylactic tranexamic acid on thromboelastography during cesarean delivery: a randomized, double-blind, placebo-controlled trial</span>. In: Society for Obstetric Anesthesia and Perinatology (SOAP) 47th Annual Meeting; 2015 May 13-17; Colorado, USA. <span class="pubYear">2015</span>:T-36. <a class="crsref citation-link central-link" data-crsref="26710119" href="" ref="info:x-wiley/crsRef/26710119" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=The+influence+of+prophylactic+tranexamic+acid+on+thromboelastography+during+cesarean+delivery:+a+randomized,+double-blind,+placebo-controlled+trial+&amp;author=JC+Markley&amp;author=LC+Tsen&amp;author=DJ+Varelmann&amp;author=MK+Farber&amp;publication_year=2015&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0136"> <div class="citation-journal">136. Javeria M, Zartaj H, Nadia A, Robina J, Nazish S, Faiza M. <span class="citation-title">Comparison of estimated blood loss between tranexamic acid and control in women undergoing elective cesarean section</span>. <span class="citation"> Pakistan Journal of Medical &amp; Health Sciences </span><span class="pubYear">2023</span>;<span class="volume">17</span>(04):288-90. <a class="crsref citation-link central-link" data-crsref="26710121" href="" ref="info:x-wiley/crsRef/26710121" target="_blank"><span style="display: none;">CENTRAL</span></a> [DOI: <a href="http://dx.doi.org/10.53350/pjmhs2023174288" target="_blank"><span>10.53350/pjmhs2023174288</span></a>] <ul class="citation-link-group"> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=Comparison+of+estimated+blood+loss+between+tranexamic+acid+and+control+in+women+undergoing+elective+cesarean+section+&amp;author=M+Javeria&amp;author=H+Zartaj&amp;author=A+Nadia&amp;author=J+Robina&amp;author=S+Nazish&amp;author=M+Faiza&amp;publication_year=2023&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0137"> <div class="citation-journal">137. Moradan S, Anaraki RM, Mirmohammadkhani M. <span class="citation-title">Prophylactic effect of misoprostol versus tranexamic acid in conjunction with oxytocin in reduction of post-partum hemorrhage after cesarean sectionin: a randomized clinical trial</span>. <span class="citation"> Koomesh </span><span class="pubYear">2018</span>;<span class="volume">20</span>(4):620-5. [CENTRAL: CN-01651839] <a class="crsref citation-link central-link" data-crsref="26710123" href="" ref="info:x-wiley/crsRef/26710123" target="_blank"><span style="display: none;">CENTRAL</span></a> [EMBASE: 624107599] <ul class="citation-link-group"> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=Prophylactic+effect+of+misoprostol+versus+tranexamic+acid+in+conjunction+with+oxytocin+in+reduction+of+post-partum+hemorrhage+after+cesarean+sectionin:+a+randomized+clinical+trial+&amp;author=S+Moradan&amp;author=RM+Anaraki&amp;author=M+Mirmohammadkhani&amp;publication_year=2018&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0138"> <div class="citation-journal">138. Nandal I, Kochar SP, Dahiya A, Kaur R. <span class="citation-title">Role of intravenous tranexamic acid in reducing blood loss during caesarean delivery</span>. <span class="citation"> International Medical Journal </span><span class="pubYear">2022</span>;<span class="volume">29(1)</span>(23):252022. <a class="crsref citation-link central-link" data-crsref="26710125" href="" ref="info:x-wiley/crsRef/26710125" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=Role+of+intravenous+tranexamic+acid+in+reducing+blood+loss+during+caesarean+delivery&amp;author=I+Nandal&amp;author=SP+Kochar&amp;author=A+Dahiya&amp;author=R+Kaur&amp;publication_year=2022&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0139"> <div class="citation-journal">139. Nargis N, Dewan F. <span class="citation-title">Prophylactic use of tranexamic acid during caesarean section in preventing postpartum haemorrhage-a prospective randomised double blind placebo controlled study</span>. <span class="citation"> Bangladesh Journal of Obstetrics and Gynecology </span><span class="pubYear">2020</span>;<span class="volume">33</span>(2):125-30. [CENTRAL: CN-02193474] <a class="crsref citation-link central-link" data-crsref="26710127" href="" ref="info:x-wiley/crsRef/26710127" target="_blank"><span style="display: none;">CENTRAL</span></a> [EMBASE: 2007609862] <ul class="citation-link-group"> <li> <a class="citation-link" href="https://doi.org/10.3329/bjog.v33i2.43564" target="_blank"> <span>Link to article</span> </a> </li> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=Prophylactic+use+of+tranexamic+acid+during+caesarean+section+in+preventing+postpartum+haemorrhage-a+prospective+randomised+double+blind+placebo+controlled+study+&amp;author=N+Nargis&amp;author=F+Dewan&amp;publication_year=2020&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0140"> <div class="citation-journal">140. Obi VO, Umeora OU, Dimejesi IB, Asiegbu O, Mgbafulu CC, Ifemelumma CC, et al. <span class="citation-title">Efficacy of intravenous tranexamic acid at reducing blood loss during elective caesarean section in Abakaliki: a double blind randomized placebo controlled trial</span>. <span class="citation"> African Journal of Medical and Health Sciences </span><span class="pubYear">2019</span>;<span class="volume">18</span>(2):10-7. <a class="crsref citation-link central-link" data-crsref="26710129" href="" ref="info:x-wiley/crsRef/26710129" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=Efficacy+of+intravenous+tranexamic+acid+at+reducing+blood+loss+during+elective+caesarean+section+in+Abakaliki:+a+double+blind+randomized+placebo+controlled+trial+&amp;author=VO+Obi&amp;author=OU+Umeora&amp;author=IB+Dimejesi&amp;author=O+Asiegbu&amp;author=CC+Mgbafulu&amp;author=CC+Ifemelumma&amp;publication_year=2019&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0141"> <div class="citation-journal">141. Ortuanya KE, Eleje GU, Ezugwu FO, Odugu BU, Ikechebelu JI, Ugwu EO, et al. <span class="citation-title">Prophylactic tranexamic acid for reducing intraoperative blood loss during cesarean section in women at high risk of postpartum hemorrhage: A double-blind placebo randomized controlled trial</span>. <span class="citation"> Women's Health (London, England) </span><span class="pubYear">2024</span>;<span class="volume">20</span>:17455057231225311. <a class="crsref citation-link central-link" data-crsref="26710131" href="" ref="info:x-wiley/crsRef/26710131" target="_blank"><span style="display: none;">CENTRAL</span></a> [DOI: <a href="http://dx.doi.org/10.1177/17455057231225311" target="_blank"><span>10.1177/17455057231225311</span></a>] [PMCID: PMC10822094.] [PMID: 38279808] <ul class="citation-link-group"> <li> <a class="citation-link" href="https://doi.org/10.1177/17455057231225311" target="_blank"> <span>Link to article</span> </a> </li> <li> <a class="citation-link" href="https://www.ncbi.nlm.nih.gov/pubmed/38279808" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=Prophylactic+tranexamic+acid+for+reducing+intraoperative+blood+loss+during+cesarean+section+in+women+at+high+risk+of+postpartum+hemorrhage:+A+double-blind+placebo+randomized+controlled+trial+&amp;author=KE+Ortuanya&amp;author=GU+Eleje&amp;author=FO+Ezugwu&amp;author=BU+Odugu&amp;author=JI+Ikechebelu&amp;author=EO+Ugwu&amp;publication_year=2024&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0142"> <div class="citation-journal">142. Poonia M, Bansal A, Bhardwaj N, Kumari S. <span class="citation-title">Role of tranexamic acid in reducing blood loss after caesarean section: a randomized case control prospective study</span>. <span class="citation"> Journal of Medical Science and Research </span><span class="pubYear">2012</span>;<span class="volume">3</span>(2):44-6. <a class="crsref citation-link central-link" data-crsref="26710133" href="" ref="info:x-wiley/crsRef/26710133" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=Role+of+tranexamic+acid+in+reducing+blood+loss+after+caesarean+section:+a+randomized+case+control+prospective+study+&amp;author=M+Poonia&amp;author=A+Bansal&amp;author=N+Bhardwaj&amp;author=S+Kumari&amp;publication_year=2012&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0143"> <div class="citation-journal">143. Ramani B. <span class="citation-title">Intravenous 1 gram tranexamic acid for prevention of blood loss and blood transfusion during caesarean section: a randomized case control study</span>. <span class="citation"> International Journal of Reproduction, Contraception, Obstetrics and Gynecology </span><span class="pubYear">2014</span>;<span class="volume">3</span>(2):366-9. <a class="crsref citation-link central-link" data-crsref="26710135" href="" ref="info:x-wiley/crsRef/26710135" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="https://doi.org/10.5455/2320-1770.ijrcog20140616" target="_blank"> <span>Link to article</span> </a> </li> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=Intravenous+1+gram+tranexamic+acid+for+prevention+of+blood+loss+and+blood+transfusion+during+caesarean+section:+a+randomized+case+control+study+&amp;author=B+Ramani&amp;publication_year=2014&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0144"> <div class="citation-journal">144. Ramesh AC, Rajni S, Deka N. <span class="citation-title">Efficacy of tranexamic acid in decreasing blood loss during and after cesarean section: A randomized case controlled prospective study</span>. <span class="citation"> Indian Journal of Public Health Research and Development </span><span class="pubYear">2015</span>;<span class="volume">6</span>(2):12-5. [CENTRAL: CN-01076660] <a class="crsref citation-link central-link" data-crsref="26710137" href="" ref="info:x-wiley/crsRef/26710137" target="_blank"><span style="display: none;">CENTRAL</span></a> [EMBASE: 604818004] <ul class="citation-link-group"> <li> <a class="citation-link" href="https://doi.org/10.5958/0976-5506.2015.00063.7" target="_blank"> <span>Link to article</span> </a> </li> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=Efficacy+of+tranexamic+acid+in+decreasing+blood+loss+during+and+after+cesarean+section:+A+randomized+case+controlled+prospective+study+&amp;author=AC+Ramesh&amp;author=S+Rajni&amp;author=N+Deka&amp;publication_year=2015&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0145"> <div class="citation-journal">145. Dr Mamun R, Dr Debdut B, Dr Ritu S, Dr Debobroto R, Dr Jayasree H. <span class="citation-title">Effectivity of intravenous tranexamic acid in addition to oxytocin on blood loss during and after caesarean delivery�a rct</span>. <span class="citation"> Journal of Cardiovascular Disease Research </span><span class="pubYear">2024</span>;<span class="volume">15</span>(1):1. <a class="crsref citation-link central-link" data-crsref="26710139" href="" ref="info:x-wiley/crsRef/26710139" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=Effectivity+of+intravenous+tranexamic+acid+in+addition+to+oxytocin+on+blood+loss+during+and+after+caesarean+delivery�a+rct+&amp;author=R+DrMamun&amp;author=B+DrDebdut&amp;author=S+DrRitu&amp;author=R+DrDebobroto&amp;author=H+DrJayasree&amp;publication_year=2024&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0146"> <div class="citation-other">146. Roy P, Sujatha MS, Bhandiwad A, Biswas B. <span class="citation-title">Role of tranexamic acid in reducing blood loss in vaginal delivery</span>. Journal of Obstetrics and Gynaecology of India<span class="pubYear">2016</span>;<span class="volume">66</span>(Suppl 1):S246-50. [CENTRAL: CN-01730606] <a class="crsref citation-link central-link" data-crsref="26710141" href="" ref="info:x-wiley/crsRef/26710141" target="_blank"><span style="display: none;">CENTRAL</span></a> [EMBASE: 609598409] [PMID: 27651612] <ul class="citation-link-group"> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=Role+of+tranexamic+acid+in+reducing+blood+loss+in+vaginal+delivery&amp;author=P+Roy&amp;author=MS+Sujatha&amp;author=A+Bhandiwad&amp;author=B+Biswas&amp;publication_year=2016&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0147"> <div class="citation-journal">147. Salas MT. <span class="citation-title">A single-blinded randomized controlled trial on the effect of prophylactic intravenous administration of tranexamic acid on the reduction of blood loss during and after primary cesarean section</span>. <span class="citation"> Journal of Obstetrics and Gynaecology Research </span><span class="pubYear">2017</span>;<span class="volume">43</span>:26-7, Abstract no: 0086. [CENTRAL: CN-01760536] <a class="crsref citation-link central-link" data-crsref="26710143" href="" ref="info:x-wiley/crsRef/26710143" target="_blank"><span style="display: none;">CENTRAL</span></a> [EMBASE: 616813053] <ul class="citation-link-group"> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=A+single-blinded+randomized+controlled+trial+on+the+effect+of+prophylactic+intravenous+administration+of+tranexamic+acid+on+the+reduction+of+blood+loss+during+and+after+primary+cesarean+section+&amp;author=MT+Salas&amp;publication_year=2017&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0148"> <div class="citation-journal">148. Pravin S, Ajay A, Shailaja C, Pappu R, Nisha K B. <span class="citation-title">Tranexamic acid in prevention of postpartum hemorrhage in elective cesarean section</span>. <span class="citation"> International Journal of Reproduction, Contraception, Obstetrics and Gynecology </span><span class="pubYear">2019</span>;<span class="volume">8</span>(2):372-6. <a class="crsref citation-link central-link" data-crsref="26710147" href="" ref="info:x-wiley/crsRef/26710147" target="_blank"><span style="display: none;">CENTRAL</span></a> [DOI: <a href="http://dx.doi.org/10.18203/2320-1770.ijrcog20190017" target="_blank"><span>10.18203/2320-1770.ijrcog20190017</span></a>] <ul class="citation-link-group"> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=Tranexamic+acid+in+prevention+of+postpartum+hemorrhage+in+elective+cesarean+section&amp;author=S+Pravin&amp;author=A+Ajay&amp;author=C+Shailaja&amp;author=R+Pappu&amp;author=B+NishaK&amp;publication_year=2019&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0149"> <div class="citation-journal">149. Agrawal A. <span class="citation-title">Tranexamic acid (TA) in prevention of postpartum haemorrhage in elective cesarean section</span>. <span class="citation"> International Journal of Gynaecology and Obstetrics </span><span class="pubYear">2018</span>;<span class="volume">143</span>(Supplement 3):294-5. [CENTRAL: CN-01654075] <a class="crsref citation-link central-link" data-crsref="26710146" href="" ref="info:x-wiley/crsRef/26710146" target="_blank"><span style="display: none;">CENTRAL</span></a> [EMBASE: 624606757] <ul class="citation-link-group"> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=Tranexamic+acid+(TA)+in+prevention+of+postpartum+haemorrhage+in+elective+cesarean+section+&amp;author=A+Agrawal&amp;publication_year=2018&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0150"> <div class="citation-journal">150. Shalaby MA, Maged AM, Al-Asmar A, El Mahy M, Al-Mohamady M, Mohamed Ali Rund N. <span class="citation-title">Safety and efficacy of preoperative tranexamic acid in reducing intraoperative and postoperative blood loss in high-risk women undergoing cesarean delivery: a randomized controlled trial</span>. <span class="citation"> BMC Pregnancy and Childbirth </span><span class="pubYear">2022</span>;<span class="volume">22</span>(1):201. <a class="crsref citation-link central-link" data-crsref="26710151" href="" ref="info:x-wiley/crsRef/26710151" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="https://doi.org/10.1186/s12884-022-04530-4" target="_blank"> <span>Link to article</span> </a> </li> <li> <a class="citation-link" href="https://www.ncbi.nlm.nih.gov/pubmed/35287618" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=Safety+and+efficacy+of+preoperative+tranexamic+acid+in+reducing+intraoperative+and+postoperative+blood+loss+in+high-risk+women+undergoing+cesarean+delivery:+a+randomized+controlled+trial+&amp;author=MA+Shalaby&amp;author=AM+Maged&amp;author=A+Al-Asmar&amp;author=M+ElMahy&amp;author=M+Al-Mohamady&amp;author=N+MohamedAliRund&amp;publication_year=2022&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0151"> <div class="citation-journal">151. Sharma R, Najam R, Misra MK. <span class="citation-title">Efficacy of tranexamic acid in decreasing blood loss during and after cesarean section</span>. <span class="citation"> Biomedical and Pharmacology Journal </span><span class="pubYear">2011</span>;<span class="volume">4</span>(1):231-5. [CENTRAL: CN-00893909] <a class="crsref citation-link central-link" data-crsref="26710153" href="" ref="info:x-wiley/crsRef/26710153" target="_blank"><span style="display: none;">CENTRAL</span></a> [EMBASE: 362564557] <ul class="citation-link-group"> <li> <a class="citation-link" href="https://doi.org/10.13005/bpj/287" target="_blank"> <span>Link to article</span> </a> </li> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=Efficacy+of+tranexamic+acid+in+decreasing+blood+loss+during+and+after+cesarean+section&amp;author=R+Sharma&amp;author=R+Najam&amp;author=MK+Misra&amp;publication_year=2011&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0152"> <div class="citation-journal">152. Suhas S, Prashant Padmakar Z, Sai W. <span class="citation-title">Study of prevention of post-partum haemorrhage after caesarean section with use of tranexamic acid</span>. <span class="citation"> Research Journal of Pharmaceutical, Biological and Chemical Sciences </span><span class="pubYear">2022</span>;<span class="volume">13</span>(5):157. <a class="crsref citation-link central-link" data-crsref="26710155" href="" ref="info:x-wiley/crsRef/26710155" target="_blank"><span style="display: none;">CENTRAL</span></a> [DOI: <a href="http://dx.doi.org/10.33887/rjpbcs/2022.13.5.25" target="_blank"><span>10.33887/rjpbcs/2022.13.5.25</span></a>] <ul class="citation-link-group"> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=Study+of+prevention+of+post-partum+haemorrhage+after+caesarean+section+with+use+of+tranexamic+acid+&amp;author=S+Suhas&amp;author=Z+PrashantPadmakar&amp;author=W+Sai&amp;publication_year=2022&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0153"> <div class="citation-journal">153. Singh KP, Singh HA. <span class="citation-title">Tranexamic acid and blood loss during and after cesarean section. A randomized case control prospective study</span>. <span class="citation"> Journal of Obstetrics and Gynaecology Research </span><span class="pubYear">2023</span>;<span class="volume">49</span>:51?522023. <a class="crsref citation-link central-link" data-crsref="26710157" href="" ref="info:x-wiley/crsRef/26710157" target="_blank"><span style="display: none;">CENTRAL</span></a> [DOI: <a href="http://dx.doi.org/10.1111/jog.15585" target="_blank"><span>10.1111/jog.15585</span></a>] <ul class="citation-link-group"> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=Tranexamic+acid+and+blood+loss+during+and+after+cesarean+section.+A+randomized+case+control+prospective+study+&amp;author=KP+Singh&amp;author=HA+Singh&amp;publication_year=2023&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0154"> <div class="citation-other">154. <span class="citation-title">Tranexamic acid and thromboelastography during cesarean delivery (TA TEG)</span>. ClinicalTrials.gov (http://Clinicaltrials.gov) (accessed 25 April 2023). <a class="crsref citation-link central-link" data-crsref="26710167" href="" ref="info:x-wiley/crsRef/26710167" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0155"> <div class="citation-journal">155. Taj N, Firdous A, Akhtar N, Chaudhary MH, Sarah, Bajwa Z, et al. <span class="citation-title">Efficacy of tranexamic acid in reducing blood loss during and after cesarean section</span>. <span class="citation"> Rawal Medical Journal </span><span class="pubYear">2014</span>;<span class="volume">39</span>(3):311-3. [CENTRAL: CN-01002077] <a class="crsref citation-link central-link" data-crsref="26710159" href="" ref="info:x-wiley/crsRef/26710159" target="_blank"><span style="display: none;">CENTRAL</span></a> [EMBASE: 373862877] <ul class="citation-link-group"> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=Efficacy+of+tranexamic+acid+in+reducing+blood+loss+during+and+after+cesarean+section&amp;author=N+Taj&amp;author=A+Firdous&amp;author=N+Akhtar&amp;author=MH+Chaudhary&amp;author=Z+Bajwa&amp;publication_year=2014&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0156"> <div class="citation-journal">156. Tarabrin O, Kaminskiy V, Galich S, Tkachenko R, Gulyaev A, Shcherbakov S, et al. <span class="citation-title">Efficacy of tranexamic acid in decreasing blood loss during cesarean section</span>. <span class="citation"> Critical Care (London, England) </span><span class="pubYear">2012</span>;<span class="volume">16 Suppl 1</span>:S157. <a class="crsref citation-link central-link" data-crsref="26710161" href="" ref="info:x-wiley/crsRef/26710161" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="https://doi.org/10.1186/cc11046" target="_blank"> <span>Link to article</span> </a> </li> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=Efficacy+of+tranexamic+acid+in+decreasing+blood+loss+during+cesarean+section&amp;author=O+Tarabrin&amp;author=V+Kaminskiy&amp;author=S+Galich&amp;author=R+Tkachenko&amp;author=A+Gulyaev&amp;author=S+Shcherbakov&amp;publication_year=2012&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0157"> <div class="citation-journal">157. Zaporozhan V, Tarabrin O, Gavrychenko D, Mazurenko G, Saleh O, Lyoshenko I. <span class="citation-title">Effcacy of tranexamic acid in decreasing blood loss during cesarean section</span>. <span class="citation"> Critical Care (London, England) </span><span class="pubYear">2013</span>;<span class="volume">17 (Suppl 2)</span>:S135-S136. <a class="crsref citation-link central-link" data-crsref="26710162" href="" ref="info:x-wiley/crsRef/26710162" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=Effcacy+of+tranexamic+acid+in+decreasing+blood+loss+during+cesarean+section&amp;author=V+Zaporozhan&amp;author=O+Tarabrin&amp;author=D+Gavrychenko&amp;author=G+Mazurenko&amp;author=O+Saleh&amp;author=I+Lyoshenko&amp;publication_year=2013&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0158"> <div class="citation-journal">158. Tarabrin O, Galich S, Tkachenko R, Gulyaev A, Shcherbakov S, Gavrychenko D. <span class="citation-title">Reduced blood loss during caesarean section under the action of tranexamic acid</span>. <span class="citation"> European Journal of Anaesthesiology </span><span class="pubYear">2012</span>;<span class="volume">29</span>:97. [CENTRAL: CN-01155631] <a class="crsref citation-link central-link" data-crsref="26710164" href="" ref="info:x-wiley/crsRef/26710164" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="https://doi.org/10.1097/00003643-201206001-00316" target="_blank"> <span>Link to article</span> </a> </li> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=Reduced+blood+loss+during+caesarean+section+under+the+action+of+tranexamic+acid&amp;author=O+Tarabrin&amp;author=S+Galich&amp;author=R+Tkachenko&amp;author=A+Gulyaev&amp;author=S+Shcherbakov&amp;author=D+Gavrychenko&amp;publication_year=2012&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0159"> <div class="citation-journal">159. Tarabrin O, Kaminskiy V, Galich S, Tkachenko R, Gulyaev A, Shcherbakov S, et al. <span class="citation-title">Efficacy of tranexamic acid in decreasing blood loss during cesarean section</span>. <span class="citation"> Critical Care (London, England) </span><span class="pubYear">2012</span>;<span class="volume">16</span>(Suppl 1):S157. [CENTRAL: CN-02272422] <a class="crsref citation-link central-link" data-crsref="26710165" href="" ref="info:x-wiley/crsRef/26710165" target="_blank"><span style="display: none;">CENTRAL</span></a> [EMBASE: 70735379] <ul class="citation-link-group"> <li> <a class="citation-link" href="https://doi.org/10.1186/cc11046" target="_blank"> <span>Link to article</span> </a> </li> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=Efficacy+of+tranexamic+acid+in+decreasing+blood+loss+during+cesarean+section&amp;author=O+Tarabrin&amp;author=V+Kaminskiy&amp;author=S+Galich&amp;author=R+Tkachenko&amp;author=A+Gulyaev&amp;author=S+Shcherbakov&amp;publication_year=2012&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0160"> <div class="citation-journal">160. Torky H, El-Desouky E-S, Abo-Elmagd I, Mohamed A, Abdalhamid A, El-Shahat A, et al. <span class="citation-title">Pre-operative tranexemic acid vs. etamsylate in reducing blood loss during elective cesarean section: randomized controlled trial</span>. <span class="citation"> Journal of Perinatal Medicine </span><span class="pubYear">2020</span>;<span class="volume">49</span>(3):353-6. [CENTRAL: CN-02191237] <a class="crsref citation-link central-link" data-crsref="26710169" href="" ref="info:x-wiley/crsRef/26710169" target="_blank"><span style="display: none;">CENTRAL</span></a> [EMBASE: 633191392] [PMID: 33064669] <ul class="citation-link-group"> <li> <a class="citation-link" href="https://doi.org/10.1515/jpm-2020-0271" target="_blank"> <span>Link to article</span> </a> </li> <li> <a class="citation-link" href="https://www.ncbi.nlm.nih.gov/pubmed/33064669" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=Pre-operative+tranexemic+acid+vs.+etamsylate+in+reducing+blood+loss+during+elective+cesarean+section:+randomized+controlled+trial+&amp;author=H+Torky&amp;author=I+Abo-Elmagd&amp;author=A+Mohamed&amp;author=A+Abdalhamid&amp;author=A+El-Shahat&amp;publication_year=2020&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0161"> <div class="citation-journal">161. Anish Kumar V, Mohit Kumar A, Sanjay Kumar S, GV Krishna P, Yashi. <span class="citation-title">Safety and efficacy of prophylactic tranexanic acid in reducing blood loss during and after caesarean delivery: a comparative study</span>. <span class="citation"> International Journal of Academic Medicine and Pharmacy </span><span class="pubYear">2023</span>;<span class="volume">5</span>(3):407-13. <a class="crsref citation-link central-link" data-crsref="26710171" href="" ref="info:x-wiley/crsRef/26710171" target="_blank"><span style="display: none;">CENTRAL</span></a> [DOI: <a href="http://dx.doi.org/10.47009/jamp.2023.5.3.88" target="_blank"><span>10.47009/jamp.2023.5.3.88</span></a>] <ul class="citation-link-group"> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=Safety+and+efficacy+of+prophylactic+tranexanic+acid+in+reducing+blood+loss+during+and+after+caesarean+delivery:+a+comparative+study+&amp;author=V+AnishKumar&amp;author=A+MohitKumar&amp;author=S+SanjayKumar&amp;author=P+GVKrishna&amp;publication_year=2023&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0162"> <div class="citation-journal">162. Zizi A, Aris S, Suharjono HN. <span class="citation-title">To study the role of tranexamic acid in reducing blood loss during and after caesarean section in Sarawak General Hospital</span>. <span class="citation"> Journal of Surgical Academia </span><span class="pubYear">2013</span>;<span class="volume">3</span>(1):50. <a class="crsref citation-link central-link" data-crsref="26710177" href="" ref="info:x-wiley/crsRef/26710177" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=To+study+the+role+of+tranexamic+acid+in+reducing+blood+loss+during+and+after+caesarean+section+in+Sarawak+General+Hospital+&amp;author=A+Zizi&amp;author=S+Aris&amp;author=HN+Suharjono&amp;publication_year=2013&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0163"> <div class="citation-journal">163. Gerdessen L, Meybohm P, Choorapoikayil S, Herrmann E, Taeuber I, Neef V, et al. <span class="citation-title">Comparison of common perioperative blood loss estimation techniques: a systematic review and meta-analysis</span>. <span class="citation"> Journal of Clinical Monitoring and Computing </span><span class="pubYear">2021</span>;<span class="volume">35</span>(2):245-58. <ul class="citation-link-group"> <li> <a class="citation-link" href="https://doi.org/10.1007/s10877-020-00579-8" target="_blank"> <span>Link to article</span> </a> </li> <li> <a class="citation-link" href="https://www.ncbi.nlm.nih.gov/pubmed/32815042" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=Comparison+of+common+perioperative+blood+loss+estimation+techniques:+a+systematic+review+and+meta-analysis+&amp;author=L+Gerdessen&amp;author=P+Meybohm&amp;author=S+Choorapoikayil&amp;author=E+Herrmann&amp;author=I+Taeuber&amp;author=V+Neef&amp;publication_year=2021&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0164"> <div class="citation-other">164. World Health Organization. <span class="citation-title">WHO recommendations on the assessment of postpartum blood loss and use of a treatment bundle for postpartum haemorrhage</span>. World Health Organization. [URL: <a href="https://www.who.int/publications/i/item/9789240085398" target="_blank">https://www.who.int/publications/i/item/9789240085398</a>] <ul class="citation-link-group"> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0165"> <div class="citation-journal">165. Diebel LN, Martin JV, Liberati DM. <span class="citation-title">Early tranexamic acid administration ameliorates the endotheliopathy of trauma and shock in an in vitro model</span>. <span class="citation"> Journal of Trauma and Acute Care Surgery </span><span class="pubYear">2017</span>;<span class="volume">82</span>:1080-1086. <ul class="citation-link-group"> <li> <a class="citation-link" href="https://doi.org/10.1097/TA.0000000000001445" target="_blank"> <span>Link to article</span> </a> </li> <li> <a class="citation-link" href="https://www.ncbi.nlm.nih.gov/pubmed/28328682" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=Early+tranexamic+acid+administration+ameliorates+the+endotheliopathy+of+trauma+and+shock+in+an+in+vitro+model+&amp;author=LN+Diebel&amp;author=JV+Martin&amp;author=DM+Liberati&amp;publication_year=2017&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0166"> <div class="citation-journal">166. Devereaux PJ, Marcucci M, Painter TW, Conen D, Lomivorotov V, Sessler DI, et al. <span class="citation-title">Tranexamic acid in patients undergoing noncardiac surgery</span>. <span class="citation"> New England Journal of Medicine </span><span class="pubYear">2022</span>;<span class="volume">386</span>:1986-97. <ul class="citation-link-group"> <li> <a class="citation-link" href="https://doi.org/10.1056/NEJMoa2201171" target="_blank"> <span>Link to article</span> </a> </li> <li> <a class="citation-link" href="https://www.ncbi.nlm.nih.gov/pubmed/35363452" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=Tranexamic+acid+in+patients+undergoing+noncardiac+surgery&amp;author=PJ+Devereaux&amp;author=M+Marcucci&amp;author=TW+Painter&amp;author=D+Conen&amp;author=V+Lomivorotov&amp;author=DI+Sessler&amp;publication_year=2022&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0167"> <div class="citation-journal">167. Myles PS, Smith JA, Forbes A, Silbert B, Jayarajah M, Painter T, et al. <span class="citation-title">Tranexamic acid in patients undergoing coronary-artery surgery</span>. <span class="citation"> New England Journal of Medicine </span><span class="pubYear">2017</span>;<span class="volume">376</span>:136-48. <ul class="citation-link-group"> <li> <a class="citation-link" href="https://doi.org/10.1056/NEJMoa1606424" target="_blank"> <span>Link to article</span> </a> </li> <li> <a class="citation-link" href="https://www.ncbi.nlm.nih.gov/pubmed/27774838" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=Tranexamic+acid+in+patients+undergoing+coronary-artery+surgery&amp;author=PS+Myles&amp;author=JA+Smith&amp;author=A+Forbes&amp;author=B+Silbert&amp;author=M+Jayarajah&amp;author=T+Painter&amp;publication_year=2017&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0168"> <div class="citation-journal">168. Mousa HA, Blum J, Abou El Senoun G, Shakur H, Alfirevic Z. <span class="citation-title">Treatment for primary postpartum haemorrhage</span>. <span class="citation"> Cochrane Database of Systematic Reviews </span><span class="pubYear">2014</span>, Issue 2. Art. No: CD003249. [DOI: <a href="http://dx.doi.org/10.1002/14651858.CD003249.pub3" target="_blank"><span>10.1002/14651858.CD003249.pub3</span></a>] <ul class="citation-link-group"> <li> <a class="citation-link" href="https://doi.org/10.1002/14651858.CD003249.pub3" target="_blank"> <span>Link to article</span> </a> </li> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=Treatment+for+primary+postpartum+haemorrhage&amp;author=HA+Mousa&amp;author=J+Blum&amp;author=G+AbouElSenoun&amp;author=H+Shakur&amp;author=Z+Alfirevic&amp;publication_year=2014&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0169"> <div class="citation-journal">169. Perel P, Ker K, Morales Uribe CH, Roberts I. <span class="citation-title">Tranexamic acid for reducing mortality in emergency and urgent surgery</span>. <span class="citation"> Cochrane Database of Systematic Reviews </span><span class="pubYear">2013</span>, Issue 1. Art. No: CD010245. [DOI: <a href="http://dx.doi.org/10.1002/14651858.CD010245.pub2" target="_blank"><span>10.1002/14651858.CD010245.pub2</span></a>] <ul class="citation-link-group"> <li> <a class="citation-link" href="https://doi.org/10.1002/14651858.CD010245.pub2" target="_blank"> <span>Link to article</span> </a> </li> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=Tranexamic+acid+for+reducing+mortality+in+emergency+and+urgent+surgery&amp;author=P+Perel&amp;author=K+Ker&amp;author=CH+MoralesUribe&amp;author=I+Roberts&amp;publication_year=2013&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0170"> <div class="citation-journal">170. Gordon HG, Andrew DO, Regina K, Jan B, Pablo A, Rind D, et al. <span class="citation-title">GRADE guidelines 6. Rating the quality of evidence - imprecision</span>. <span class="citation"> Journal of Clinical Epidemiology </span><span class="pubYear">2011</span>;<span class="volume">64</span>:1283-93. [DOI: <a href="http://dx.doi.org/10.1016/j.jclinepi.2011.01.012" target="_blank"><span>10.1016/j.jclinepi.2011.01.012</span></a>] <ul class="citation-link-group"> <li> <a class="citation-link" href="https://www.ncbi.nlm.nih.gov/pubmed/21839614" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=GRADE+guidelines+6.+Rating+the+quality+of+evidence+-+imprecision&amp;author=HG+Gordon&amp;author=DO+Andrew&amp;author=K+Regina&amp;author=B+Jan&amp;author=A+Pablo&amp;author=D+Rind&amp;publication_year=2011&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0171"> <div class="citation-journal">171. Al-Dardery NM, Abdelwahab OA, Abouzid M, Albakri K, Elkhadragy A, Katamesh BE, et al. <span class="citation-title">Efficacy and safety of tranexamic acid in prevention of postpartum hemorrhage: a systematic review and meta-analysis of 18,649 patients</span>. <span class="citation"> BioMed Central Pregnancy and Childbirth </span><span class="pubYear">2023</span>;<span class="volume">23</span>(1):817. <ul class="citation-link-group"> <li> <a class="citation-link" href="https://doi.org/10.1186/s12884-023-06100-8" target="_blank"> <span>Link to article</span> </a> </li> <li> <a class="citation-link" href="https://www.ncbi.nlm.nih.gov/pubmed/38001439" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=Efficacy+and+safety+of+tranexamic+acid+in+prevention+of+postpartum+hemorrhage:+a+systematic+review+and+meta-analysis+of+18,649+patients+&amp;author=NM+Al-Dardery&amp;author=OA+Abdelwahab&amp;author=M+Abouzid&amp;author=K+Albakri&amp;author=A+Elkhadragy&amp;author=BE+Katamesh&amp;publication_year=2023&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0172"> <div class="citation-journal">172. Assis IC, Goveia CS, Miranda D, Ferreira RS, Riccio LG. <span class="citation-title">Analysis of the efficacy of prophylactic tranexamic acid in preventing postpartum bleeding: systematic review with meta-analysis of randomized clinical trials</span>. <span class="citation"> Brazilian Journal of Anesthesiology </span><span class="pubYear">2023</span>;<span class="volume">73</span>(4):467-76. <ul class="citation-link-group"> <li> <a class="citation-link" href="https://www.ncbi.nlm.nih.gov/pubmed/35995323" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=Analysis+of+the+efficacy+of+prophylactic+tranexamic+acid+in+preventing+postpartum+bleeding:+systematic+review+with+meta-analysis+of+randomized+clinical+trials+&amp;author=IC+Assis&amp;author=CS+Goveia&amp;author=D+Miranda&amp;author=RS+Ferreira&amp;author=LG+Riccio&amp;publication_year=2023&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0173"> <div class="citation-journal">173. Cheema HA, Ahmad AB, Ehsan M, Shahid A, Ayyan M, Azeem S, et al. <span class="citation-title">Tranexamic acid for the prevention of blood loss after cesarean section: an updated systematic review and meta-analysis of randomized controlled trials</span>. <span class="citation"> American Journal of Obstetrics &amp; Gynecology MFM </span><span class="pubYear">2023</span>;<span class="volume">5</span>(8):101049. <ul class="citation-link-group"> <li> <a class="citation-link" href="https://doi.org/10.1016/j.ajogmf.2023.101049" target="_blank"> <span>Link to article</span> </a> </li> <li> <a class="citation-link" href="https://www.ncbi.nlm.nih.gov/pubmed/37311484" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=Tranexamic+acid+for+the+prevention+of+blood+loss+after+cesarean+section:+an+updated+systematic+review+and+meta-analysis+of+randomized+controlled+trials+&amp;author=HA+Cheema&amp;author=AB+Ahmad&amp;author=M+Ehsan&amp;author=A+Shahid&amp;author=M+Ayyan&amp;author=S+Azeem&amp;publication_year=2023&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0174"> <div class="citation-journal">174. Ferrari FA, Garzon S, Raffaelli R, Cromi A, Casarin J, Ghezzi F, et al. <span class="citation-title">Tranexamic acid for the prevention and the treatment of primary postpartum haemorrhage: a systematic review</span>. <span class="citation"> Journal of Obstetrics and Gynaecology </span><span class="pubYear">2022</span>;<span class="volume">42</span>(5):1-13. <ul class="citation-link-group"> <li> <a class="citation-link" href="https://doi.org/10.1080/01443615.2021.2013784" target="_blank"> <span>Link to article</span> </a> </li> <li> <a class="citation-link" href="https://www.ncbi.nlm.nih.gov/pubmed/33938346" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=Tranexamic+acid+for+the+prevention+and+the+treatment+of+primary+postpartum+haemorrhage:+a+systematic+review+&amp;author=FA+Ferrari&amp;author=S+Garzon&amp;author=R+Raffaelli&amp;author=A+Cromi&amp;author=J+Casarin&amp;author=F+Ghezzi&amp;publication_year=2022&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0175"> <div class="citation-journal">175. Lee AL, Wang M, Roy D, Wang J, Gokhale A, Miranda-Cacdac L, et al. <span class="citation-title">Prophylactic tranexamic acid prevents postpartum hemorrhage and transfusions in cesarean deliveries: a systematic review and meta-analysis</span>. <span class="citation"> American Journal of Perinatology </span><span class="pubYear">2024</span>;<span class="volume">41</span>(S 01):e2254-e2268. [DOI: <a href="http://dx.doi.org/10.1055/a-2109-3730" target="_blank"><span>10.1055/a-2109-3730</span></a>] [PMID: 37311543] <ul class="citation-link-group"> <li> <a class="citation-link" href="https://doi.org/10.1055/a-2109-3730" target="_blank"> <span>Link to article</span> </a> </li> <li> <a class="citation-link" href="https://www.ncbi.nlm.nih.gov/pubmed/37311543" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=Prophylactic+tranexamic+acid+prevents+postpartum+hemorrhage+and+transfusions+in+cesarean+deliveries:+a+systematic+review+and+meta-analysis+&amp;author=AL+Lee&amp;author=M+Wang&amp;author=D+Roy&amp;author=J+Wang&amp;author=A+Gokhale&amp;author=L+Miranda-Cacdac&amp;publication_year=2024&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0176"> <div class="citation-journal">176. Yang F, Wang H, Shen M. <span class="citation-title">Effect of preoperative prophylactic intravenous tranexamic acid on perioperative blood loss control in patients undergoing cesarean delivery: a systematic review and meta-analysis</span>. <span class="citation"> BioMed Central Pregnancy and Childbirth </span><span class="pubYear">2023</span>;<span class="volume">23</span>(1):420. <ul class="citation-link-group"> <li> <a class="citation-link" href="https://doi.org/10.1186/s12884-023-05753-9" target="_blank"> <span>Link to article</span> </a> </li> <li> <a class="citation-link" href="https://www.ncbi.nlm.nih.gov/pubmed/37280562" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=Effect+of+preoperative+prophylactic+intravenous+tranexamic+acid+on+perioperative+blood+loss+control+in+patients+undergoing+cesarean+delivery:+a+systematic+review+and+meta-analysis+&amp;author=F+Yang&amp;author=H+Wang&amp;author=M+Shen&amp;publication_year=2023&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0177"> <div class="citation-journal">177. Henry DA, Carless PA, Moxey AJ, O'Connell D, Stokes BJ, Fergusson DA, et al. <span class="citation-title">Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion</span>. <span class="citation"> Cochrane Database of Systematic Reviews </span><span class="pubYear">2011</span>, Issue 3. Art. No: CD001886. [DOI: <a href="http://dx.doi.org/10.1002/14651858.CD001886.pub4" target="_blank"><span>10.1002/14651858.CD001886.pub4</span></a>] <ul class="citation-link-group"> <li> <a class="citation-link" href="https://doi.org/10.1002/14651858.CD001886.pub3" target="_blank"> <span>Link to article</span> </a> </li> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=Anti-fibrinolytic+use+for+minimising+perioperative+allogeneic+blood+transfusion&amp;author=DA+Henry&amp;author=PA+Carless&amp;author=AJ+Moxey&amp;author=D+O'Connell&amp;author=BJ+Stokes&amp;author=DA+Fergusson&amp;publication_year=2011&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0178"> <div class="citation-journal">178. CRASH-2 trial collaborators, Shakur H, Roberts I, Bautista R, Caballero J, Coats T, et al. <span class="citation-title">Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial</span>. <span class="citation"> Lancet </span><span class="pubYear">2010</span>;<span class="volume">376</span>(9734):23-32. [DOI: <a href="http://dx.doi.org/10.1016/S0140-6736(10)60835-5" target="_blank"><span>10.1016/S0140-6736(10)60835-5</span></a>] <ul class="citation-link-group"> <li> <a class="citation-link" href="https://www.ncbi.nlm.nih.gov/pubmed/20554319" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=Effects+of+tranexamic+acid+on+death,+vascular+occlusive+events,+and+blood+transfusion+in+trauma+patients+with+significant+haemorrhage+(CRASH-2):+a+randomised,+placebo-controlled+trial+&amp;author=H+Shakur&amp;author=I+Roberts&amp;author=R+Bautista&amp;author=J+Caballero&amp;author=T+Coats&amp;publication_year=2010&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0179"> <div class="citation-journal">179. Gandhi R, Evans HM, Mahomed SR, Mahomed NN. <span class="citation-title">Tranexamic acid and reduction of blood loss in total knee and hip arthroplasty: a meta-analysis</span>. <span class="citation"> BMC Research Notes </span><span class="pubYear">2013</span>;<span class="volume">6</span>:184. <ul class="citation-link-group"> <li> <a class="citation-link" href="https://doi.org/10.1186/1756-0500-6-184" target="_blank"> <span>Link to article</span> </a> </li> <li> <a class="citation-link" href="https://www.ncbi.nlm.nih.gov/pubmed/23651507" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=Tranexamic+acid+and+reduction+of+blood+loss+in+total+knee+and+hip+arthroplasty:+a+meta-analysis+&amp;author=R+Gandhi&amp;author=HM+Evans&amp;author=SR+Mahomed&amp;author=NN+Mahomed&amp;publication_year=2013&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0180"> <div class="citation-journal">180. Ker K, Edwards P, Perel P, Shakur H, Roberts I. <span class="citation-title">Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysis</span>. <span class="citation"> BMJ </span><span class="pubYear">2012</span>;<span class="volume">344</span>:e3054. <ul class="citation-link-group"> <li> <a class="citation-link" href="https://doi.org/10.1136/bmj.e3054" target="_blank"> <span>Link to article</span> </a> </li> <li> <a class="citation-link" href="https://www.ncbi.nlm.nih.gov/pubmed/22611164" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=Effect+of+tranexamic+acid+on+surgical+bleeding:+systematic+review+and+cumulative+meta-analysis&amp;author=K+Ker&amp;author=P+Edwards&amp;author=P+Perel&amp;author=H+Shakur&amp;author=I+Roberts&amp;publication_year=2012&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0181"> <div class="citation-journal">181. Poeran J, Rasul R, Suzuki S, Danninger T, Opperer, Boettner F, et al. <span class="citation-title">Tranexamic acid use and postoperative outcomes in patients undergoing total hip or knee arthroplasty in the United States: retrospective analysis of effectiveness and safety</span>. <span class="citation"> BMJ (Clinical Research Ed.) </span><span class="pubYear">2014</span>;<span class="volume">349</span>:4829. <ul class="citation-link-group"> <li> <a class="citation-link" href="https://doi.org/10.1136/bmj.g4829" target="_blank"> <span>Link to article</span> </a> </li> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=Tranexamic+acid+use+and+postoperative+outcomes+in+patients+undergoing+total+hip+or+knee+arthroplasty+in+the+United+States:+retrospective+analysis+of+effectiveness+and+safety+&amp;author=J+Poeran&amp;author=R+Rasul&amp;author=S+Suzuki&amp;author=T+Danninger&amp;author=F+Boettner&amp;publication_year=2014&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0182"> <div class="citation-journal">182. Mergoum AM, Mergoum AS, Larson NJ, Dries DJ, Cook A, Blondeau B, et al. <span class="citation-title">Tranexamic acid use in the surgical arena: a narrative review</span>. <span class="citation"> Journal of Surgical Research </span><span class="pubYear">2024</span>;<span class="volume">5</span>:302:208-2210. <ul class="citation-link-group"> <li> <a class="citation-link" href="https://doi.org/10.1016/j.jss.2024.07.042" target="_blank"> <span>Link to article</span> </a> </li> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=Tranexamic+acid+use+in+the+surgical+arena:+a+narrative+review&amp;author=AM+Mergoum&amp;author=AS+Mergoum&amp;author=NJ+Larson&amp;author=DJ+Dries&amp;author=A+Cook&amp;author=B+Blondeau&amp;publication_year=2024&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0183"> <div class="citation-journal">183. Ducloy-Bouthors AS, Jude B, Duhamel A, Broisin F, Huissoud C, Keita-Meyer, et al. <span class="citation-title">High-dose tranexamic acid reduces blood loss in postpartum haemorrhage</span>. <span class="citation"> Critical Care (London, England) </span><span class="pubYear">2011</span>;<span class="volume">15</span>:R177. <ul class="citation-link-group"> <li> <a class="citation-link" href="https://doi.org/10.1186/cc10143" target="_blank"> <span>Link to article</span> </a> </li> <li> <a class="citation-link" href="https://www.ncbi.nlm.nih.gov/pubmed/21791090" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=High-dose+tranexamic+acid+reduces+blood+loss+in+postpartum+haemorrhage&amp;author=AS+Ducloy-Bouthors&amp;author=B+Jude&amp;author=A+Duhamel&amp;author=F+Broisin&amp;author=C+Huissoud&amp;publication_year=2011&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0184"> <div class="citation-journal">184. Peitsidis P, Kadir RA. <span class="citation-title">Antifibrinolytic therapy with tranexamic acid in pregnancy and postpartum</span>. <span class="citation"> Expert Opinion on Pharmacotherapy </span><span class="pubYear">2011</span>;<span class="volume">12</span>(4):503-16. <ul class="citation-link-group"> <li> <a class="citation-link" href="https://doi.org/10.1517/14656566.2011.545818" target="_blank"> <span>Link to article</span> </a> </li> <li> <a class="citation-link" href="https://www.ncbi.nlm.nih.gov/pubmed/21294602" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=Antifibrinolytic+therapy+with+tranexamic+acid+in+pregnancy+and+postpartum&amp;author=P+Peitsidis&amp;author=RA+Kadir&amp;publication_year=2011&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="nrf-reference-section" id="CD016278-bib-0185"> <div class="citation-journal">185. Moran NF, Bishop DG, Fawcus S, Morris E, Shakur-Still H, Devall AJ, et al. <span class="citation-title">Tranexamic acid at cesarean delivery: drug-error deaths</span>. <span class="citation"> British Journal of Obstetrics and Gynaecology </span><span class="pubYear">2023</span>;<span class="volume">130</span>(1):114-7. [DOI: <a href="http://dx.doi.org/10.1111/1471-0528" target="_blank"><span>10.1111/1471-0528</span></a>] <ul class="citation-link-group"> <li> <a class="citation-link" href="https://doi.org/10.1111/1471-0528.17292" target="_blank"> <span>Link to article</span> </a> </li> <li> <a class="citation-link" href="https://www.ncbi.nlm.nih.gov/pubmed/36300729" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="https://scholar.google.com/scholar_lookup?title=Tranexamic+acid+at+cesarean+delivery:+drug-error+deaths&amp;author=NF+Moran&amp;author=DG+Bishop&amp;author=S+Fawcus&amp;author=E+Morris&amp;author=H+Shakur-Still&amp;author=AJ+Devall&amp;publication_year=2023&amp;hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> </section> <div class="disclaimer"> <div class="full_disclaimer"> <p> <i>The content of this article (as distinct from the content of the ‘Supplementary materials’, ‘Related’ and ‘About this Review’ sections) has been peer reviewed and prepared for publication in accordance with</i> <a href="https://www.cochranelibrary.com/cdsr/editorial-policies" target="_blank"> <i>Cochrane’s editorial policies</i></a> <i>. Though the aim of these processes is, among other things, to check the accuracy of such content, responsibility for the content remains that of the author(s) and Cochrane gives no representations or warranties of any kind in relation to, and accepts no liability for any reliance on or use of, the content of the article.</i> </p> </div> </div> <div class="figures-list"> <div class="figure" id="CD016278-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD016278/media/CDSR/CD016278/urn:x-wiley:14651858:media:CD016278:CD016278-FIG-01" target="_blank"><b></b></a></p> </div><img alt="Applying the trustworthiness screening tool criteria. No Copyright, reproduced with permission from author Zarko Alfirevic. Alfirevic Z, Kellie FJ, Weeks J, Stewart F, Jones L, Hampson L, on behalf of the Pregnancy and Childbirth Editorial Board. Identifying and handling potentially untrustworthy trials – Trustworthiness Screening Tool (TST) developed by the Cochrane Pregnancy and Childbirth Group. Version 3.0. 2023." data-id="CD016278-fig-0001" src="/cdsr/doi/10.1002/14651858.CD016278/media/CDSR/CD016278/image_n/nCD016278-FIG-01.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD016278/media/CDSR/CD016278/image_t/tCD016278-FIG-01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Applying the trustworthiness screening tool criteria. No Copyright, reproduced with permission from author Zarko Alfirevic. Alfirevic Z, Kellie FJ, Weeks J, Stewart F, Jones L, Hampson L, on behalf of the Pregnancy and Childbirth Editorial Board. Identifying and handling potentially untrustworthy trials – Trustworthiness Screening Tool (TST) developed by the Cochrane Pregnancy and Childbirth Group. Version 3.0. 2023. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD016278/full#CD016278-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD016278/media/CDSR/CD016278/image_n/nCD016278-FIG-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD016278-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD016278/media/CDSR/CD016278/urn:x-wiley:14651858:media:CD016278:CD016278-FIG-02" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD016278-fig-0002" src="/cdsr/doi/10.1002/14651858.CD016278/media/CDSR/CD016278/image_n/nCD016278-FIG-02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD016278/media/CDSR/CD016278/image_t/tCD016278-FIG-02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD016278/full#CD016278-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD016278/media/CDSR/CD016278/image_n/nCD016278-FIG-02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD016278-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD016278/media/CDSR/CD016278/urn:x-wiley:14651858:media:CD016278:CD016278-FIG-03" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD016278-fig-0003" src="/cdsr/doi/10.1002/14651858.CD016278/media/CDSR/CD016278/image_n/nCD016278-FIG-03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD016278/media/CDSR/CD016278/image_t/tCD016278-FIG-03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD016278/full#CD016278-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD016278/media/CDSR/CD016278/image_n/nCD016278-FIG-03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD016278-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD016278/media/CDSR/CD016278/urn:x-wiley:14651858:media:CD016278:CD016278-FIG-04" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD016278-fig-0004" src="/cdsr/doi/10.1002/14651858.CD016278/media/CDSR/CD016278/image_n/nCD016278-FIG-04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD016278/media/CDSR/CD016278/image_t/tCD016278-FIG-04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD016278/full#CD016278-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD016278/media/CDSR/CD016278/image_n/nCD016278-FIG-04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD016278-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD016278/media/CDSR/CD016278/urn:x-wiley:14651858:media:CD016278:CD016278-FIG-05" target="_blank"><b></b></a></p> </div><img alt="Forest plot (1.1 Estimated blood loss ≥ 1000 mL)." data-id="CD016278-fig-0005" src="/cdsr/doi/10.1002/14651858.CD016278/media/CDSR/CD016278/image_n/nCD016278-FIG-05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD016278/media/CDSR/CD016278/image_t/tCD016278-FIG-05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 5</div> <div class="figure-caption"> <p>Forest plot (1.1 Estimated blood loss ≥ 1000 mL).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD016278/full#CD016278-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD016278/media/CDSR/CD016278/image_n/nCD016278-FIG-05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD016278-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD016278/media/CDSR/CD016278/urn:x-wiley:14651858:media:CD016278:CD016278-FIG-06" target="_blank"><b></b></a></p> </div><img alt="Sensitivity analysis." data-id="CD016278-fig-0006" src="/cdsr/doi/10.1002/14651858.CD016278/media/CDSR/CD016278/image_n/nCD016278-FIG-06.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD016278/media/CDSR/CD016278/image_t/tCD016278-FIG-06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 6</div> <div class="figure-caption"> <p>Sensitivity analysis.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD016278/full#CD016278-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD016278/media/CDSR/CD016278/image_n/nCD016278-FIG-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD016278-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD016278/media/CDSR/CD016278/urn:x-wiley:14651858:media:CD016278:CD016278-FIG-07" target="_blank"><b></b></a></p> </div><img alt="Forest plot (1.2 Calculated blood loss ≥ 1000 mL)." data-id="CD016278-fig-0007" src="/cdsr/doi/10.1002/14651858.CD016278/media/CDSR/CD016278/image_n/nCD016278-FIG-07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD016278/media/CDSR/CD016278/image_t/tCD016278-FIG-07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 7</div> <div class="figure-caption"> <p>Forest plot (1.2 Calculated blood loss ≥ 1000 mL).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD016278/full#CD016278-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD016278/media/CDSR/CD016278/image_n/nCD016278-FIG-07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD016278-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD016278/media/CDSR/CD016278/urn:x-wiley:14651858:media:CD016278:CD016278-FIG-08" target="_blank"><b></b></a></p> </div><img alt="Forest plot (1.2 Maternal death)." data-id="CD016278-fig-0008" src="/cdsr/doi/10.1002/14651858.CD016278/media/CDSR/CD016278/image_n/nCD016278-FIG-08.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD016278/media/CDSR/CD016278/image_t/tCD016278-FIG-08.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 8</div> <div class="figure-caption"> <p>Forest plot (1.2 Maternal death).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD016278/full#CD016278-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD016278/media/CDSR/CD016278/image_n/nCD016278-FIG-08.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD016278-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD016278/media/CDSR/CD016278/urn:x-wiley:14651858:media:CD016278:CD016278-FIG-09" target="_blank"><b></b></a></p> </div><img alt="Forest plot (1.4 Blood transfusion)." data-id="CD016278-fig-0009" src="/cdsr/doi/10.1002/14651858.CD016278/media/CDSR/CD016278/image_n/nCD016278-FIG-09.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD016278/media/CDSR/CD016278/image_t/tCD016278-FIG-09.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 9</div> <div class="figure-caption"> <p>Forest plot (1.4 Blood transfusion).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD016278/full#CD016278-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD016278/media/CDSR/CD016278/image_n/nCD016278-FIG-09.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD016278-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD016278/media/CDSR/CD016278/urn:x-wiley:14651858:media:CD016278:CD016278-FIG-10" target="_blank"><b></b></a></p> </div><img alt="Forest plot (1.5 Receipt of additional surgical intervention to control PPH)." data-id="CD016278-fig-0010" src="/cdsr/doi/10.1002/14651858.CD016278/media/CDSR/CD016278/image_n/nCD016278-FIG-10.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD016278/media/CDSR/CD016278/image_t/tCD016278-FIG-10.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 10</div> <div class="figure-caption"> <p>Forest plot (1.5 Receipt of additional surgical intervention to control PPH).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD016278/full#CD016278-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD016278/media/CDSR/CD016278/image_n/nCD016278-FIG-10.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD016278-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD016278/media/CDSR/CD016278/urn:x-wiley:14651858:media:CD016278:CD016278-FIG-11" target="_blank"><b></b></a></p> </div><img alt="Forest plot (1.7 Thrombembolic events)." data-id="CD016278-fig-0011" src="/cdsr/doi/10.1002/14651858.CD016278/media/CDSR/CD016278/image_n/nCD016278-FIG-11.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD016278/media/CDSR/CD016278/image_t/tCD016278-FIG-11.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 11</div> <div class="figure-caption"> <p>Forest plot (1.7 Thrombembolic events).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD016278/full#CD016278-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD016278/media/CDSR/CD016278/image_n/nCD016278-FIG-11.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD016278-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD016278/media/CDSR/CD016278/urn:x-wiley:14651858:media:CD016278:CD016278-FIG-12" target="_blank"><b></b></a></p> </div><img alt="Forest plot (1.8 Receipt of additional uterotonics)." data-id="CD016278-fig-0012" src="/cdsr/doi/10.1002/14651858.CD016278/media/CDSR/CD016278/image_n/nCD016278-FIG-12.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD016278/media/CDSR/CD016278/image_t/tCD016278-FIG-12.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 12</div> <div class="figure-caption"> <p>Forest plot (1.8 Receipt of additional uterotonics).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD016278/full#CD016278-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD016278/media/CDSR/CD016278/image_n/nCD016278-FIG-12.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD016278-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD016278/media/CDSR/CD016278/urn:x-wiley:14651858:media:CD016278:CD016278-FIG-13" target="_blank"><b></b></a></p> </div><img alt="Forest plot (1.8 Hysterectomy)." data-id="CD016278-fig-0013" src="/cdsr/doi/10.1002/14651858.CD016278/media/CDSR/CD016278/image_n/nCD016278-FIG-13.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD016278/media/CDSR/CD016278/image_t/tCD016278-FIG-13.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 13</div> <div class="figure-caption"> <p>Forest plot (1.8 Hysterectomy).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD016278/full#CD016278-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD016278/media/CDSR/CD016278/image_n/nCD016278-FIG-13.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD016278-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD016278/media/CDSR/CD016278/urn:x-wiley:14651858:media:CD016278:CD016278-FIG-14" target="_blank"><b></b></a></p> </div><img alt="Forest plot (1.12 Clinical diagnosis of PPH)." data-id="CD016278-fig-0014" src="/cdsr/doi/10.1002/14651858.CD016278/media/CDSR/CD016278/image_n/nCD016278-FIG-14.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD016278/media/CDSR/CD016278/image_t/tCD016278-FIG-14.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 14</div> <div class="figure-caption"> <p>Forest plot (1.12 Clinical diagnosis of PPH).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD016278/full#CD016278-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD016278/media/CDSR/CD016278/image_n/nCD016278-FIG-14.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD016278-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD016278/media/CDSR/CD016278/urn:x-wiley:14651858:media:CD016278:CD016278-FIG-15" target="_blank"><b></b></a></p> </div><img alt="Forest plot (1.13 Estimated mean blood loss (mL))." data-id="CD016278-fig-0015" src="/cdsr/doi/10.1002/14651858.CD016278/media/CDSR/CD016278/image_n/nCD016278-FIG-15.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD016278/media/CDSR/CD016278/image_t/tCD016278-FIG-15.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 15</div> <div class="figure-caption"> <p>Forest plot (1.13 Estimated mean blood loss (mL)).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD016278/full#CD016278-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD016278/media/CDSR/CD016278/image_n/nCD016278-FIG-15.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD016278-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD016278/media/CDSR/CD016278/urn:x-wiley:14651858:media:CD016278:CD016278-FIG-16" target="_blank"><b></b></a></p> </div><img alt="Forest plot (1.14 Calculated mean blood loss (mL))." data-id="CD016278-fig-0016" src="/cdsr/doi/10.1002/14651858.CD016278/media/CDSR/CD016278/image_n/nCD016278-FIG-16.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD016278/media/CDSR/CD016278/image_t/tCD016278-FIG-16.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 16</div> <div class="figure-caption"> <p>Forest plot (1.14 Calculated mean blood loss (mL)).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD016278/full#CD016278-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD016278/media/CDSR/CD016278/image_n/nCD016278-FIG-16.svg" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD016278-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Summary of findings table ‐ Prophylactic tranexamic acid in addition to standard care compared to placebo with standard care or standard care alone in women having caesarean births</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Prophylactic tranexamic acid in addition to standard care compared to placebo with standard care or standard care alone in women having caesarean births</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> women having caesarean births<br/><b>Setting:</b> hospitals (mainly in high‐resource settings)<br/><b>Intervention:</b> prophylactic tranexamic acid in addition to standard care<br/><b>Comparison:</b> placebo with standard care or standard care alone </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p>Outcomes</p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p>Anticipated absolute effects<sup>*</sup> (95% CI) </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p>Relative effect<br/>(95% CI) </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p>№ of participants<br/>(studies) </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p>Certainty of the evidence<br/>(GRADE) </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p>Comments</p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p>Risk with placebo with standard care or standard care alone</p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p>Risk with prophylactic tranexamic acid in addition to standard care</p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Estimated blood loss ≥ 1000 mL ‐ total</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>142 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>133 per 1000</b><br/>(112 to 157) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.94</b><br/>(0.79 to 1.11) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13042<br/>(4 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/>High </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Prophylactic tranexamic acid in addition to standard care results in little to no difference in estimated blood loss ≥ 1000 mL. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Calculated blood loss ≥ 1000 mL</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>312 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>259 per 1000</b><br/>(237 to 287) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.83</b><br/>(0.76 to 0.92) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4327<br/>(2 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/>Moderate<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Prophylactic tranexamic acid in addition to standard care likely results in a slight reduction in calculated blood loss ≥ 1000 mL. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Maternal death</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>1 per 10,000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>0 per 10,000</b><br/>(0 to 10) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.33</b><br/>(0.01 to 8.10) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15858<br/>(6 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>Very low<sup>b,</sup><sup>c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The evidence is very uncertain about the effect of tranexamic acid on maternal death. Our findings are based on one event in one trial. Five other trials that measured this outcome reported no deaths in either study arm. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Severe morbidity</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Not pooled</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Not pooled</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not pooled</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(0 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No studies measured this outcome.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Blood transfusion</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>36 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>31 per 1000</b><br/>(26 to 38) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.88</b><br/>(0.72 to 1.08) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15740<br/>(5 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/>Moderate<sup>b,</sup><sup>d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Tranexamic acid likely results in little to no difference in blood transfusion.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Receipt of surgical interventions to control PPH</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>31 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>31 per 1000</b><br/>(27 to 38) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.02</b><br/>(0.86 to 1.22) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15631<br/>(4 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/>High<sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Tranexamic acid results in little to no difference in use of surgical interventions to control postpartum haemorrhage. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Thromboembolic events</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>2 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>3 per 1000</b><br/>(0 to 19) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.40</b><br/>(0.22 to 8.90) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>14480<br/>(4 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>Very low<sup>e,</sup><sup>f</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The evidence is very uncertain about the effect of tranexamic acid on thromboembolic events. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Receipt of additional uterotonics</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>121 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>107 per 1000</b><br/>(95 to 121) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.88</b><br/>(0.78 to 1.00) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15728<br/>(4 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/>High </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Tranexamic acid results in little to no difference in receipt of additional uterotonics.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hysterectomy</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>13 per 10,000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>11 per 10,000</b><br/>(3 to 44) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.80</b><br/>(0.20 to 3.29) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4546<br/>(2 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>Very low<sup>g,</sup><sup>h</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The evidence is very uncertain about the effect of tranexamic acid in addition to standard care on hysterectomy. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Maternal satisfaction</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Not pooled</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Not pooled</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not pooled</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(0 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>One study measured this outcome using a Likert scale questionnaire with no difference between groups. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Breastfeeding at discharge</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Not pooled</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Not pooled</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not pooled</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(0 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No studies measured this outcome.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> confidence interval; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>See interactive version of this table: <a href="https://gdt.gradepro.org/presentations/#/isof/isof_question_revman_web_450054892459696039" target="_blank">https://gdt.gradepro.org/presentations/#/isof/isof_question_revman_web_450054892459696039</a>. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup> Study limitations: concerns about accuracy of measurement of blood loss as the calculated method is dependent on normovolaemia. Tranexamic acid has effects on both the endothelium and renal function which may affect intravascular volume and cause changes in haematocrit/haemoglobin concentrations unrelated to blood loss.<br/><sup>b</sup> No serious concerns about study limitations: studies with unclear or high risk of performance and/or detection bias contributed very little to the overall effect. <br/><sup>c</sup> Extremely serious concerns about imprecision: the 95% confidence interval includes both suggested appreciable benefit and harm. Death was a rare event with one study reporting an event. Five studies reported no death in either study arm. Downgrade by three levels.<br/><sup>d</sup> Serious concern about imprecision: the 95% confidence interval includes both suggested appreciable harm and benefit. Downgrade by one level.<br/><sup>e</sup> Serious concern about inconsistency: statistical heterogeneity present. Two studies show inconsistent direction of effect. Downgrade by one level.<br/><sup>f</sup> Very serious imprecision: the 95% confidence interval includes both suggested appreciable harm and benefit. Downgrade by two levels.<br/><sup>g</sup> No serious concerns about study limitations: knowledge of intervention received unlikely to influence surgical intervention. <br/><sup>h</sup> Extremely serious imprecision: the confidence interval is very wide and crosses both suggested appreciable harm and benefit. Downgrade by three levels. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Summary of findings table ‐ Prophylactic tranexamic acid in addition to standard care compared to placebo with standard care or standard care alone in women having caesarean births</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD016278/full#CD016278-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD016278-tbl-0002"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Overview of included studies and synthesis table</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p>Study ID</p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p>Trial registration number</p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p>Country</p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p>Participants</p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p>Intervention</p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p>Control</p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p>Additional interventions</p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p>Outcomes</p> </th> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p>Alam 2023</p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NCT03069859</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Canada</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Women giving birth vaginally or via CB (elective or urgent), gestational age ≥ 32 weeks. Women at low risk of PPH; n= 27 total (15 VB and 12 CB) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD016278-list-0017"> <li> <p>Tranexamic acid</p> </li> <li> <p>1 g</p> </li> <li> <p>IVI</p> </li> <li> <p>At time of shoulder delivery (VB) or during surgical site skin preparation (CB)</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Standardised protocol for oxytocin, additional uterotonics at the discretion of the physician </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD016278-list-0018"> <li> <p>PPH defined as blood loss &gt; 1000 mL</p> </li> <li> <p>Severe PPH</p> </li> <li> <p>Blood transfusion within 48 hours</p> </li> <li> <p>Emergency hysterectomy</p> </li> <li> <p>Other operative intervention</p> </li> <li> <p>Admission to ICU</p> </li> <li> <p>Safety‐related secondary outcomes</p> </li> </ul> </p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p>Lee 2023</p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NCT04427618</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Singapore</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Women ≥ 21 years old undergoing elective CB. Women at low and at high risk of PPH (44 women at high risk and 54 at low risk in the placebo group; 37 women at high risk and 59 at low risk in the TXA group; n = 200) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD016278-list-0019"> <li> <p>Tranexamic acid</p> </li> <li> <p>1 g</p> </li> <li> <p>IVI</p> </li> <li> <p>10 minutes prior to skin incision</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5 IU of oxytocin IV on delivery of baby</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD016278-list-0020"> <li> <p>Calculated estimated blood loss (cEBL)</p> </li> <li> <p>Gravimetrically estimated of blood loss</p> </li> <li> <p>Provider‐estimated blood loss</p> </li> <li> <p>Need for additional medical interventions (additional uterotonics, additional TXA, blood transfusion) </p> </li> <li> <p>Need for additional surgical interventions</p> </li> <li> <p>Maternal and neonatal adverse event</p> </li> </ul> </p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p>Ogunkua 2022</p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NCT03856164</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>USA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Women ≥ 18 years old with singleton, term pregnancies, with elective repeat CB (second or third). Women at low risk of PPH; n = 110 </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD016278-list-0021"> <li> <p>Tranexamic acid</p> </li> <li> <p>1 g x 2 (before and after delivery)</p> </li> <li> <p>IVI</p> </li> <li> <p>10 minutes prior to skin incision and immediately following placental delivery</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Oxytocin infusion on delivery of baby (all participants)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD016278-list-0022"> <li> <p>Mean calculated blood loss at 24 hours</p> </li> <li> <p>Provider‐estimated blood loss</p> </li> </ul> </p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p>Pacheco 2023</p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NCT03364491</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>USA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Women ≥ 18 years old, giving birth by scheduled or unscheduled caesarean section. Women at low risk of PPH; n = 11,000 </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD016278-list-0023"> <li> <p>Tranexamic acid</p> </li> <li> <p>1 g</p> </li> <li> <p>IVI</p> </li> <li> <p>Immediately after cord clamping</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>At the dicretion of the physician. Not clear whether all women received oxytocin or not </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD016278-list-0024"> <li> <p>Maternal death or blood transfusion before hospital discharge or 7 days' postpartum, whichever occurred first </p> </li> <li> <p>Estimated blood loss &gt; 1000 mL</p> </li> <li> <p>Intervention in response to bleeding and related complications</p> </li> <li> <p>Surgical or radiologic intervention</p> </li> <li> <p>Blood transfusion</p> </li> <li> <p>Thromboembolic events</p> </li> <li> <p>New‐onset seizures</p> </li> <li> <p>Admission to ICU for more than 24 h</p> </li> <li> <p>Side effects (nausea, vomiting, dizziness)</p> </li> </ul> </p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p>Sentilhes 2021</p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NCT03431805</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>France</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Women ≥ 18 years old, singleton or multiple pregnancy, 34 weeks and more gestational age, elective or emergency CB. Women at low risk of PPH; n = 4551 </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD016278-list-0025"> <li> <p>Tranexamic acid</p> </li> <li> <p>1 g</p> </li> <li> <p>IVI</p> </li> <li> <p>3 minutes after birth, after prophylactic uterotonic agent and cord had been clamped</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Prophylactic oxytocin (5 or 10 IU) or 100 μg carbetocin and additional prophylactic uterotonic agent if necessary </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD016278-list-0026"> <li> <p>Calculated estimated blood loss ≥ 1000 mL</p> </li> <li> <p>PPH</p> </li> <li> <p>Gravimetrically estimated blood loss</p> </li> <li> <p>Surgical intervention</p> </li> <li> <p>Transfusion</p> </li> <li> <p>Adverse events</p> </li> <li> <p>Maternal satisfaction</p> </li> </ul> </p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p>Shakur‐Still 2023</p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NCT04274335</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pakistan and Zambia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Women ≥ 18 years old giving birth by caesarean section. Women at high risk of PPH (1 or more risk factors for PPH); n = 120 </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD016278-list-0027"> <li> <p>Tranexamic acid</p> </li> <li> <p>IVI, IMI: 1 g</p> </li> <li> <p>Oral: 4 g</p> </li> <li> <p>1 hour before CB</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No intervention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All women received prophylactic uterotonics (details not reported).</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD016278-list-0028"> <li> <p>Blood loss</p> </li> <li> <p>Maternal death</p> </li> <li> <p>Use of additional uterotonics</p> </li> <li> <p>Adverse events</p> </li> </ul> </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="8"> <div class="table-footnote"> <p>CB: caesarean birth<br/>ICU: intensive care unit<br/>IMI: intramuscular injection<br/>IV: intravenous<br/>IVI: intravenous injection<br/>IU: international units<br/>PPH: postpartum haemorrhage<br/>TXA: tranexamic acid<br/>VB: vaginal birth </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Overview of included studies and synthesis table</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD016278/full#CD016278-tbl-0002">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD016278&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD016278-note-0003">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD016278-note-0008">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD016278-note-0006">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD016278-note-0007">Français</a> </li> <li class="section-language"> <a class="" href="ru#CD016278-note-0005">Русский</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD016278-note-0004">繁體中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD016278\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD016278\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD016278\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD016278"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD016278\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD016278\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD016278\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD016278\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD016278\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD016278"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD016278\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD016278\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD016278\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD016278"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD016278\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD016278\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD016278\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD016278"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=6nHUP32m&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD016278&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD016278';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD016278/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD016278/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD016278%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740717698452"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD016278/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740717698455"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD016278/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918dbe496bc2936b',t:'MTc0MDcxNzY5OC4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 